
| Product Name | CAS | MF | MW | Synonyms |
|---|---|---|---|---|
| 2,6-Diiodo-1,5,7-trimethyl-3-[4-(N,N-dimethylamino)phenylethenyl]-8-phenyl-4,4-difluoroboradiazasindacene | 1329012-12-5 | C28H26BF2I2N3 | 707.151 | |
| 2,6-Diiodo-1,5,7-trimethyl-3-[4-(N,N-dimethylamino)phenylethenyl]-8-(4-propargyloxyphenyl)-4,4-difluoroboradiazasindacene | 1608488-47-6 | C31H28BF2I2N3O | 761.2 | |
| 2,6-Diiodo-1,5,7-trimethyl-3-(4-propargyloxyphenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1632007-42-1 | C29H23BF2I2N2O | 718.131 | |
| 2,6-Diiodo-1,3,5,7-tetramethyl-8-phenyl-4,4-difluoroboradiazasindacene | 1083009-44-2 | C19H17BF2I2N2 | 575.974 | |
| 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4-pyridyl)-4,4-difluoroboradiazasindacene | 1434003-53-8 | C18H16BF2I2N3 | 576.962 | |
| 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4-propargyloxyphenyl)-4,4-difluoroboradiazasindacene | 1188931-06-7 | C22H19BI2F2N2O | 630.022 | |
| 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4-iodophenyl)-4,4-difluoroboradiazasindacene | 1031443-56-7 | C19H16BF2I3N2 | 701.871 | |
| 2,6-Diiodo-1,3,5,7-tetramethyl-8-(3-zaidopropyl)-4,4-difluoroboradiazasindacene | 1459727-95-7 | C16H18BF2I2N5 | 582.969 | |
| 2,6-Diiodo-1,3,5,7,8-pentaethyl-BODIPY | 1031443-55-6 | C14H15BF2I2N2 | 513.903 | |
| 2,5-Bis(4-biphenylyl)oxazole | 2083-09-2 | C27H19NO | 373.455 | 2,5-bis([1,1'-biphenyl]-4-yl)-oxazole |
| 2,4-Dichlorophenoxyacetic acid | 94-75-7 | C8H6Cl2O3 | 221.04 | 2-(2,4-dichlorophenoxy)acetic acid |
| L-2,4-Dichlorophenylalanine | 111119-36-9 | C9H9NO2Cl2 | 234.20 | L-Phe(2,4-DiCl)-OH; H-L-Phe(2,4-Cl2)-OH; (S)-2-Amino-3-(2,4-dichlorophenyl)propionic acid |
| 2,6-Diethoxycarbonyl-1,3,5,7-tetramethyl-8-(2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecin-15-yl)-4,4-difluoroboradiazasindacene | 314262-68-5 | C33H41BF2N2O9 | 658.504 | |
| 2,6-Dibromo-1,3,5,7-tetramethyl-8-(4-propargyloxyphenyl)-4,4-difluoroboradiazasindacene | 1357004-07-9 | C22H19BBr2F2N2O | 536.022 | |
| 2,5-Diphenyloxazole | 92-71-7 | C15H11NO | 221.259 | PPO |
| 2,5-dioxopyrrolidin-1-yl 7,10,13-trioxa-4-azahexadec-1-yn-16-oate | 1214319-94-4 | C16H24N2O7 | 356.37 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-(prop-2-ynylamino)ethoxy]ethoxy]ethoxy]propanoate; |
| 2,5-dioxopyrrolidin-1-yl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | 890409-85-5 | C15H18N2O4S2 | 354.439 | (2,5-dioxopyrrolidin-1-yl) 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate |
| 2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 663598-98-9 | C15H17N3O6S2 | 399.44 | (2,5-dioxopyrrolidin-1-yl) 4-methyl-4-[(5-nitropyridin-2-yl)disulfanyl]pentanoate; |
| 2,5-dioxopyrrolidin-1-yl 4-formylbenzoate | 60444-78-2 | C12H9NO5 | 247.20 | (2,5-dioxopyrrolidin-1-yl) 4-formylbenzoate; |
| 2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 663598-61-6 | C14H15N3O6S2 | 385.42 | (2,5-dioxopyrrolidin-1-yl) 4-[(5-nitropyridin-2-yl)disulfanyl]pentanoate; |
| 2,5-dioxopyrrolidin-1-yl 4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoate | 663599-05-1 | C16H19N3O5S2 | 397.47 | (2,5-dioxopyrrolidin-1-yl) 4-[[5-(dimethylcarbamoyl)pyridin-2-yl]disulfanyl]butanoate; |
| 2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate | 663599-10-8 | C17H21N3O5S2 | 411.50 | (2,5-dioxopyrrolidin-1-yl) 4-[[3-(dimethylcarbamoyl)pyridin-4-yl]disulfanyl]pentanoate; |
| 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate | 107348-47-0 | C13H14N2O4S2 | 326.39 | (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)butanoate |
| 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate | 1006592-59-1 | C22H34N2O7 | 438.52 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(undec-10-ynoylamino)ethoxy]ethoxy]propanoate; |
| 2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate | 1193111-73-7 | C15H19N3O4S2 | 369.46 | (2,5-dioxopyrrolidin-1-yl) 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate |
| 2,5-dioxopyrrolidin-1-yl 2-(cyclooct-2-ynyloxy)acetate | 1425803-45-7 | C14H17NO5 | 279.29 | (2,5-dioxopyrrolidin-1-yl) 2-cyclooct-2-yn-1-yloxyacetate; |
| 2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate | 1232769-29-7 | C22H30N2O12 | 514.48 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate; |
| 2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate | 1263044-88-7 | C26H31N3O11 | 561.54 | |
| 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)pentanoyloxy)pyrrolidine-3-sulfonic acid | 452072-27-4 | C14H16N2O7S3 | 420.48 | 2,5-dioxo-1-[4-(pyridin-2-yldisulfanyl)pentanoyloxy]pyrrolidine-3-sulfonic acid; |
| 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid | 1628113-16-5 | C13H14N2O7S3 | 406.45 | 2,5-dioxo-1-[4-(pyridin-2-yldisulfanyl)butanoyloxy]pyrrolidine-3-sulfonic acid; |
| 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid | 121115-30-8 | C12H12N2O7S3 | 392.43 | 2,5-dioxo-1-[3-(pyridin-2-yldisulfanyl)propanoyloxy]pyrrolidine-3-sulfonic acid; |
| 2,5-Dihydroxybenzaldehyde | 1194-98-5 | C7H6O3 | 138.12 | 2,5-dihydroxybenzaldehyde |
| 2,5-Dibromopyridine | 624-28-2 | C5H3Br2N | 236.89 | 2,5-Dibromo-pyridine; 3,6-Dibromopyridine; NSC 76597 |
| 2,5-Bis(5-tert-butyl-2-benzoxazolyl)thiophene | 7128-64-5 | C26H26N2O2S | 430.56 | 5-tert-butyl-2-[5-(5-tert-butyl-1,3-benzoxazol-2-yl)-2-thiophenyl]-1,3-benzoxazole; 5-tert-butyl-2-[5-(5-tert-butyl-1,3-benzoxazol-2-yl)thiophen-2-yl]-1,3-benzoxazole |
| 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-threonine | 130548-92-4 | C33H37NO14 | 671.66 | Fmoc-Thr(Beta-D-Glc(Ac)4)-OH; N-(9H-Fluorene-9-Ylmethoxycarbonyl)-O-(2-O,3-O,4-O,6-O-Tetraacetyl-Beta-D-Glucopyranosyl)-L-Threonine |
| 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-Fmoc serine | 118358-38-6 | C32H35NO14 | 657.63 | Fmoc-L-Ser(Beta-D-Glc(Ac)4)-OH; N-(9H-Fluorene-9-Ylmethoxycarbonyl)-O-(2-O,3-O,4-O,6-O-Tetraacetyl-Beta-D-Glucopyranosyl)-L-Serine |
| 2,4-Pyridinedicarboxylic acid monohydrate | 207671-42-9 | C7H5NO4 · H2O | 185.13 | pyridine-2,4-dicarboxylic acid;hydrate |
| trans,trans-2,4-Hexadienyl acetate | 1516-17-2 | C8H12O2 | 140.18 | [(2E,4E)-hexa-2,4-dienyl] acetate |
| trans,trans-2,4-Hexadienal | 142-83-6 | C6H8O | 96.13 | (2E,4E)-hexa-2,4-dienal |
| 2,4-Heptadienal | 4313-03-5 | C7H10O | 110.15 | (2E,4E)-hepta-2,4-dienal |
| 2,4-Dihydroxybenzoic acid | 89-86-1 | C7H6O4 | 154.12 | beta-Resorcylic acid; 4-Carboxyresorcinol |
| D-2,4-Dichlorophenylalanine | 114872-98-9 | C9H9NO2Cl2 | 234.08 | D-Phe(2,4-DiCl)-OH; H-D-Phe(2,4-Cl2)-OH; (R)-2-Amino-3-(2,4-dichlorophenyl)propionic acid |
| 2,4-Dichloro-DL-phenylalanine | 5472-68-4 | C9H9Cl2NO2 | 234.08 | H-DL-Phe(2,4-Cl2)-OH; 2-amino-3-(2,4-dichlorophenyl)propanoic acid |
| 2,4-Dichloro-3-nitroquinoline | 132521-66-5 | 2,4-dichloro-3-nitro-quinoline; Quinoline, 2,4-dichloro-3-nitro-; 2,4-dichloro-3-nitro quinoline | ||
| H-DL-Dab 2HCl | 65427-54-5 | C4H10N2O2·2HCl | 191.05 | DL-2,4-Diaminobutyric acid dihydrochloride; 2,4-diaminobutanoic acid dihydrochloride |
| 2,4-Diamino-6-hydroxypyrimidine | 56-06-4 | C4H6N4O | 126.12 | 2,4-diamino-1H-pyrimidin-6-one |
| 1,3,5-triazine-2,4-diamine | 504-08-5 | C3H5N5 | 111.108 | 1,3,5-triazine-2,4-diamine; 1,3,5-triazine-2,4-diamine |
| trans,trans-2,4-Decadienal | 25152-84-5 | C10H16O | 152.23 | (2E,4E)-deca-2,4-dienal |
| 2,4,6-Tris(4-aminophenyl)-1,3,5-triazine | 14544-47-9 | 4,4',4''-(1,3,5-Triazine-2,4,6-triyl)trianiline | ||
| 2,4,5-Trimethylthiazole | 13623-11-5 | C6H9NS | 127.21 | 2,4,5-trimethyl-1,3-thiazole |
| 2,4,5-Trimethoxybenzaldehyde | 4460-86-0 | C10H12O4 | 196.20 | 2,4,5-trimethoxybenzaldehyde |
| (S)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde | 22323-80-4 | C6H10O3 | 130.14 | (4S)-2,2-dimethyl-1,3-dioxolane-4-carboxaldehyde; (4S)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde |
| (R)-(+)-2,2-Dimethyl-1,3-dioxolane-4-carboxaldehyde | 15186-48-8 | C6H10O3 | 130.14 | (4R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde |
| 2',3'-Isopropylidene Adenosine | 362-75-4 | C13H17N5O4 | 307.31 | 2',3'-O-(1-Methylethylidene)adenosine; NSC 29413 |
| 2'',3,3',3'''-tetramethyl-1,1':4'1'':4'',1'''-quaterphenyl | 4575-13-7 | C28H26 | 362.51 | TMQ |
| 2,3-Dimethyl-6-nitro-2H-indazole | 444731-73-1 | C9H9N3O2 | 191.19 | 2,3-dimethyl-6-nitroindazole; 2,3-dimethyl-6-nitroindazole |
| 5,6,7,8-Tetrahydroquinoline | 10500-57-9 | C9H11N | 133.19 | 5,6,7,8-tetrahydroquinoline; 5,6,7,8-tetrahydroquinoline |
| Methyl 2-Fluoro-3-nitrobenzoate | 946126-94-9 | C8H6FNO4 | 199.14 | 2-fluoro-3-nitrobenzoic acid methyl ester; methyl 2-fluoro-3-nitrobenzoate |
| (-)-2,3:4,6-Di-O-isopropylidene-2-keto-L-gulonic Acid Monohydrate | 68539-16-2 | C12H20O8 | 292.28 | (1R,2S,6R,8S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[6.4.0.0^{2,6}]dodecane-6-carboxylic acid;hydrate; (1R,2S,6R,8S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[6.4.0.0^{2,6}]dodecane-6-carboxylic acid;hydrate |
| 2,3,7,8,12,13,17,18-tetrobenzeo-5,10,15,20-(tetraphenyl)porphyrin | 80528-89-8 | C60H38N4 | 814.992 | H2Tptbp; Tetraphenyltetrabenzoporphine; Meso-Tetraphenylbenzoporphyrin |
| 2,3,5-Triphenyltetrazolium Chloride | 298-96-4 | C19H15ClN4 | 334.80 | 2,3,5-triphenyltetrazol-2-ium;chloride; 2,3,5-triphenyltetrazol-2-ium;chloride |
| 2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone | 55094-52-5 | C26H26O5 | 418.48 | AK-77581 |
| 2,3,5,6-Tetramethylpyrazine | 1124-11-4 | C8H12N2 | 136.19 | 2,3,5,6-tetramethylpyrazine |
| 2,3,4,6-Tetra-O-benzyl-D-galactose | 53081-25-7 | C34H36O6 | 540.65 | (2R,3S,4S,5R)-5-hydroxy-2,3,4,6-tetrakis(phenylmethoxy)hexanal |
| 2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl-(N2-Fmoc)-L-threonine | 127656-85-3 | C33H37NO14 | 671.65 | Fmoc-L-Thr(beta-D-Gal(Ac)4)-OH |
| 2,2,5,5-Tetramethylimidazolidin-4-one | 16256-42-1 | 2,2,5,5-tetramethyl-4-oxoimidazolidine | ||
| 4-Bromo-6-methylpyridin-2-amine | 524718-27-2 | C6H7BrN2 | 187.04 | |
| 2,3,5-Triiodobenzoic acid | 88-82-4 | C7H3I3O2 | 499.81 | 2,3,5-triiodobenzoic acid |
| 2,2''-Dimethyl-p-terphenyl | 53092-64-1 | C20H18 | 258.36 | 2,2''-dimethyl-1,1':4'1''-terphenyl; BM-Terphenyl; BMT; 1,2-Bis(2-methylphenyl)benzene |
| 2,2-Diethoxyacetophenone | 6175-45-7 | C12H16O3 | 208.25 | 2,2-diethoxy-1-phenylethanone; 2,2-diethoxy-1-phenylethanone |
| 2,2'-Anhydrouridine | 3736-77-4 | C9H10N2O5 | 226.19 | 2,2'-Anhydro-b-D-arabinofuranosyl uracil; O-2,2'-Cyclouridine; 2,2'-Anhydro-D-uridine |
| 2,2'-Anhydrothymidine | 22423-26-3 | C10H12N2O5 | 240.21 | 2,2'-Anhydro-5-methyl-D-uridine; 2,2'-Anhydro-(1-b-D-arabinofuranosyl)-5-methyluracil; 2,2'-Anhydro-D-thymidine |
| Fmoc-TOAC-OH | 93372-25-9 | C25H29N2O5 | 437.51 | 2,2,6,6-Tetramethylpiperidine-N-oxyl-4-(9-fluorenylmethyloxycarbonyl-amino)-4-carboxylic acid; 4-(9H-fluoren-9-ylmethoxycarbonylamino)-2,2,6,6-tetramethyl-1-oxidopiperidin-1-ium-4-carboxylic acid; 4-((9-fluorenylmethyloxycarbonyl)amino)-4-carboxy-2,2,6,6- |
| 2,2,2-Trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)ethanone | 120122-47-6 | C7H5Cl3N2O3 | 271.49 | 1-Methyl-4-nitro-2-(trichloroacetyl)-1H-pyrrole |
| 2-(trimethylsilyl)ethyl P-nitrophenyl carbonate | 80149-80-0 | C12H17NO5Si | 283.35 | TEOC-ONP; 4-Nitrophenyl 2-(Trimethylsilyl)Ethyl Carbonate; 4-NITROPHENYL 2-(TRIMETHYLSILYL)ETHYL CARBONATE; 2-(TRIMETHYLSILYL)ETHYL 4-NITROPHENYL CARBONATE; 2-(TRIMETHYLSILYL)ETHYL P-NITROPHENYL CARBONATE; TEOC-ONP; P-NITROPHENYL 2-(TRIMETHYLSILYL)ETHYL C |
| H-D-Phe(2-trifluoromethyl)-OH | 130930-49-3 | C10H10F3NO2 | 233.19 | D-Phe(2-CF3)-OHo-Trifluoromethyl-D-phenylalanine; (R)-2-Amino-3-(2-trifluoromethyl-phenyl)propionic acid |
| Boc-D-phenylglycine | 33125-05-2 | C13H17NO4 | 251.28 | Boc-D-phenylglycine; (R)-Boc-2-aminophenylacetic acid |
| 2-(4-Biphenylyl)-6-phenylbenzoxazole | 17064-47-0 | C25H17NO | 347.417 | 2-[1,1'-biphenyl]-4-yl-6-phenyl-benzoxazole; 6-phenyl-2-(4-phenylphenyl)-1,3-benzoxazole |
| 2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole | 852-38-0 | C20H14N2O | 298.345 | 2-[1,1'-biphenyl]-4-yl-5-phenyl-1,3,4-oxadiazole; 2-Phenyl-5-(4-biphenylyl)-1,3,4-oxadiazole; PBD |
| 2-(4-Biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole | 15082-28-7 | C24H22N2O | 354.453 | BPBD-365; 2-[1,1'-biphenyl]-4-yl-5-[4-(1,1-dimethylethyl)phenyl]-1,3,4-oxadiazole; Butyl PBD; 2-(4-tert-Butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole |
| 2-(Hydroxymethyl)anthraquinone | 17241-59-7 | C15H10O3 | 238.24 | Anthraquinone-2-methanol; 2-(hydroxymethyl)anthracene-9,10-dione |
| 2-(4-formylbenzamido)ethyl nitrate | 141534-26-1 | C10H10N2O5 | 238.19 | 4-[(2-Nitroxyethyl)aminocarbonyl]benzaldehyde; |
| Fmoc-aminoxyacetic acid | 123106-21-8 | C17H15NO5 | 313.30 | Fmoc-Aoa-OH; (Fmoc-aminooxy)acetic acid; Fmoc Aoa OH |
| 7-Methoxycoumarin-4-acetic acid | 62935-72-2 | C12H10O5 | 234.20 | 7-Methoxy-2-oxo-2H-1-benzopyran-4-acetic acid; Mca-OH; 2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetic acid; 2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetic acid; 2H-1-Benzopyran-4-acetic acid, 7-methoxy-2-oxo-; Mca-OH |
| Alexa Fluor 350 | 244636-14-4 | C12H11NO7S | 7-Amino-4-methyl-6-sulfocoumarin-3-acetic acid; Alexa 350 | |
| 2-(4-Methoxyphenyl)pyrrole | 4995-12-4 | C11H11NO | 173.21 | 2-(4-methoxyphenyl)-1H-pyrrole; 2-(4-methoxyphenyl)-1H-pyrrole |
| 2-(4-Hydroxyphenyl)ethanol | 501-94-0 | C8H10O2 | 138.16 | 4-(2-hydroxyethyl)phenol |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-4-phenylbutanoic acid | 885274-45-3 | C19H28N2O4 | 348.44 | 2-(4-Boc-piperazinyl)-4-phenylbutanoic acid; 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-4-phenylbutanoic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(4-cyanophenyl)acetic acid | 885274-36-2 | C18H23N3O4 | 345.39 | 2-(4-Boc-piperazinyl)-2-(4-cyanophenyl)acetic acid; 2-(4-cyanophenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(4-bromophenyl)acetic acid | 763109-75-7 | C17H23BrN2O4 | 399.28 | 2-(4-Boc-piperazinyl)-2-(4-bromophenyl)acetic acid; 2-(4-bromophenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(3-nitrophenyl)acetic acid | 885274-17-9 | C17H23N3O6 | 365.38 | 2-(4-Boc-piperazinyl)-2-(3-nitrophenyl)acetic acid; 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-2-(3-nitrophenyl)acetic acid; 2-(2-CHLORO-PHENOXY)-PROPIONIC ACID ETHYL ESTER; 1-Piperazineaceticacid,4-[(1,1-dimethylethoxy)carbonyl]-a-(3-nitrophe |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(3-methylphenyl)acetic acid | 885274-08-8 | C18H26N2O4 | 334.41 | 2-(4-Boc-piperazinyl)-2-(3-methylphenyl)acetic acid; 2-(3-methylphenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(3-methoxyphenyl)acetic acid | 868151-10-4 | C18H26N2O5 | 350.41 | 2-(4-Boc-piperazinyl)-2-(3-methoxyphenyl)acetic acid; 2-(3-methoxyphenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(3-bromophenyl)acetic acid | 885273-07-4 | C17H23BrN2O4 | 399.28 | 2-(4-Boc-piperazinyl)-2-(3-bromophenyl)acetic acid; 2-(3-bromophenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid; 1-Piperazineaceticacid,a-(3-bromophenyl)-4-[(1,1-dimethylethoxy)carbonyl]; 2-(2-CHLORO-BENZYLOXYMETHYL)-BENZOIC ACID M |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(3,5-dimethoxyphenyl)acetic acid | 885274-69-1 | C19H28N2O6 | 380.44 | 2-(4-Boc-piperazinyl)-2-(3,5-dimethoxyphenyl)acetic acid; 2-(3,5-dimethoxyphenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2-nitrophenyl)acetic acid | 885274-14-6 | C17H23N3O6 | 365.38 | 2-(4-Boc-piperazinyl)-2-(2-nitrophenyl)acetic acid; 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-2-(2-nitrophenyl)acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2-naphthalenyl)acetic acid | 885274-80-6 | C21H26N2O4 | 370.44 | 2-(4-Boc-piperazinyl)-2-(2-naphthalenyl)acetic acid; 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-2-naphthalen-2-ylacetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2-cyanophenyl)acetic acid | 885274-31-7 | C18H23N3O4 | 345.39 | 2-(4-Boc-piperazinyl)-2-(2-cyanophenyl)acetic acid; (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-trityloxypropanoic acid; Fmoc-O-trityl-D-serine; Fmoc-D-Ser(trt)-OH |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2-bromophenyl)acetic acid | 885273-04-1 | C17H23BrN2O4 | 399.28 | 2-(4-Boc-piperazinyl)-2-(2-bromophenyl)acetic acid; 2-(2-bromophenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2,4-dichlorophenyl)acetic acid | 885274-57-7 | C17H22Cl2N2O4 | 389.27 | 2-(4-Boc-piperazinyl)-2-(2,4-dichlorophenyl)acetic acid; 2-(2,4-dichlorophenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| 2-[4-(t-Butoxycarbonyl)piperazinyl]-2-(2,3-dimethoxyphenyl)acetic acid | 885274-63-5 | C19H28N2O6 | 380.44 | 2-(4-Boc-piperazinyl)-2-(2,3-dimethoxyphenyl)acetic acid; 2-(2,3-dimethoxyphenyl)-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]acetic acid |
| Ivdde-OH | 172611-72-2 | C13H20O3 | 224.3 | 2-(3-Methylbutyryl)-5,5-dimethyl-1,3-cyclohexandione |
| 2-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-Tetramethyluroniumhexafluorophosphate | 164861-52-3 | C12H16N5O2.PF6 | 407.25 | 2-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; HDBTU; 1,1,3,3-Tetramethyl-2-(4-oxobenzo[d][1,2,3]triazin-3(4H) |
| 2-(2-carboxyethyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 126250-37-1 | C16H19BF2N2O2 | 320.147 | |
| 2-(2-Chloroethoxy)ethanol | 628-89-7 | C4H9ClO2 | 124.57 | 2-(2-chloroethoxy)ethanol |
| 2-(2,5-Dioxopyrrolidin-1-yloxy)-1,3-dimethyl-3,4,5,6-tetrahydropyrimidin-1-ium tetrafluoroborate | 443305-34-8 | C10H16N3O3.BF4 | 313.06 | TPD-OSu; O-Succinimidyl-1,3-dimethylpropyleneuronium tetrafluoroborate; DTXSID50726223; AS-11081; M-1225; J-523841; 2-[(2,5-Dioxopyrrolidin-1-yl)oxy]-1,3,5-trimethyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate |
| 2-(1-Oxy-pyridin-2-yl)-1,1,3,3-tetramethylisothiouronium tetrafluoroborate | 255825-38-8 | C10H16BF4N3OS | 313.12 | TOTTS-(1-Oxo-2-pyridyl)-thio-N,N,N',N'-tetramethyluronium tetrafluoroborate; TOTT S-(1-Oxo-2-pyridyl)-thio-N,N,N',N'-tetramethyluronium tetrafluoroborate; N,N,N',N'-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronium tetrafluoroborate; N,N,N inverted exclamation |
| 2-(1-Naphthyl)-5-phenyloxazole | 846-63-9 | C19H13NO | 271.319 | 2-(1-naphthalenyl)-5-phenyl-oxazole; alpha-NPO; a-NPO |
| 1-Methylhistamine | 501-75-7 | C6H11N3 | 125.17 | 2-(1-methyl-4-imidazolyl)ethanamine; 2-(1-methylimidazol-4-yl)ethanamine |
| Boc-Hyp-OEt | 37813-30-2 | C12H21NO5 | 259.3 | (2S,4R)-1-Tert-Butyl 2-Ethyl 4-Hydroxypyrrolidine-1,2-Dicarboxylate; 1-Tert-Butoxycarbonyl-4-Hydroxy-L-Proline Ethyl Ester |
| 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine | 19420-57-6 | C26H54NO7P | 523.68 | Stearoyl Lysophosphatidylcholine; 1-O-Stearoyl-2-lyso-sn-glycero-3-phosphocholine; 1-O-Stearoyl-sn-glycero-3-phosphocholine; 1-Octadecanoyl-sn-glycerol-3-phosphorylcholine; 1-Octadecanoyllysolecithin; 1-Stearoyl-sn-glycerol-3-phosphorylcholine; Coatsome M |
| N-Boc-2-piperidinecarboxylic acid | 98303-20-9 | C11H19NO4 | 229.3 | Boc-DL-HomoPro-OH; Boc-DL-pipecolic acid |
| 1-Palmitoyl-sn-glycero-3-phosphocholine | 17364-16-8 | C24H50NO7P | 495.63 | 1-hexadecanoyl-sn-glycero-3-phosphocholine; LysoPC(16:0); 1-16:0-lysoPC; LPC(16:0/0:0); 1-palmitoyl-phosphatidylcholine; 16:0 LYSO-PC; LysoPC(16:0/0:0); CHEBI:72998; PC(16:0/0:0); Lysophosphatidylcholine(16:0/0:0); Lysophosphatidylcholine(16:0); 3,5,9-Tri |
| 2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-2-(pent-4-enyl)hept-6-enoic acid | 1068435-19-7 | C27H31NO4 | 433.54 | 2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-pent-4-enylhept-6-enoic acid; 1068435-19-7; 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(pent-4-en-1-yl)hept-6-enoic acid; 2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-2-(pent-4-enyl)hept-6-enoic acid; 2-[[(9H- |
| Pyrenebutyric acid NHS ester | 114932-60-4 | C24H19NO4 | 385.41 | |
| 1-Pyrenebutyric Acid | 3443-45-6 | C20H16O2 | 288.34 | 4-(1-pyrenyl)butanoic acid; 4-pyren-1-ylbutanoic acid |
| Phthalazone | 119-39-1 | C8H6N2O | 146.15 | 2H-phthalazin-1-one |
| 1-Naphthaleneacetic acid | 86-87-3 | C12H10O2 | 186.21 | 2-naphthalen-1-ylacetic acid |
| 1-Phenylbiguanide hydrochloride | 55-57-2 | C8H12ClN5 | 213.67 | 1-(diaminomethylidene)-2-phenylguanidine;hydrochloride |
| 3,4-Difluorophenylacetonitrile | 658-99-1 | C8H5F2N | 153.13 | 2-(3,4-difluorophenyl)acetonitrile |
| 1-Penten-3-ol | 616-25-1 | C5H10O | 86.13 | pent-1-en-3-ol |
| N-n-Octyl-D-glucamine | 23323-37-7 | C14H31NO5 | 293.40 | (2R,3R,4R,5S)-6-(octylamino)hexane-1,2,3,4,5-pentol; (2R,3R,4R,5S)-6-(octylamino)hexane-1,2,3,4,5-pentol |
| 1-Octen-3-yl Acetate | 2442-10-6 | C10H18O2 | 170.25 | acetic acid oct-1-en-3-yl ester; oct-1-en-3-yl acetate |
| 1-Octen-3-ol | 3391-86-4 | C8H16O | 128.21 | oct-1-en-3-ol |
| 1-Octadecene | 112-88-9 | C18H36 | 252.48 | octadec-1-ene |
| 1-O-Acetyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranose | 6974-32-9 | C28H24O9 | 504.48 | benzoic acid [(2R,3R,4R,5S)-5-acetyloxy-3,4-dibenzoyloxy-2-oxolanyl]methyl ester; [(2R,3R,4R,5S)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate |
| Boc-azetidine-3-carboxylic acid | 142253-55-2 | C9H15NO4 | 201.22 | Azetidine-1,3-dicarboxylic acid 1-tert-butyl ester |
| 1-Naphthyl-N-methylcarbamate | 63-25-2 | C12H11NO2 | 201.22 | naphthalen-1-yl N-methylcarbamate |
| 1-Myristoyl-sn-glycero-3-phosphocholine | 20559-16-4 | C22H46NO7P | 467.58 | 3-sn-Lysophosphatidylcholine; lysomyristoyl phosphatidylcholine; Lysolecithin,tetradecanoyl; 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphatidylcholine; M-lyso-PC; 1-Tetradecanoyl-sn-glycero-3-phosphocholine; (7R)-,7-Dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-tri |
| 1-Methylguanine | 938-85-2 | C6H7N5O | 165.15 | 2-amino-1-methyl-7H-purin-6-one |
| 1-methyladenosine | 15763-06-1 | C11H15N5O4 | 281.27 | Adenosine, 1-methyl-; N1-Methyladenosine; N1-Methyl-D-adenosine |
| BiotinTEG Phosphoramidite | 198080-44-3 | C52H76N5O11PS | 1010.24 | 1-Dimethoxytrityloxy-3-O-(N-biotinyl-3-aminopropyl)-triethyleneglycolyl-glyceryl-2-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite |
| 1-Methyl-6-oxopyridine-3-carboxylic acid | 3719-45-7 | C7H7NO3 | 153.14 | 1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid; 1,6-dihydro-1-methyl-6-oxo-3-pyridinecarboxylic acid |
| 1-Ethynyl pyrene | 34993-56-1 | C18H10 | 226.27 | |
| 1,2,4-Triazole | 288-88-0 | C2H3N3 | 69.07 | 1H-1,2,4-triazole |
| 1-Hydroxycyclohexyl Phenyl Ketone | 947-19-3 | C13H16O2 | 204.26 | (1-hydroxycyclohexyl)-phenylmethanone; (1-hydroxycyclohexyl)-phenylmethanone |
| 1-Hydroxybenzotriazole hydrate | 123333-53-9 | C6H5N3O.H2O | 153.14 | N-HYDROXYBENZOTRIAZOL MONOHYDRATE; N-HYDROXYBENZOTRIAZOLE HYDRATE; N-HYDROXYBENZOTRIAZOLE H2O; TIMTEC-BB SBB000114; 1H-1,2,3-BENZOTRIAZOL-1-OL HYDRATE; HOBT.H2O; 1-Hydroxy benzotriazole monohydrate; 1h-1,2,3-benzotriazol-1-ol hydrate |
| 1-Hydroxy-1H-benzotriazole | 2592-95-2 | C6H5N3O | 135.12 | HOBT; N-Hydroxybenzotrizole; HOBt,Anhydrous; N-hydroxy-benzotriazole; 1H-Benzotriazole, 1-hydroxy-; BENZOTRIAZOL-1-OL; 1,2,3-Benzotriazol-1-ol; 1H-Benzo[d][1,2,3]triazol-1-ol; HBT; 1-hydroxy-1,2,3-benzotriazole; 1-HOB; HOBt solution; HOBTA; 1-hydroxy-1H-1 |
| 1-Hydroxy-7-azabenzotriazole | 39968-33-7 | C5H4N4O | 136.11 | HOAt; [1,2,3]Triazolo[4,5-b]pyridin-3-ol; 1H-[1,2,3]triazolo[4,5-b]pyridine 3-Oxide; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol; 3-hydroxytriazolo[4,5-b]pyridine; 3H-1,2,3-Triazolo[4,5-b]pyridine, 3-hydroxy-; UNII-TX8XYH09H0; HOAT 1M DMA Solution; HOAT [1-Hydr |
| Deamino-histidine | 1074-59-5 | C6H8N2O2 | 140.14 | 3-(Imidazol-4-yl)propionic acid; Dihydrourocanic acid |
| DL-Phenylalanine amide hydrochloride | 108321-83-1 | C9H12N2O·HCl | 200.70 | DL-Phe-NH2 HCl; 2-AMINO-3-PHENYLPROPANAMIDE HYDROCHLORIDE |
| 4,5-Dicyanoimidazole | 1122-28-7 | C5H2N4 | 118.10 | DCI; 4,5-Imidazoledicarbonitrile; Imidazole-4,5-dicarbonitrile; 4,5-Dicyanoimidazole (DCI); Moa 7; 2H-Imidazole-4,5-dicarbonitrile; MOA 7; NSC 113954 |
| Imidazole-1-sulfonyl Azide Hydrochloride | 952234-36-5 | C3H4ClN5O2S | 209.61 | N-diazo-1-imidazolesulfonamide;hydrochloride; N-diazoimidazole-1-sulfonamide;hydrochloride |
| 1-Hexen-3-ol | 4798-44-1 | C6H12O | 100.16 | hex-1-en-3-ol |
| 1H-1,2,3-Triazole | 288-36-8 | C2H3N3 | 69.07 | 2H-triazole |
| 2-(Perfluorooctyl)ethyl Acrylate | 27905-45-9 | C13H7F17O2 | 518.17 | 2-propenoic acid 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl ester; 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl prop-2-enoate |
| Azido myristic acid | 80667-36-3 | C12H23N3O2 | 241.33 | 12-azidododecanoic acid; 12-azido-dodecanoic acid; 12Az lauric acid; 12-(Azido)lauric acid; Dodecanoic acid, 12-azido-; 12AZ; Click-iT.(R). Az-C12; Click-iT.(R). myristic acid |
| 12-Aminododecanoic acid | 693-57-2 | C12H25NO2 | 215.34 | 12-Aminolauric acid; 12-Ado-OH; 12-Aminododecanoic acid; 12-AMINO-DODECANOIC ACID; Dodecanoic acid, 12-amino-; omega-Aminolauric acid; Omega-Aminododecanoic acid; 12-aminododecanic acid; H-Adod(12)-OH |
| 1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester | 94242-51-0 | C15H12F3NO3 | 311.25 | |
| H-cHxOn-OH | 285996-77-2 | C7H11NO3 | 157.17 | 1-Amino-1-carboxy-4-cyclohexanone; 1-amino-4-oxocyclohexane-1-carboxylic acid; Cyclohexanecarboxylic acid,1-amino-4-oxo- |
| 10-(but-3-yn-1-yl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 1448171-74-1 | C17H19BF2N2 | 300.159 | |
| 1-Cyclohexenylisocyanide | 1121-57-9 | C7H9N | 107.15 | 1-Isocyanocyclohexene; 1-isocyanocyclohex-1-ene; Cyclohexene,1-isocyano-; 1-Isocyano-cyclohexene |
| 1-Chloropropane-[d7] | 761374-88-3 | C3D7Cl | 85.58 | n-Propyl Chloride-d7; 1-Chloropropane D7 |
| 2-Deoxy-3,5-di-O-(4-chlorobenzoyl)-alpha-D-ribofuranosyl Chloride | 21740-23-8 | C19H15Cl3O5 | 429.68 | 4-chlorobenzoic acid [(2R,3S)-5-chloro-3-[(4-chlorophenyl)-oxomethoxy]-2-oxolanyl]methyl ester; [(2R,3S)-5-chloro-3-(4-chlorobenzoyl)oxyoxolan-2-yl]methyl 4-chlorobenzoate |
| 2-Deoxy-3,5-di-O-p-toluoyl-alpha-L-ribofuranosyl Chloride | 141846-57-3 | C21H21ClO5 | 388.84 | 4-methylbenzoic acid [(2S,3R,5R)-5-chloro-3-[(4-methylphenyl)-oxomethoxy]-2-oxolanyl]methyl ester; [(2S,3R,5R)-5-chloro-3-(4-methylbenzoyl)oxyoxolan-2-yl]methyl 4-methylbenzoate |
| 2-Deoxy-3,5-di-O-p-toluoyl-D-ribofuranosyl Chloride | 3601-89-6 | C21H21ClO5 | 388.84 | 4-methylbenzoic acid [(2R,3S)-5-chloro-3-[(4-methylphenyl)-oxomethoxy]-2-oxolanyl]methyl ester; [(2R,3S)-5-chloro-3-(4-methylbenzoyl)oxyoxolan-2-yl]methyl 4-methylbenzoate |
| Boc-isonipecotic acid | 84358-13-4 | C11H19NO4 | 229.27 | Boc-Inp-OH; Boc-piperidine-4-carboxylic acid; Boc Inp OH |
| 1-Boc-piperidine-4-Fmoc-amino-4-carboxylic acid | 183673-66-7 | C26H30N2O6 | 466.53 | Fmoc-L-Pip(Boc)-OH; 1-Boc-4-Fmoc-Pip-OH; 4-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1,4-piperidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester; 1-(tert-Butoxycarbonyl)-4-[[[(9H-fluoren-9-yl)methoxy]carbonyl]amino]piperidine-4-carboxylic Acid; N-Boc-amin |
| 1-(t-Butoxycarbonyl)homopiperazine hydrochloride | 1049743-87-4 | C10H21ClN2O2 | 236.74 | Boc-homoPiz HCl; Boc-Homopiperazine HCl; tert-butyl 1,4-diazepane-1-carboxylate,hydrochloride; 1-Boc-homopiperazine HCl; Tert-butyl 1,4-diazepane-1-carboxylate Hydrochloride; 1-Boc-Homopiperazine hydrochloride; Boc-homopiperazine hydrochloride; [1,4]Diaze |
| 1-Benzyl-4-methyl-3-(methylamino)piperidine Dihydrochloride | 1228879-37-5 | C14H24Cl2N2 | 291.26 | N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine;dihydrochloride; 1-benzyl-N,4-dimethylpiperidin-3-amine;dihydrochloride |
| 1-Benzylimidazole | 4238-71-5 | C10H10N2 | 158.20 | 1-(phenylmethyl)imidazole; 1-benzylimidazole |
| 1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine Hydrochloride | 1034439-57-0 | C24H32ClNO2 | 401.97 | 4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine;hydrochloride; 1-benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine;hydrochloride |
| 1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine | 120013-45-8 | C24H29NO2 | 363.49 | 4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine; 1-benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine |
| 1-Benzoylnapelline | 198126-85-1 | C29H37NO4 | 463.6084 | |
| 1-Aminoindane Hydrochloride | 70146-15-5 | C9H12ClN | 169.65 | 2,3-dihydro-1H-inden-1-amine;hydrochloride; 2,3-dihydro-1H-inden-1-amine;hydrochloride |
| 1-Aminocyclopropanecarboxylic acid | 22059-21-8 | C4H7NO2 | 101.1 | ACC; ACPC; NSC 98430; 1-Aminocyclopropane-1-carboxylic acid |
| Ethyl 1-aminocyclopropanecarboxylate hydrochloride | 42303-42-4 | C6H11NO2·HCl | 165.62 | 1-Aminocyclopropane-1-carboxylic acid ethyl ester hydrochloride; Acpc-OEt HCl; Acpc OEt HCl |
| H-AC4C-OH HCl | 98071-16-0 | C5H9NO2·HCl | 151.59 | 1-Amino-1-cyclobutane carboxylic acid hydrochloride; 1-aminocyclobutanecarboxylic acid hydrochloride; 1-aminocyclobutane-1-carboxylic acid hydrochloride |
| 1-Aminocyclohexane carboxylic acid | 2756-85-6 | C7H13NO2 | 143.19 | Homocycoleucine; 1-Amino-1-cyclohexanecarboxylic acid; 1-Aminocyclohexanecarboxylic Acid; 1-amino-cyclohexane-1-carboxylic acid; Cyclohexanecarboxylic acid, 1-amino; a-Aminocyclohexanecarboxylic acid; 1-amino-1-cyclohexane carboxylic acid; 1-aminocyclohex |
| 1-Allylimidazole | 31410-01-2 | C6H8N2 | 108.14 | Imidazole,1-allyl; 1-Allyl-1H-imidazole; N-allylimidazole; 1-propenylimidazole; 3-(2-propenyl)imidazole; 1-(prop-2-en-1-yl)-1H-imidazole; 1-(prop-2-enyl)-1H-imidazole; 1-(2-propenyl)imidazole; 1-ALLYLIMIDAZOLE; 1-allyl-1h-imidazole; ALLYL IMIDAZOLE; N-ALL |
| 1-Adamantanethiol | 34301-54-7 | C10H16S | 168.30 | adamantane-1-thiol |
| 1-Acetylimidazole | 2466-76-4 | C5H6N2O | 110.10 | 1-(1H-imidazol-1-yl)ethanone |
| N-Acetylindol-3-yl acetate | 16800-67-2 | C12H11NO3 | 217.22 | 1,3-Diacetoxyindole1-Acetyl-1H-indol-3-yl acetate |
| Fmoc-AEEA-AEEA-OH | 560088-89-3 | C27H34N2O9 | 530.6 | Fmoc-AEEA-AEEA; Fmoc-8-amino-3,6-dioxaoctanoyl-8-amino-3,6-dioxaoctanoic acid |
| 10-(4-(dodecyloxy)phenyl)-5,5-difluoro-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 1029138-21-3 | C27H35BF2N2O | 452.39 | |
| 10-(4-(bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 886212-86-8 | C23H28BF2N3O2 | 427.302 | |
| 10-(4-(bis(2-acetoxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 886212-87-9 | C27H32BF2N3O4 | 511.377 | |
| Fmoc-isonipecotic acid | 148928-15-8 | C21H21NO4 | 351.40 | Fmoc-Inp-OH; Fmoc-piperidine-4-carboxylic acid; Fmoc Inp OH |
| 14-Azido-3,6,9,12-tetraoxatetradecan-1-ol | 86770-68-5 | C10H21N3O5 | 263.30 | N3-EEEEE2-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethoxy)ethanol; 2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethanol; Azido-PEG5-alcohol; 14-Azido-3,6,9,12-tetraoxatetradecanol; N3-PEG5-OH; PEG5-Azide; azido-PEG5-OH; ACMC-20aoz6; azido PEG5 OH; N3 PEG5 |
| 14-Acetylvirescenine | 71609-79-5 | C25H39NO7 | 465.58 | |
| 10-(Phosphonooxy)decyl Methacrylate | 85590-00-7 | C14H27O6P | 322.33 | 2-methyl-2-propenoic acid 10-phosphonooxydecyl ester; 10-phosphonooxydecyl 2-methylprop-2-enoate |
| 1-[[2,4,6-Tris(isopropyl)phenyl]sulphonyl]-1H-1,2,4-triazole | 54230-60-3 | C17H25N3O2S | 335.46 | 1-(2,4,6-TRIISOPROPYLBENZENESULPHONYL)-1,2,4-TRIAZOLE; 1-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-1H-1,2,4-TRIAZOLE; TPST; 1-Trisyl-1,2,4-triazole; TPST, 2,4,6-Triisopropylbenzenesulfonyl-1H-1,2,4-triazole; 1H-1,2,4-Triazole, 1-[[2,4,6-tris(1-methylethyl)phenyl |
| 1,7-Dimethyl-3,5-bis[4-(N,N-dimethylamino)phenylethenyl]-8-phenyl-4,4-difluoroboradiazasindacene | 1039552-26-5 | C37H37BF2N4 | 586.536 | |
| 1,7-Dimethyl-3,5-bis[4-(N,N-dimethylamino)phenylethenyl]-8-(4-ethenylphenyl)-4,4-difluoroboradiazasindacene | 1151530-90-3 | C39H37BF2N4 | 610.558 | |
| 1,7-Dimethyl-3,5-bis(phenylethenyl)-8-(4-iodophenyl)-4,4-difluoboradiazasindacene | 1256917-88-0 | C53H34BF2IN2 | 874.579 | |
| 1,7-Dimethyl-3,5-bis(4-trifluoromethylphenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1238620-12-6 | C35H25BF8N2 | 636.395 | |
| 1,7-Dimethyl-3,5-bis(4-methoylphenylethenyl)-8-(4-iodophenyl)-4,4-difluoroboradiazasindacene | 1189528-66-2 | C35H30BF2IN2O2 | 686.348 | |
| 1,7-Dimethyl-3,5-bis(4-iodophenylethenyl)-8-(4-nitrophenyl)-4,4-difluoroboradiazasindacene | 1627681-12-2 | C33H26BF2N3O2 | 545.396 | |
| 1,7-Dimethyl-3,5-bis(4-iodophenylethenyl)-8-(4-iodophenyl)-4,4-difluoroboradiazasindacene | 1257341-75-5 | C33H24BF2I3N2 | 878.088 | |
| 1,4-Cyclohexanedimethanol | 105-08-8 | C8H16O2 | 144.21 | [4-(hydroxymethyl)cyclohexyl]methanol |
| 10-Undecenoic acid | 112-38-9 | C11H20O2 | 184.28 | undec-10-enoic acid |
| 10-Undecen-1-ol | 112-43-6 | C11H22O | 170.29 | undec-10-en-1-ol |
| 10-Phenyl-9-anthraceneboronic Acid | 334658-75-2 | C20H15O2B | 298.14 | (10-phenyl-9-anthracenyl)boronic acid; (10-phenylanthracen-9-yl)boronic acid |
| 10-O-[1-Propyl-3-N-carbamoylcholesteryl]-TEG-CE phosphoramidite | 1325147-19-0 | C46H82N3O7P | 820.13 | 5'-Cholesterol-TEG-CE Phosphoramidite; 10-O-[1-Propyl-3-N-carbamoylcholesteryl]-triethyleneglycol-1-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite |
| 10-(3-Sulfopropyl)acridinium betaine | 83907-41-9 | C16H15NO3S | 301.36 | SPA |
| 10-(3-amino-4-hydroxyphenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 1181844-41-6 | C19H20BF2N3O | 355.195 | |
| 10-(2,3,5,6,8,9,11,12,14,15-decahydrobenzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 1196879-10-3 | C29H37BF2N2O6 | 558.43 | |
| 1-{[4-({4-[(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy]-4-oxobutyl}disulfanyl)butanoyl]oxy}-2,5-dioxopyrrolidine-3-sulfonic acid | 98604-89-8 | C16H20N2O14S4 | 592.59 | 1,1'-{Disulfanediylbis[(1-oxo-4,1-butanediyl)oxy]}bis(2,5-dioxo-3-pyrrolidinesulfonic acid); |
| 1,8-Diazabicyclo[5.4.0]undec-7-ene | 6674-22-2 | C9H16N2 | 152.24 | DBU; 1,8-Diazabicyclo[5.4.0]undecene-7; Alcanpoudre DBU 70-3KG; Amicure DBUE; Dabco DBU; Lupragen N 700; NSC 111184; NSC 230466; PC CAT DBU; Polycat DBU; U-CAT SA 851 |
| 2-Mercaptopyridine N-oxide sodium salt | 3811-73-2 | C5H4NNaOS | 149.15 | sodium;1-oxidopyridine-2-thione |
| 1,8-Dihydroxyanthraquinone | 117-10-2 | C14H8O4 | 240.21 | 1,8-dihydroxyanthracene-9,10-dione |
| 1,8-Dihydroxy-3-methylanthraquinone | 481-74-3 | C15H10O4 | 254.24 | 1,8-dihydroxy-3-methylanthracene-9,10-dione |
| Azelaic acid | 123-99-9 | C9H16O4 | 188.22 | nonanedioic acid |
| 1,6-Diphenyl-1,3,5-hexatriene | 1720-32-7 | C18H16 | 232.32 | DPH |
| (1R,2R,4S,5S,6R)-5-Hydroxy-3,7,9-Trioxatricyclo[4.2.1.02,4]nonane | 3868-04-0 | C6H8O4 | 144.13 | 3,7,9-trioxatricyclo[4.2.1.0^{2,4}]nonan-5-ol; 3,7,9-trioxatricyclo[4.2.1.0^{2,4}]nonan-5-ol |
| 1,5,7-Trimethyl-3-[6-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethenyl]-8-[4-(2,4-dinitrophenoxy)-phenyl]-4,4-difluoroboradiazasindacene | 1403241-80-4 | C38H34BF2N5O5 | 689.526 | |
| 1,5,7-Trimethyl-3-[4-(N,N-dimethylamino)phenylethenyl]-8-(4-N,N-dimethylaminophenyl)-4,4-difluoroboradiazasindacene | 937737-73-0 | C30H33BF2N4 | 498.427 | |
| 1,5,7-Trimethyl-3-[3-amino-4-hydroxyphenyl)ethenyl]-8-phenyl-4,4-difluoroboradiazasindacene | 1802553-24-7 | C26H22BF2N3O3 | 473.287 | |
| 1,5,7-Trimethyl-3-(E-4-hydroxyphenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1373612-56-6 | C26H23BF2N2O | 428.289 | |
| 1,5,7-Trimethyl-3-(4-nitrophenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1802553-26-9 | C26H22BF2N3O2 | 457.288 | |
| 1,5,7-Trimethyl-3-(4-methoxyphenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1144030-44-3 | C27H25BF2N2O | 442.316 | |
| 1,5,7-Trimethyl-3-(4-aminophenylethenyl)-8-phenyl-4,4-difluoroboradiazasindacene | 1802553-30-5 | C26H24BF2N3 | 427.305 | |
| 1,5,7-Trimethyl-3-(1-pyrenylethenyl)-8-(4-iodophenyl)-4,4-difluoroboradiazasindacene | 1256917-87-9 | C36H26BF2IN2 | 662.328 | |
| 1,5,7-Trimethyl-3-(1H-pyrrol-2-ylethenyl)-8-(4-bromophenyl)-4,4-difluoroboradiazasindacene | 1388221-01-9 | C24H21BBrF2N3 | 480.163 | |
| (2S,4S)-Fmoc-(4-FmocNH)homoproline | 252029-00-8 | C36H32N2O6 | 588.66 | Fmoc-HoPro(Fmoc)-OH; Fmoc-Pip(Fmoc)-OH; Fmoc-4-Pip(Fmoc)-OH; 1-fmoc-4-(fmoc-amino)-piperidine-4-carboxylic acid; 1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)piperidine-4-carboxylic acid; J-504012; 1,4-Piperidinedica |
| 1,4-Naphthoquinone | 130-15-4 | C10H6O2 | 158.15 | naphthalene-1,4-dione |
| (2R,4S,5R)-5-Hydroxy-2-phenyl-1,3-dioxane-4-methanol | 117122-84-6 | C11H14O4 | 210.23 | (2R,4S,5R)-4-(hydroxymethyl)-2-phenyl-1,3-dioxan-5-ol; (2R,4S,5R)-4-(hydroxymethyl)-2-phenyl-1,3-dioxan-5-ol |
| 1,2-Dioleoyl-sn-glycero-3-N-carboxyfluoroscein-PE | 384832-91-1 | C62H88NO14P·2NH3 | 1136.4 | 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine N-carboxyfluorescein; 9Z-octadecenoic acid, 1,1'-[(1R)-1-[8-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-3-hydroxy-3-oxido-8-oxo-2,4-dioxa-7-aza-3-phosphaoct-1-yl]-1,2-ethanediyl] este |
| 1,4-Dithio-DL-threitol | 3483-12-3 | C4H10O2S2 | 154.25 | DL-1,4-Dithiothreitol; DTT; Cleland's reagent; threo-1,4-Dimercapto-2,3-butanediol; Dithiothreitol; dl-Dithiothreitol; 1,4-Dithiothreitol; D-Dtt; 1,4-Dithio-dl-threitol; DL-Dithiothreitol; threo-1,4-Dimercapto-2,3-butanediol |
| Glycolaldehyde dimer | 23147-58-2 | C4H8O4 | 120.10 | 1,4-dioxane-2,5-diol |
| 1,4-Dimethylquinolin-2(1H)-one | 2584-47-6 | C11H11NO | 173.21 | 1,4-dimethyl-2-quinolinone; 1,4-dimethylquinolin-2-one |
| Isomannide | 641-74-7 | C6H10O4 | 146.14 | (3R,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol; (3R,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol |
| 2,2'-[[Methylenebis(oxy)]bis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] | 6228-26-8 | C11H24O8 | 284.30 | 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methoxymethyl]-2-(hydroxymethyl)propane-1,3-diol; 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methoxymethyl]-2-(hydroxymethyl)propane-1,3-diol |
| 1,3-Propanediol | 504-63-2 | C3H8O2 | 76.09 | propane-1,3-diol |
| 1,3-Diaminopropane-[d4] Dihydrochloride | 193945-44-7 | C3H8D4Cl2N2 | 151.07 | 1,3-Propane-1,1,3,3-D4-diamine 2HCl |
| 1,3-Dioxolo[4,5-g]quinolin-8(5H)-one | 154504-43-5 | C10H7NO3 | 189.16 | 5H-[1,3]dioxolo[4,5-g]quinolin-8-one; 4-Hydroxy-6,7-methylenedioxyquinoline; 2H-[1,3]Dioxolo[4,5-g]quinolin-8(5H)-one; 6,7-methylenedioxy-4-quinolinol; 5,8-Dihydro-1,3-dioxolo[4,5-g]quinoline-8-one |
| 1,3-Dimethylbarbituric acid | 769-42-6 | C6H8N2O3 | 156.14 | 1,3-dimethyl-1,3-diazinane-2,4,6-trione |
| 1,3-Dimethyladamantane | 702-79-4 | C12H20 | 164.29 | 1,3-dimethyladamantane |
| 1,2,4-Trichloro-5-(chloromethyl)benzene | 3955-26-8 | C7H4Cl4 | 229.92 | 2,4,5-Trichlorobenzyl chloride; Benzene,1,2,4-trichloro-5-(chloromethyl)- |
| 1,3-Cyclohexanedione | 504-02-9 | C6H8O2 | 112.13 | cyclohexane-1,3-dione; cyclohexane-1,3-dione |
| 1,3,5,7-Tetramethyl-8-phenyl-4,4-difluoroboradiazaindacene | 194235-40-0 | C19H19BF2N2 | 324.18 | 8-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene |
| 1,3,5,7-Tetramethyl-8-pentafluorophenyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1299467-50-7 | C19H14BF7N2 | 414.133 | |
| 1,3,5,7-Tetramethyl-8-(C3-COOH)4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 878674-84-1 | C17H21BF2N2O2 | 334.17 | 4-(4,4-Difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid |
| 1,3,5,7-tetramethyl-2,6-diiodo-C3-SE-BODIPYs | 1825368-13-5 | C21H22BF2I2N3O4 | 683.04 | |
| 1,3,5,7,8-Pentamethyl-8-thienyl-pyrromethene-difluoroborate | 1359876-93-9 | C17H17BF2N2S | 330.209 | |
| 1,3,5,7,8-Pentamethyl-8-furanyl-pyrromethene-difluoroborate | 954147-80-9 | C13H9BF2N2O | 258.035 | |
| 1,3,5,7,8-Pentamethyl-2-iodo-6-formyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1372549-74-0 | C15H16BF2IN2O | 416.017 | |
| 1,3,5,7,8-Pentamethyl-2-iodo-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1031443-53-4 | C14H16BF2IN2 | 388 | |
| 1,3,5,7,8-Pentamethyl-2-formyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 198149-19-8 | C15H17BF2N2O | 290.121 | |
| 1,3,5,7,8-Pentamethyl-2-bormo-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1859909-59-3 | C14H16BBrF2N2 | 341 | |
| 1,3,5,7,8-Pentamethyl-2,6-dithienyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1439436-85-7 | C22H21BF2N2S2 | 426.362 | |
| 1,3,5,7,8-Pentamethyl-2,6-dipyridyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1478660-41-1 | C24H23BF2N4 | 416.281 | |
| 1,3,5,7,8-Pentamethyl-2,6-dinitro-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 131083-17-5 | C14H15BF2N4O4 | 352.105 | |
| 1,3,5,7,8-Pentamethyl-2,6-diethynyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1394861-86-9 | C18H17BF2N2 | 310.154 | |
| 1,3,5,7,8-Pentamethyl-2,6-diethylpyrromethene-BODIPY | 131083-16-4 | C18H25BF2N2 | 318.219 | 1,3,5,7,8-Pentamethyl-2,6-diethyl-4,4-difluoro-3a-azonia-4a-aza-4-bora(V)-s-indacene-4-ide |
| 1,3,5,7,8-Pentamethyl-2,6-diethyl-8-phenyl-pyrromethene-difluoroborate | 189264-25-3 | C23H27BF2N2 | 380.289 | 2,6-diethyl-8-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene |
| 1,3,5,7,8-Pentamethyl-2,6-diethoxycarbonyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 21658-72-0 | C20H25BF2N2O4 | 406.237 | |
| 1,3,5,7,8-Pentamethyl-2,6-dibormo-BODIPY | 134382-52-8 | C14H15Br2F2N2 | 409.091 | |
| 1,3,5,7,8-Pentamethyl-2,6-di(trimethylsilylethynyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1394861-84-7 | C24H33BF2N2Si2 | 454.518 | |
| 1,3,5,7,8-Pentamethyl-2,6-di(tert-butyl)-pyrromethene-difluoroborate | 137829-79-9 | C22H33BF2N2 | 374.32 | 2,6-di-tert-Butyl-1,3,5,7-pentamethylpyrromethenedifluoroborate complex; [[(4-tert-Butyl-3,5-dimethyl-1H-pyrrol-2-yl)(4-tert-butyl-3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]methane](difluoroborane); Difluoro(4-(1,1-dimethylethyl)-2-{1-[4-(1,1-dimethylethyl) |
| 1,3,5,7,8-Pentamethyl-2,6-di(phenylethynyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 1870842-52-6 | C30H25BF2N2 | 462.35 | |
| 2-Azido-D-galactose tetraacetate | 84278-00-2 | C14H19N3O9 | 373.32 | [(2R,3R,4R,5R)-3,4,6-triacetyloxy-5-azidooxan-2-yl]methyl acetate |
| Z-L-4-trans-hydroxyproline methyl ester | 64187-48-0 | C14H17NO5 | 279.3 | Z-L-Hyp-OMe |
| Boc-L-trans-4-hydroxyproline tert-butyl ester | 170850-75-6 | C14H25NO5 | 287.35 | Boc-L-Hyp-OtBu; Boc L Hyp OtBu |
| Fmoc-4,4-difluoro-L-Proline | 203866-21-1 | C20H17F2NO4 | 373.3 | (2S)-Fmoc-4,4-difluoro-pyrrolidine-2-carboxylic acid |
| Fmoc-L-proline pentafluorophenyl ester | 86060-90-4 | C26H18NO4F5 | 503.40 | Fmoc-L-Pro-OPfp; (S)-Fmoc-pyrrolidine-2-carboxylic acid pentafluorophenyl ester; Fmoc-Pro-OPfp; Fmoc-proline perfluorophenyl ester; Fmoc-Pro-pentafluorophenyl ester; Fmoc-L-proline pentafluorophenyl ester |
| DL-1,2-Isopropylideneglycerol | 100-79-8 | C6H12O3 | 132.16 | (2,2-dimethyl-1,3-dioxolan-4-yl)methanol |
| 1,2-O-Isopropylidene-alpha-D-xylofuranose | 20031-21-4 | C8H14O5 | 190.19 | (3aR,5R,6S,6aR)-5-(hydroxymethyl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol; (3aR,5R,6S,6aR)-5-(hydroxymethyl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol |
| 1,2-Distearoyl-sn-glycero-3-phosphate sodium salt | 108321-18-2 | C39H76NaO8P | 726.98 | Sodium (R)-2,3-bis(stearoyloxy)propyl hydrogenphosphate; 1,2-distearoyl-sn-glycero-3-phosphatidic acid sodium salt; DSPA-Na; AKOS015911827; 1-O,2-O-Distearoyl-3-O-(sodiooxyphosphonyl)-L-glycerol; Octadecanoicacid,1,1'-(1R)-1-[(phosphonooxy)methyl]-1,2-eth |
| 1,2-dipiperidinoethane | 1932-04-3 | 1,2-Bis(piperidino)ethane; dipiperidinoethane; 1,1-(1,2-Ethanediyl)bispiperidine; 1,1'-ethylenedipiperidine | ||
| Bibenzyl | 103-29-7 | C14H14 | 182.26 | 2-phenylethylbenzene |
| 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine | 923-61-5 | C37H74NO8P | 691.96 | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine; Dipalmitoyl phosphatidylethanolamine; UNII-4FWH120Z1Z; PE(16:0/16:0); GPEtn(32:0); Phophatidylethanolamine(32:0); DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE; GPEtn(16:0/16:0); (2R)-3-(((2-Aminoethoxy)(h |
| 1,2-dipalmitoyl-sn-glycero-3-phosphocholine | 63-89-8 | C40H80NO8P | 734.04 | DPPC; Colfosceril palmitate; 1,2-Dipalmitoyl-L-lecithin; Colfosceril palmitate; PC(16:0/16:0); Palmitate de colfosceril; (R)-2,3-Bis(palmitoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate; Palmitato decolfoscerilo; diPalmitoylphosphatidylcholine; UNII- |
| 1,2-Dipalmitoyl-sn-glycero-3-phospho-L-serine, sodium salt | 145849-32-7 | C38H73NNaO10P | 757.95 | 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-L-SERINE (MONOSODIUM SALT); 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-L-SERINE, SODIUM SALT; DTXSID70677081; AS-71551; 16:0 PS (1,2-dihexadecanoyl-sn-glycero-3-phospho-L-serine (sodium salt)); 16:0 PS, 1,2-dipalmitoyl-sn-gl |
| 1,2-Dipalmitoyl-sn-glycero-3-phosphate, sodium salt | 169051-60-9 | C35H68NaO8P | 670.87 | Sodium (R)-2,3-bis(palmitoyloxy)propyl phosphate; L-beta, gamma-Dipalmitoyl-alpha-phosphatidic acid sodium salt; 1,2-Dipalmitoyl-sn-glycero-3-phosphate monosodium salt; Dipalmitoyl-L-alpha-phosphatidic acid sodium; DPPA, Na; DPPA-Na; 1,2-dihexadecanoyl-sn |
| 1,2-Dioleyloxy-3-dimethylamino-propane | 104162-47-2 | C41H81NO2 | 620.08 | 1-Propanamine, N,N-dimethyl-2,3-bis[(9Z)-9-octadecenyloxy]-; DODMA; ACMC-20m6xx; ACMC-20m7p2; 1-Propanamine, N,N-dimethyl-2,3-bis[(9Z)-9-octadecenyloxy]-, (2S)-; CTK0G6558; (2,3-bis-octadec-9-enyloxypropyl)-dimethylamine; 1,2-dioleyloxy-N,N-dimethylaminop |
| 1,2-Dioleoyl-sn-glycero-3-phosphoric acid monosodium salt | 108392-02-5 | C39H72NaO8P | 722.94 | 1,2-dioleoyl-sn-glycero-3-phosphate sodium salt; 3-sn-Phosphatidic acid, 1,2-dioleoyl monosodium salt; L-1,2-Dioleoyl--phosphatidic acid monosodium salt; DOPA monosodium salt; Phosphatidic Acid, Dioleoyl; 108392-02-5; CTK8E7719; CID 71433692 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 4235-95-4 | C44H84NO8P | 786.11 | DOPC; Dioleoyl lecithin; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine DOPC; (R)-2,3-Bis(oleoyloxy)propyl [2-(Trimethylammonio)ethyl] Phosphate; UNII-H026DM5V6U; 1,2-Dioleoyl-L-alpha-lecithin; PC(18:1(9Z)/18:1(9Z)); H026DM5V6U; (R-(Z,Z))-(7-Oleoyl- |
| 1,2-Dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt | 200880-40-6 | C34H66NaO10P | 688.84 | (1R)-1-[[[(2,3-Dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl Ester Tetradecanoic Acid Sodium Salt; (1R)-1-[[[(2,3-Dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl Ester Tetradecanoic Acid Monosodium Salt; 1,2-Dimyristoyl-sn-gl |
| 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine | 998-07-2 | C33H66NO8P | 635.85 | L-Myristin 1,2-Di-, 2-aminoethyl hydrogen phosphate; (R)-Tetradecanoic Acid 1-[[[(2-Aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl Ester; L-Phosphoric Acid Mono(2-aminoethyl) Ester Monoester with 1,2-Dimyristin; (R)-Dimyristoylphosphatidylethano |
| 1,2-Dimyristoyl-sn-glycero-3-phosphocholine | 18194-24-6 | C36H72NO8P | 677.93 | DMPC; Dimyristoyl phosphatidylcholine; 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine; Dimyristoyl phosphatidylcholine; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYL LECITHIN; UNII-52QK2NZ2T0; DMPC; PC(14:0/14:0); (R)-2,3-Bis(tetradecanoyloxy)propyl (2-(tr |
| 1,2-Dierucoyl-sn-glycero-3-phosphocholine | 51779-95-4 | C52H100NO8P | 898.32 | DEPC; L-Dierucoyl lecithin; (7R,22Z)-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[[(13Z)-1-oxo-13-docosen-1-yl]oxy]-3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium 4-Oxide Inner Salt; [R-(Z,Z)]-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-13-docosenyl)oxy]-3,5,9-t |
| 1,10-Phenanthroline monohydrochloride monohydrate | 18851-33-7 | C12H8N2 · HCl · H2O | 234.68 | 1,10-phenanthroline;hydrate;hydrochloride |
| 1-(4-Methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline | 51072-36-7 | C17H23NO | 257.37 | 1-[(4-methoxyphenyl)methyl]-1,2,3,4,5,6,7,8-octahydroisoquinoline; 1-[(4-methoxyphenyl)methyl]-1,2,3,4,5,6,7,8-octahydroisoquinoline |
| 1,2,2,6,6-Pentamethylpiperidine | 79-55-0 | C10H21N | 155.28 | 1,2,2,6,6-pentamethylpiperidine |
| 1,1-Dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine Iodide | 100068-60-8 | C63H101IN2 | 1013.41 | DiIC18(7); DiR; XenoLight DiR; 2-[7-(1,3-Dihydro-3,3-dimethyl-1-octadecyl-2H-indol-2-ylidene)-1,3,5-heptatrienyl]-3,3-dimethyl-1-octadecyl-3H-indolium Iodide |
| 1,1-Dimethylbiguanide hydrochloride | 1115-70-4 | C4H12ClN5 | 165.62 | 3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride |
| 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl]-1-piperidinium Bromide | 844694-85-5 | C31H36BrNO3 | 550.53 | 2-[[1,1-bis(phenylmethyl)-4-piperidin-1-iumyl]methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;bromide; 2-[(1,1-dibenzylpiperidin-1-ium-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;bromide |
| 1,1'-Carbonyldipyrrolidine | 81759-25-3 | C9H16N2O | 168.24 | CDP; Di(pyrrolidin-1-yl)methanone; DITETRAHYDRO-1H-PYRROL-1-YLMETHANONE; CARBONYLDIPYRROLIDINE; CARBODIPIPERIDIDE; BIS(TETRAMETHYLEN)UREA; CDP (1,1'-Carbonyldipyrrolidine); Bis(tetramethylen)urea, Carbodipiperidide |
| 1,1'-Carbonyldi(1,2,4-triazole) | 41864-22-6 | C5H4N6O | 164.13 | CDT; 1,1'-Carbonyl-di-(1,2,4-triazole) |
| Boc-cycloleucine | 35264-09-6 | C11H19NO4 | 229.27 | Boc-1-aminocyclopentane-1-carboxylic acid |
| Boc-1-aminocyclohexane carboxylic acid | 115951-16-1 | C12H21NO4 | 243.30 | Boc-homocycloleucine; 1-(Boc-amino)cyclohexanecarboxylic acid; 1-[(tert-butoxycarbonyl)amino]cyclohexanecarboxylic acid; 1-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylic acid; Boc-1-aminocyclohexane-1-carboxylic acid; Cyclohexanecarboxylic acid, 1 |
| Boc-4-carboxymethyl-piperidine | 157688-46-5 | C12H21NO4 | 243.30 | Boc-Cmp-OH; Boc-4-piperidylacetic acid; Boc Cmp OH |
| 1,1,1-Trichloro-2-methyl-2-propanol hemihydrate | 6001-64-5 | C8H16Cl6O3 | 186.46 | 1,1,1-trichloro-2-methylpropan-2-ol;hydrate |
| Boc-AMCP-OH | 204376-48-7 | C10H17NO4 | 215.25 | 1-(t-Butyloxycarbonyl-aminomethyl)-cyclopropyl-1-carboxylic acid; 1-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]cyclopropane-1-carboxylic acid; racemic 1-(tert-butoxycarbonylamino-methyl)-cyclopropanecarboxylic acid; Boc-Amcp-OH; 1-((((tert-butoxy)carb |
| N-(t-Butoxycarbonyl)-DL-nipecotic acid | 84358-12-3 | C11H19NO4 | 229.27 | Boc-DL-Pic(3)-OH; Boc-DL-Nipc-OH; (±)-1-(t-Butoxycarbonyl)piperidine-3-carboxylic acid; N-BOC-Piperidine-3-carboxylic acid; 1-(tert-Butoxycarbonyl)nipecotic Acid; Boc-DL-Nip-OH duplicate; Boc-(R,S)piperidine-3-carboxylic acid; Boc-3-carboxypiperidine |
| Fmoc-1-aminocyclopropane-1-carboxylic acid | 126705-22-4 | C19H17NO4 | 323.34 | Fmoc-Acpc-OH; Fmoc Acpc OH |
| Fmoc-1-aminocyclopentane-1-carboxylic acid | 117322-30-2 | C21H21NO4 | 351.40 | Fmoc-cycloleucine |
| Fmoc-1-aminocyclohexane carboxylic acid | 162648-54-6 | C22H23NO4 | 365.42 | Fmoc-homocycloleucine1-(Fmoc-amino)cyclohexanecarboxylic acid |
| 1-(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide | 162558-52-3 | C14H16BrN3 | 326.19 | MQAE; N-(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide; (6-Methoxyquinolinio)acetic acid ethyl ester bromide |
| 1-(Chloro-1-pyrrolidinylmethylene)pyrrolidinium tetrafluoroborate | 115007-14-2 | C9H16BClF4N2 | 274.49 | 1-(CHLORO-1-PYRROLIDINYLMETHYLENE)PYRROLIDINIUM TETRAFLUOROBORATE; Chloro-N,N,N',N'-bis(tetramethylene)formamidinium Tetrafluoroborate; 1-(Chloro-1-pyrrolidinemethylene)pyrrolidinium tetrafluoroborate; Pyrrolidinium, 1-(chloro-1-pyrrolidinylmethylene)-, t |
| Z-1-aminocyclopropane-1-carboxylic acid | 84677-06-5 | C12H13NO4 | 235.20 | Z-Acpc-OH |
| N-Acryloyloxysuccinimide | 38862-24-7 | C7H7NO4 | 169.13 | N-ACRYLOXYSUCCINIMIDE; ACRYLIC ACID N-HYDROXY-SUCCINIMIDE ESTER; AKOS MSC-0123; 1-[(1-OXO-2-PROPENYL)OXY]-2,5-PYRROLIDINEDIONE; 1-(ACRYLOYLOXY)-2,5-PYRROLIDINEDIONE; N-Acryloxysuccinimide (NAS); N-SucciniMidyl Acrylate; Acrylic Acid N-Succinimidyl Ester; |
| 1-(4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-00-6 | C15H17N3O9S3 | 479.51 | 1-[4-methyl-4-[(5-nitropyridin-2-yl)disulfanyl]pentanoyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid; |
| 1-(4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-ioxopyrrolidine-3-sulfonic acid | 663598-66-1 | C14H15N3O9S3 | 465.48 | 1-[4-[(5-nitropyridin-2-yl)disulfanyl]pentanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid; |
| 1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663598-89-8 | C13H13N3O9S3 | 451.45 | 1-[4-[(5-nitropyridin-2-yl)disulfanyl]butanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid; |
| 1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-07-3 | C16H19N3O8S3 | 477.53 | 1-[4-[[5-(dimethylcarbamoyl)pyridin-2-yl]disulfanyl]butanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid; |
| 1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-11-9 | C17H21N3O8S3 | 491.56 | 1-[4-[[3-(dimethylcarbamoyl)pyridin-4-yl]disulfanyl]pentanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid; |
| 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide | 1892-57-5 | C8H17N3 | 155.24 | WSCI; EDCI |
| 1-(3',6'-bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthene]-2-yl)-3-phenylurea | 957493-98-0 | C33H33N5O3 | 547.65 | |
| 1-[(1S,3R,4R,7S)-7-Hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4(1H,3H)-dione | 206055-67-6 | C11H14N2O6 | 270.24 | 1-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4-dione; 1-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4-dione |
| 1-(2-Mesitylenesulfonyl)-1H-1,2,4-triazole | 54230-59-0 | C11H13N3O3S | 267.30 | 1-(Mesitylsulfonyl)-1H-1,2,4-triazole; 11-Mesitylenesulfonyl-1,2,4-triazole; N-Mesitylenesulfonyl-1,2,4-triazole; Mesityl 1,2,4-triazole-1-sulphonate; 1-(2-Mesitylenesulfonyl)-1,2,4-triazole; MST, 1-(2-Mesitylenesulfonyl)-1H-1,2,4-triazole; J-503027; 1-(M |
| 1-(1,1-Dimethylheptyl)-3,5-dimethoxybenzene | 60526-81-0 | C17H28O2 | 264.40 | 1,3-dimethoxy-5-(2-methyloctan-2-yl)benzene |
| 1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)uracil 3'-CE-phosphoramidite | 1190089-70-3 | |||
| 1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid | 1193111-37-3 | C13H13N3O9S3 | 451.45 | 1-(2,5-dioxopyrrolidin-1-yl)oxy-4-[(5-nitropyridin-2-yl)disulfanyl]-1-oxobutane-2-sulfonic acid |
| 1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid | 1193111-39-5 | C13H14N2O7S3 | 406.45 | 1-(2,5-dioxopyrrolidin-1-yl)oxy-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid; |
| 1-(2,4,6-Triisopropylbenzenesulfonyl)imidazole | 50257-40-4 | C18H26N2O2S | 334.48 | TPSI; 1-[(2,4,6-Triisopropylphenyl)sulfonyl]-1H-imidazole; 1H-Imidazole, 1-[[2,4,6-tris(1-methylethyl)phenyl]sulfonyl]-; Imidazole, 1-[2,4,6-tris(1-methylethyl)phenylsulfonyl)-; N-(2,4,6-Triisopropylbenzenesulfonyl)imidazole |
| 1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 1286837-77-1 | C16H18N2O9S | 414.39 | 1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid; |
| {2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid | 166108-71-0 | C21H23NO6 | 385.42 | |
| [Sar9,Met(O2)11]-Substance P | 110880-55-2 | C64H100N18O15S | 1393.66 | H-DL-Arg-DL-Pro-DL-Lys-DL-Pro-DL-Gln-DL-Gln-DL-Phe-DL-Phe-Sar-DL-Leu-DL-Met(O2)-NH2; DL-arginyl-DL-prolyl-DL-lysyl-DL-prolyl-DL-glutaminyl-DL-glutaminyl-DL-phenylalanyl-DL-phenylalanyl-sarcosyl-DL-leucyl-S,S-dioxo-DL-methioninamide |
| [Pyr1]-Apelin-13 | 217082-60-5 | C69H108N22O16S | 1533.81 | [Pyr1]-Apelin-13; [Pyr1]-Apelin13; [Pyr1]-Apelin 13; 5-Oxo-L-prolyl-L-arginyl-L-prolyl-L-arginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine; Pyroglutamated apelin-13; [pGlu1]-apelin-13 |
| Boc-NH-4,4-dimethylpentanal | 892874-26-9 | C12H23NO3 | 229.32 | tert-butyl N-(4,4-dimethyl-1-oxopentan-3-yl)carbamate; TERT-BUTYL 4,4-DIMETHYL-1-OXOPENTAN-3-YLCARBAMATE |
| Ac-2-Nal-OH | 37439-99-9 | C15H15NO3 | 257.3 | (S)-N-ACETYL-2-NAPHTHYLALANINE; (S)-2-Acetamido-3-(naphthalen-2-yl)propanoic acid |
| (S)-N-4-Fmoc-N-8-Boc-diaminooctanoic acid | 268542-17-2 | C28H36N2O6 | 496.59 | (S)-N-4-Fmoc-N-8-Boc-diaminooctanoic acid; (S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-8-((tert-butoxycarbonyl)amino)octanoic acid; (S)-N-4-Fmoc-N-8-Boc-diaminooctanoic acid; (4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-8-[(2-methylpropan-2-yl)oxyca |
| Glycolaldehyde-1-[13C] | 71122-42-4 | C[13C]H4O2 | 61.04 | Glycolaldehyde-1-13C; [1-13C]GLYCOLALDEHYDE; Hydroxy(1-13C)acetaldehyde; CTK8F2344; DTXSID00724572; 2-Hydroxyacetaldehyde-1-13C; 2-Hydroxyethanal-1-13C; 2-Oxoethanol-1-13C; Hydroxyacetaldehyde-1-13C; Diose-1-13C; Glicolaldehido-1-13C; Glycolic Aldehyde-1- |
| [1 2 5]Triazepane-1-carboxylic acid t-butyl ester | 1138150-46-5 | C9H19N3O2 | 201.27 | Boc(1)-Triazepane; 1-Boc-[1.2.5]Triazepane; 1-(t-Butoxycarbonyl)-[1.2.5]triazepane |
| N-[(6-Chloropyridin-3-yl)methyl]-N-methylamine | 120739-62-0 | C7H9ClN2 | 156.61 | N-[(6-chloropyridin-3-yl)methyl]methylamine |
| Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](benzylidene)bis(3-bromopyridine)ruthenium(II) | 900169-53-1 | C38H41Br2Cl2N4Ru- | 885.5 | Grubbs Catalyst, 3nd Generation |
| Fmoc-4-chloro-L-phenylalanine | 175453-08-4 | C24H20ClNO4 | 421.87 | Fmoc-L-Phe(4-Cl)-OH; (S)-2-(Fmoc-amino)-3-(4-chlorophenyl)propionic acid; (S)-Fmoc-2-amino-3-(4-chlorophenyl)propionic acid |
| (S)-3-[(9-Fluorenylmethoxycarbonyl)amino]-5-phenylpentanoic acid | 219967-74-5 | C26H25NO4 | 415.49 | Fmoc-Hph-(C#CH2)OH; Fmoc-Phe(#CH2,C#CH2)-OH; Fmoc-(S)-3-amino-5-phenylpentanoic acid; Fmoc-b-Nva(5-phenyl)-OH; N-(9-FLUORENYLMETHOXYCARBONYL)-(S)-3-AMINO-5-PHENYLPENTANOIC ACID; (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpentanoic acid; Fmo |
| (S)-3-[(t-Butoxycarbonyl)amino]-5-phenylpentanoic acid | 218608-84-5 | C16H23NO4 | 293.36 | Boc-Hph-(CCH2)OH; Boc-Phe(CH2,CCH2)-OH; Boc-b-Nva(5-phenyl)-OH; Boc-(S)-Amino-5-phenyl-pentanoic acid; BOC-(S)-3-AMINO-5-PHENYL-PENTANOIC ACID; BOC-HPH-(CCH2)OH; (S)-3-<<(tert-butoxy)carbonyl>amino>-5-phenylpentanoic acid |
| (S)-2-[(9-Fluorenylmethoxycarbonyl)amino]heptanoic acid | 1197020-22-6 | C22H25NO4 | 367.45 | Fmoc-Ahp(2)-OH; Fmoc-L-2-aminoheptanoic acid; Fmoc-S-2-aminoheptanoic acid; (S)-2-{[((9H-fluoren-9-yl)methoxy)carbonyl]amino}heptanoic acid |
| Boc-(R,S)-1,3-dihydro-2H-isoindole carboxylic acid | 221352-46-1 | C14H17NO4 | 263.29 | Boc-DL-Disc-OH; 2-(tert-butoxycarbonyl)isoindoline-1-carboxylic acid; (R,S)-BOC-1,3-DIHYDRO-2H-ISOINDOLE CARBOXYLIC ACID; 1,3-Dihydro-isoindole-1,2-dicarboxylic acid 2-tert-butyl ester; 2-[(2-methylpropan-2-yl)oxycarbonyl]-1,3-dihydroisoindole-1-carboxyli |
| (R)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid | 87226-41-3 | C17H21NO3 | 287.35 | 2-[(1R)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid; 2-[(1R)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid |
| (Z-Ala-Ala-Ala-Ala)2Rh110 | 149695-85-2 | C60H66N10O15 | 1167.2 | (Cbz-ala4)2-rhodamine; Bzt-ala-R; (Z-Ala-Ala-Ala-Ala)2Rhodamine110; bis-(CBZ-L-alanyl-L-arginine amide) Rhodamine 110; N-[(phenylmethoxy)carbonyl]-L-alanyl-L-alanyl-L-alanyl-N-[3-oxo-6'-[[N-[N-[N-[N-[(phenylmethoxy)carbonyl]-L-alanyl]-L-alanyl]-L-alanyl]- |
| Tyr0-C-Type Natriuretic Peptide (32-53) | 142878-79-3 | C102H166N28O30S3 | 2360.77 | H-Tyr-Gly-Leu-Ser-Lys-Gly-Cys(1)-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(1)-OH |
| (S,S,S)-AHPC hydrochloride | 2115897-23-7 | C22H30N4O3S·xHCl | 430.56 (free base) | (2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
| E3 ligase Ligand 10 | 1073560-68-5 | C47H52N4O7 | 784.94 | (2S)-2-[[(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]propanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-3,3-diphenylpropanoic acid |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | 2097971-11-2 | C30H45N5O7S·xHCl | 619.77 (free base) | VH 032-linker 1; (2S,4R)-1-((S)-14-Amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
| (S,R,S)-AHPC-PEG2-NH2 hydrochloride | 2097973-72-1 | C28H41N5O6S·xHCl | 575.72 (free base) | (2S,4R)-1-((S)-2-(2-(2-(2-Aminoethoxy)ethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
| (S,R,S)-AHPC-PEG2-azide | 2010159-45-0 | C28H39N7O6S | 601.72 | (2S,4R)-1-((S)-2-(2-(2-(2-Azidoethoxy)ethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| (S,R,S)-AHPC-PEG1-azide | 2101200-09-1 | C26H35N7O5S | 557.67 | (2S,4R)-1-((S)-2-(2-(2-Azidoethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| L-tert-Leucinol | 112245-13-3 | C6H15NO | 117.19 | H-Tle-ol; H-(tBu)Gly-ol; (S)-2-Amino-3,3-dimethyl-1-butanol; S-Tert-Leucinol; L-t-butyl leucinol |
| (S)-Sitagliptin N-Boc-Acid Impurity | 922178-94-7 | C15H18F3NO4 | 333.31 | |
| Fmoc-3-(2-naphthyl)-L-alanine | 112883-43-9 | C28H23NO4 | 437.49 | Fmoc-L-Ala(2-naphthyl)-OH |
| Fmoc-2,6-dimethyl-L-tyrosine | 206060-54-0 | C26H25NO5 | 431.48 | (S)-N-Fmoc-2,6-Dimethyltyrosine |
| Fmoc-3-(1-naphthyl)-L-alanine | 96402-49-2 | C28H23NO4 | 437.49 | Fmoc-L-Ala(1-naphthyl)-OH; (S)-N-Fmoc-1-naphthylalanine |
| Z-D-alanine-N-hydroxysuccinimide ester | 27167-53-9 | C15H16N2O6 | 320.30 | Z-D-Ala-OSu |
| (S)-(+)-1-Cbz-3-pyrrolidinol | 100858-32-0 | C12H15NO3 | 221.25 | (3S)-3-hydroxy-1-pyrrolidinecarboxylic acid (phenylmethyl) ester; benzyl (3S)-3-hydroxypyrrolidine-1-carboxylate |
| Boc-4-bromo-L-phenylalanine | 62129-39-9 | C14H18BrNO4 | 344.20 | Boc-L-Phe(4-Br)-OH; Boc-p-bromo-L-Phe-OH; (S)-Boc-2-amino-3-(4-bromophenyl)propionic acid |
| Boc-2-bromo-L-phenylalanine | 261165-02-0 | C14H18BrNO4 | 344.20 | Boc-L-Phe(2-Br)-OH; Boc-o-bromo-L-Phe-OH; (S)-Fmoc-2-amino-3-(2-bromophenyl)propionic acid; Boc-L-2-Bromophenylalanine; (S)-N-Boc-2-Bromophenylalanine; BOC-PHE(2-BR)-OH; N-Boc-2-bromo-L-phenylalanine; L-Phenylalanine, 2-bromo-N-[(1,1-dimethylethoxy)carbon |
| Boc-3-(1-naphthyl)-L-alanine | 55447-00-2 | C18H21NO4 | 315.36 | Boc-L-Ala(1-naphthyl)-OH; Boc-(S)-2-amino-3-(naphthalen-1-yl)propanoic acid; Boc-3-(1-naphthyl)-L-alanine; Boc-L-1-naphthylalanine; Boc-1-Nal-OH; (S)-N-Boc-L-(1-naphthyl)alanine; (2S)-2-[(tert-butoxy)carbonylamino]-3-naphthylpropanoic acid; Boc-L-3-(1-Nap |
| Z-Leu-Leu-Norvalinal | 133407-86-0 | C25H39N3O5 | 461.59 | benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxopentan-2-yl]amino]pentan-2-yl]amino]-1-oxopentan-2-yl]carbamate |
| S-Methylisothiourea hemisulfate salt | 867-44-7 | C4H14N4O4S3 | 139.19 | methyl carbamimidothioate;sulfuric acid |
| (S)-methyl 2-(tert-butoxycarbonylamino)-3-iodopropanoate | 170848-34-7 | C9H16INO4 | 329.13 | Boc-3-Iodo-D-Alanine Methyl Ester |
| (S)-Lisinopril-[d5] | 1356905-39-9 | C21H26D5N3O5 | 410.52 | ((S)-1-carboxy-3-(phenyl-d5)propyl)-L-lysyl-L-proline; Unk-Lys-Pro-OH-d5; (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline-d5 |
| Boc-L-homoproline | 26250-84-0 | C11H19NO4 | 229.27 | Boc-L-HomoPro-OH; (S)-1-Boc-piperidine-2-carboxylic acid; Boc L HomoPro OH |
| Benzyl-L-proline | 31795-93-4 | C12H15NO2 | 205.30 | Bzl-L-Pro-OH; (S)-Benzyl-pyrrolidine-2-carboxylic acid |
| D-Phenylglycine ethyl ester hydrochloride | 17609-48-2 | C10H13NO2·HCl | 215.68 | D-Phg-OEt HCl; (R)-(-)-2-Aminophenylacetic acid ethyl ester hydrochloride; D Phg OEt HCl |
| (S)-Boc-4-amino-pentanoic acid | 207924-92-3 | C10H19NO4 | 217.26 | (S)-4-((tert-Butoxycarbonyl)amino)pentanoic acid |
| (S)-5-Bromo-2,3-dihydro-1H-inden-1-amine Hydrochloride | 916210-93-0 | C9H11BrClN | 248.55 | (1S)-5-bromo-2,3-dihydro-1H-inden-1-amine;hydrochloride; (1S)-5-bromo-2,3-dihydro-1H-inden-1-amine;hydrochloride |
| (S)-4-Phenyloxazolidin-2-one | 99395-88-7 | C9H9NO2 | 163.18 | (4S)-(+)-4-Phenyl-1,3-oxazolidin-2-one |
| H-Phe(4-Br)-OH HCl | 122839-59-2 | C9H10BrNO2·HCl | 280.6 | 4-bromophenylalanine hydrochloride; (S)-2-amino-3-(4-bromophenyl)propanoic acid hydrochloride |
| (S)-3-Isopropylamino-1,2-propanediol | 90742-94-2 | C6H15NO2 | 133.19 | (S)-1-Isopropylaminopropanediol |
| (S)-3-Aminopentanoic acid | 14389-77-6 | C5H11NO2 | 117.15 | H-Ape(3)-OH; H-Abu(2)-(C#CH2)OH |
| H-D-Phe(4-Br)-Ome HCl | 270062-84-5 | C10H12BrNO2·HCl | 294.5 | (S)-3-Amino-4-(4-Bromophenyl)Butyric Acid Hydrochloride; 4-Bromo-L-Beta-Homophenylalanine Hydrochloride |
| (S)-2-hydroxy-3-(4-hydroxyphenyl)-propionic acid | 23508-35-2 | C9H10O4 | 182.17 | (S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid |
| Boc-3-(4'-pyridyl)-L-alanine | 37535-57-2 | C13H18N2O4 | 266.29 | Boc-L-Ala(4'-pyridyl)-OH; Boc-(S)-2-amino-3-(4'-pyridyl)propanoic acid; Boc-L-4-Pyridylalanine; Boc-Ala(4-pyridyl)-OH; Boc-3-(4-pyridyl)-L-alanine; Boc-4-Pal-Oh; (S)-2-((tert-Butoxycarbonyl)amino)-3-(pyridin-4-yl)propanoic acid; N-(tert-butoxycarbonyl)-3- |
| Boc-3-(3'-pyridyl)-L-alanine | 117142-26-4 | C13H18N2O4 | 266.29 | Boc-L-Ala(3'-pyridyl)-OH; (S)-N-Boc-(3-pyridyl)alanine; Boc-3-(3-pyridyl)-L-alanine; Boc-L-3-Pyridylalanine; Boc-3-(3-pyridyl)-alanine; BOC-3-PAL-OH; (S)-2-((tert-Butoxycarbonyl)amino)-3-(pyridin-3-yl)propanoic acid; Boc-3-(3-pyridyl)-Ala-OH; Boc-L-3-(3-p |
| Boc-L-meta-tyrosine | 90819-30-0 | C14H19NO5 | 281.30 | Boc-m-L-Tyr-OH; Boc-3-hydroxy-L-phenylalanine; (S)-Boc-2-amino-3-(3-hydroxyphenyl)propionic acid; Boc m L Tyr OH |
| Boc-Nin-formyl-L-1,2,3,4-tetrahydronorharmane-3-carboxylic acid | 327603-46-3 | C18H20N2O5 | 344.36 | Boc-L-Tpi(For)-OH |
| (S)-2-[(t-Butoxycarbonyl)amino]heptanoic acid | 71066-01-8 | C12H23NO4 | 245.32 | Boc-Ahp(2)-OH; (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]heptanoic acid; boc-ahep(2)-oh; n-boc-(s)-2-aminoheptanoic acid; (S)-2-tert-butoxycarbonylamino-heptanoic acid; (S)-2-n-boc-amino-heptanoic acid; boc-(2S)-2-amino-heptanoic acid |
| (S)-2-Methylpyrrolidine | 59335-84-1 | C5H11N | 85.15 | (2S)-2-methylpyrrolidine; (2S)-2-methylpyrrolidine |
| Boc-(3S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid | 78879-20-6 | C15H19NO4 | 277.30 | Boc-Tic-OH; (S)-2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (S)-N-Boc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (S)-2-Boc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; Boc-(S)-1,2,3,4-tetrahydroisoquinoline-3-carb |
| Boc-(S)-3-Amino-2-benzylpropanoic acid | 189619-55-4 | C15H21NO4 | 279.3 | (S)-2-benzyl-3-(tert-butoxycarbonylamino)propanoic acid |
| L-Phenylalaninol | 3182-95-4 | C9H13NO | 151.2 | (S)-2-amino-3-phenylpropan-1-ol; Phenylalaninol; (S)-(-)-2-Amino-3-phenyl-1-propanol |
| O-Benzyl-D-serinol | 58577-88-1 | C10H15NO2 | 181.24 | H-D-Ser(Bzl)-ol; (S)-2-Amino-3-benzyloxy-1-propanol; (S)-2-Amino-3-(benzyloxy)propan-1-ol;(2S)-2-Amino-3-(benzyloxy)propan-1-ol; 1-Propanol, 2-amino-3-(phenylmethoxy)-,(2S)-; H-Serinol(Bzl); O-Benzyl-D-Serinol |
| H-Trp(7-Me)-OH | 33468-36-9 | C12H14N2O2 | 218.25 | 7-methyl-L-tryptophan |
| 6-Methoxy-L-tryptophan | 16730-11-3 | C12H14N2O3 | 234.25 | (S)-2-Amino-3-(6-methoxy-1H-indol-3-yl)propanoic acid |
| H-6-F-Trp-OH | 19310-00-0 | C11H11FN2O2 | 222.2 | (S)-2-Amino-3-(6-fluoro-1H-indol-3-yl)propanoic acid |
| Nim-Benzyl-L-histidine | 16832-24-9 | C13H15N3O2 | 245.28 | L-His(Bzl)-OH; 2-amino-3-(1-benzylimidazol-4-yl)propanoic acid; Nim-benzyl-L-histidine; 1-benzyl-histidine; im-Benzyl-L-histidine; 1-benzyl-L-histidine; N-BENZYL-L-HISTIDINE |
| (S)-4-Bromo-alpha-methylbenzyl Alcohol | 100760-04-1 | C8H9BrO | 201.06 | (1S)-1-(4-bromophenyl)ethanol; (1S)-1-(4-bromophenyl)ethanol |
| O-Trityl-L-Pyroglutaminol | 105526-85-0 | C24H23NO2 | 357.5 | (S)-5-(Trityloxymethyl)-2-pyrrolidinone |
| (R)-3-Isopropylamino-1,2-propanediol | 97988-45-9 | C6H15NO2 | 133.19 | (+)-3-Isopropylamino-1,2-Propanediol |
| Boc-L-methionine sulfone | 60280-45-7 | C10H19NO6S | 281.30 | Boc-L-Met(O2)-OH; N-alpha-t-Butoxycarbonyl-L-methionine sulfone; (S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-4-METHYLSULFONYLBUTANOIC ACID |
| (S)-2-[(t-Butoxycarbonyl)amino]-4-methylpentanethioic acid 1-(6-nitro)benzotriazolide | 214750-70-6 | C17H23N5O4S | 393.47 | Boc-Thionoleu-1-(6-nitro)benzotriazolide; tert-butyl N-[(2S)-4-methyl-1-(6-nitrobenzotriazol-1-yl)-1-sulfanylidenepentan-2-yl]carbamate; Boc-L-thionoleucine-1-(6-nitro)benzotriazolide |
| Fmoc-(S)-2-Amino-4,4-difluorobutyric acid | 467442-21-3 | C19H17F2NO4 | 361.3 | Fmoc-Ala(CHF2)-OH; (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4,4-difluorobutanoic acid |
| N-(9-Fluorenylmethoxycarbonyl)-L-methioninol | 133565-47-6 | C20H23NO3S | 357.48 | Fmoc-Met-ol; (S)-2-[(9-Fluorenylmethoxycarbonyl)amino]-4-methylthio-1-butanol; Fmoc-b-HoTrp-OH |
| (R)-(+)-Glycidol | 57044-25-4 | C3H6O2 | 74.08 | [(2R)-2-oxiranyl]methanol; [(2R)-oxiran-2-yl]methanol |
| Z-L-cis-4-hydroxyproline | 13504-86-4 | C13H15NO5 | 265.30 | Z-cis-L-Hyp-OH |
| (E)-10-(4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-3-(4-(dimethylamino)styryl)-5,5-difluoro-1,7,9-trimethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 949108-72-9 | C33H37B2F2N3O2 | 567.295 | |
| Z-L-proline amide | 34079-31-7 | C13H16N2O3 | 248.28 | Z-L-Pro-NH2; (S)-Z-pyrrolidine-2-carboxylic acid amide |
| Boc-L-azetidine-2-carboxylic acid | 51077-14-6 | C9H15NO4 | 201.22 | Boc-(S)-azetidine-2-carboxylic acid |
| (S)-1-Benzyl-3-((p-tolylsulfonyl)oxy)-pyrrolidine | 116183-79-0 | C18H21NO3 | 331.4 | Toluene-4-sulfonic acid (S)-1-benzyl-pyrrolidin-3-yl ester |
| (S)-1,2,3,4-Tetrahydro-1-naphthoic Acid | 85977-52-2 | C11H12O2 | 176.21 | (1S)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid; (1S)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid |
| (S)-(+)-1,2,3,4-Tetrahydro-1-naphthylamine | 23357-52-0 | C10H13N | 147.22 | (1S)-1,2,3,4-tetrahydronaphthalen-1-amine; (1S)-1,2,3,4-tetrahydronaphthalen-1-amine |
| (S)-alpha-Methyl-4-methoxybenzyl Alcohol | 1572-97-0 | C9H12O2 | 152.19 | (1S)-1-(4-methoxyphenyl)ethanol; (1S)-1-(4-methoxyphenyl)ethanol |
| (S)-alpha-Methyl-3-methoxybenzyl Alcohol | 129940-69-8 | C9H12O2 | 152.19 | (1S)-1-(3-methoxyphenyl)ethanol; (1S)-1-(3-methoxyphenyl)ethanol |
| (S)-1-(3-Fluorophenyl)ethanol | 126534-32-5 | C8H9FO | 140.15 | (1S)-1-(3-fluorophenyl)ethanol; (1S)-1-(3-fluorophenyl)ethanol |
| (S)-1-(2-Methoxyphenyl)ethanol | 108100-06-7 | C9H12O2 | 152.19 | (1S)-1-(2-methoxyphenyl)ethanol; (1S)-1-(2-methoxyphenyl)ethanol |
| (S)-1-(2-Fluorophenyl)ethanol | 171032-87-4 | C8H9FO | 140.15 | (1S)-1-(2-fluorophenyl)ethanol; (1S)-1-(2-fluorophenyl)ethanol |
| (S)-2-Chloro-alpha-methylbenzyl Alcohol | 131864-71-6 | C8H9ClO | 156.61 | (1S)-1-(2-chlorophenyl)ethanol; (1S)-1-(2-chlorophenyl)ethanol |
| (S)-2-Bromo-alpha-methylbenzyl Alcohol | 114446-55-8 | C8H9BrO | 201.06 | (1S)-1-(2-bromophenyl)ethanol; (1S)-1-(2-bromophenyl)ethanol |
| (S)-1-Fmoc-4-Boc-piperazine-2-carboxylic acid | 244132-27-2 | C25H28N2O6 | 452.5 | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid |
| Boc-Tryptophanol | 82689-19-8 | C16H22N2O3 | 290.3 | Boc-L-Trp-ol; N-BOC-L-Tryptophanol; Boc-L-tryptophanol |
| Boc-(S)-3-amino-2-oxo-1-pyrrolidine-acetic acid | 79839-26-2 | C11H18N2O5 | 258.27 | (S)-2-(3-((tert-Butoxycarbonyl)amino)-2-oxopyrrolidin-1-yl)acetic acid; (S)-(3-N-Boc-Amino-2-oxo-pyrrolidin-1-yl)-aceticacid; (s)-3-(boc-amino)-2-oxo-1-pyrrolidine-acetic acid; (3S)-3-(tert-Butoxycarbonylamino)-2-oxopyrrolidine-1-acetic acid; 2-[(3S)-3-[( |
| (S)-(+)-1,2-Propanediol | 4254-15-3 | C3H8O2 | 76.09 | (2S)-propane-1,2-diol; (2S)-propane-1,2-diol |
| (S)-Glycidyl Butyrate | 65031-96-1 | C7H12O3 | 144.17 | butanoic acid [(2S)-2-oxiranyl]methyl ester; [(2S)-oxiran-2-yl]methyl butanoate |
| (S)-Glycidol | 60456-23-7 | C3H6O2 | 74.08 | [(2S)-2-oxiranyl]methanol; [(2S)-oxiran-2-yl]methanol |
| (2S)-2-methylpiperazine | 74879-18-8 | C5H12N2 | 100.165 | (2S)-2-methylpiperazine; (2S)-2-methylpiperazine |
| (S)-(+)-1-Amino-2-propanol | 2799-17-9 | C3H9NO | 75.11 | (S)-1-Aminopropan-2-Ol; (2S)-1-Aminopropan-2-Ol; (+)-Isopropanolamine; (S)-1-Amino-2-Propanol |
| (S)-(-)-Propranolol hydrochloride | 4199-10-4 | 295.8 | (S)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride | |
| (S)-(-)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene | 76189-56-5 | C44H32P2 | 622.67 | [1-(2-diphenylphosphino-1-naphthalenyl)-2-naphthalenyl]-diphenylphosphine; [1-(2-diphenylphosphanylnaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane |
| (S)-(-)-Tetrahydro-2-furoic Acid | 87392-07-2 | C5H8O3 | 116.12 | (2S)-2-oxolanecarboxylic acid; (2S)-oxolane-2-carboxylic acid |
| L-Azetidine-2-carboxylic acid | 2133-34-8 | C4H7NO2 | 101.10 | (S)-2-Azetidine-2-carboxylic acid |
| (S)-3-(Boc-Amino)pyrrolidine | 122536-76-9 | C9H18N2O2 | 186.25 | N-[(3S)-3-pyrrolidinyl]carbamic acid tert-butyl ester; tert-butyl N-[(3S)-pyrrolidin-3-yl]carbamate |
| Fmoc-(R,S)-Boc-imidazolidine-2-carboxylic acid | 207129-12-2 | C24H26N2O6 | 438.47 | RARECHEM EM WB 0139; (R,S)-N-FMOC-N'-BOC-IMIDAZOLIDINE-2-CARBOXYLIC ACID; FMOC-(R,S)-BOC-IMIDAZOLIDINE-2-CARBOXYLIC ACID |
| Fmoc-(R,S)-3-amino-3-(1-naphthyl)propionic acid | 269078-77-5 | C28H23NO4 | 437.49 | Fmoc-DL-3-(naphthalene-1-yl)-3-amino-propionic acid |
| DL-Isopropylideneglycerol-1,1,2,3,3-[d5] | 74300-14-4 | C6H7D5O3 | 137.19 | DL-Isopropylideneglycerol-1,1,2,3,3-d5; (R,S)-2,2-Dimethyl-1,3-dioxolane-4-methanol-d5; (RS)-Solketal-d5; (+/-)-1,2-O-Isopropylideneglycerol-d5; (+/-)-Glycerol 1,2-Acetonide-d5; 1,2-Isopropylideneglycerin-d5; 1,2-Isopropylideneglycerol-d5; 2,3-(Isopropyli |
| (R)-1-Boc-pyrrolidine-3-carbaldehyde | 191347-94-1 | C10H17NO3 | 199.25 | (3R)-3-formyl-1-pyrrolidinecarboxylic acid tert-butyl ester; tert-butyl (3R)-3-formylpyrrolidine-1-carboxylate |
| (R)-Propranolol HCl | 13071-11-9 | C16H21NO2.HCl | 295.81 | (2R)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol Hydrochloride; (+)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol Hydrochloride; (+)-Anapriline; (+)-Propranolol Hydrochloride; (R)-(+)-Propranolol Hydrochloride; AY 20694; Dexpropranolol Hyd |
| (R)-2-Pentanol | 31087-44-2 | C5H12O | 88.15 | (2R)-2-pentanol; (2R)-pentan-2-ol |
| (R)-2-Octanol | 5978-70-1 | C8H18O | 130.23 | (2R)-2-octanol; (2R)-octan-2-ol |
| Fmoc-D-Aze-OH | 374791-02-3 | C19H17NO4 | 323.3 | D-Fmoc-Azetidine-2-carboxylic acid; (R)-N-Fmoc-azetidine-2-carboxylic acid; Fmoc D Aze OH |
| Fmoc-4-fluoro-D-phenylalanine | 177966-64-2 | C24H20FNO4 | 405.42 | Fmoc-4-fluoro-D-phenylalanine; Fmoc-p-fluoro-D-Phe-OH; (R)-Fmoc-2-amino-3-(4-fluorophenyl)propionic acid |
| Z-L-glutamine methyl ester | 2650-67-1 | C14H18N2O5 | 294.31 | Z-L-Gln-OMe |
| Fmoc-3-(2-naphthyl)-D-alanine | 138774-94-4 | C28H23NO4 | 437.49 | Fmoc-D-Ala(2-naphthyl)-OH |
| Fmoc-2-fluoro-D-phenylalanine | 198545-46-9 | C24H20FNO4 | 405.42 | Fmoc-D-Phe(2-F)-OH; Fmoc-o-fluoro-D-Phe-OH; (R)-Fmoc-2-amino-3-(2-fluorophenyl)propionic acid |
| Fmoc-3-(2'-pyridyl)-D-alanine | 185379-39-9 | C23H20N2O4 | 388.42 | Fmoc-D-Ala(2'-pyridyl)-OH; (R)-N-Fmoc-(2-pyridyl)alanine |
| (R)-(-)-1-Cbz-3-pyrrolidinol | 100858-33-1 | C12H15NO3 | 221.25 | (3R)-3-hydroxy-1-pyrrolidinecarboxylic acid (phenylmethyl) ester; benzyl (3R)-3-hydroxypyrrolidine-1-carboxylate |
| Boc-4-chloro-D-phenylalanine | 57292-44-1 | C14H18ClNO4 | 299.75 | Boc-D-Phe(4-Cl)-OH; Boc-p-chloro-D-Phe-OH; (R)-Boc-2-amino-3-(4-chlorophenyl)propionic acid |
| Boc-4-bromo-D-phenylalanine | 79561-82-3 | C14H18BrNO4 | 344.20 | Boc-D-Phe(4-Br)-OH; Boc-p-bromo-D-Phe-OH; (R)-Boc-2-amino-3-(4-bromophenyl)propionoic acid |
| Boc-2-bromo-D-phenylalanine | 261360-76-3 | C14H18BrNO4 | 344.20 | Boc-D-Phe(2-Br)-OH; Boc-o-bromo-D-Phe-OH; (R)-Fmoc-2-amino-3-(2-bromophenyl)propionic acid; Boc-D-2-Bromophenylalanine; (R)-N-Boc-2-Bromophenylalanine; N-Boc-2-bromo-D-phenylalanine; (R)-3-(2-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid; D-Ph |
| Boc-3-(4-pyridyl)-D-alanine | 37535-58-3 | C13H18N2O4 | 266.29 | Boc-D-Ala(4'-pyridyl)-OH; (R)-N-Boc-(4'-pyridyl)alanine; BOC-D-4-PYRIDYLALANINE; Boc-D-4-Pal-OH; (R)-2-((tert-Butoxycarbonyl)amino)-3-(pyridin-4-yl)propanoic acid; (2R)-2-[(tert-butoxy)carbonylamino]-3-(4-pyridyl)propanoic acid; BOC-4'-PYRIDYL-D-ALA; BOC- |
| Boc-3-(2'-pyridyl)-D-alanine | 98266-32-1 | C13H18N2O4 | 266.29 | Boc-D-Ala(2'-pyridyl)-OH; (R)-2-tert-Butoxycarbonylamino-3-pyridin-2-yl-propionic acid; Boc-D-2-pyridylalanine; BOC-D-2-PAL-OH; BOC-2'-PYRIDYL-D-ALA; Boc-D-3-(2-pyridyl)-alanine; BOC-D-ALA(2-PYRI)-OH; N-Boc-beta-(2-pyridinyl)-D-alanine; (2R)-2-[(2-methylp |
| (R)-Fmoc-4-amino-5-(3-indolyl)pentanoic acid | 917099-01-5 | C28H26N2O4 | 454.5 | (R)-Fmoc-4-amino-5-(1h-indol-3-yl)-pentanoic acid |
| D-Phenylalanine ethyl ester hydrochloride | 63060-94-6 | C11H15NO2·HCl | 229.70 | D-Phe-OEt HCl; (R)-Ethyl 2-amino-3-phenylpropanoate hydrochloride |
| (R)-Cetirizine-[d4] Dihydrochloride | 1133210-23-7 | C21H23D4Cl3N2O3 | 465.83 | Levocetirizine D4 Dihydrochloride; 2-[2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-d4]acetic Acid Dihydrochloride; (-)-Cetirizine-d4 Dihydrochloride |
| Boc-4-oxo-D-Pro-OH | 364077-84-9 | C10H15NO5 | 229.23 | (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid; (R)-4-Oxo-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester |
| Fmoc-(R)-3-Amino-2-methylpropanoic acid | 211682-15-4 | C19H19NO4 | 325.4 | (R)-3-(Fmoc-amino)-2-methylpropionic acid |
| Boc-(R)-3-Amino-2-methylpropanoic acid | 132696-45-8 | C9H17NO4 | 203.24 | (R)-3-((tert-butoxycarbonyl)amino)-2-methylpropanoic acid; (R)-3-(Boc-amino)-2-methylpropionic acid |
| 2-Methoxy-D-phenylglycine | 103889-84-5 | C9H11NO3 | 181.19 | H-D-Phg(2-OMe)-OH; (R)-2-Methoxyphenylglycine |
| (R)-(-)-2-(Methoxymethyl)pyrrolidine | 84025-81-0 | C6H13NO | 115.16 | O-Methyl-D-Prolinol; (R)-2-(Methoxymethyl)pyrrolidine; (R)-(-)-2-(Methoxymethyl)pyrrolidine; (2R)-2-(methoxymethyl)pyrrolidine |
| Fmoc-D-cyclopentylglycine | 136555-16-3 | C22H23NO4 | 365.42 | Fmoc-D-Gly(cyclopentyl)-OH; (R)-2-Cyclopentyl-2-(Fmoc-amino)-acetic acid |
| (R)-2-Benzyl-3-((tert-butoxycarbonyl)amino)propanoic acid | 262301-38-2 | C15H21NO4 | 279.33 | (R)-2-benzyl-3-(tert-butoxycarbonylamino)propanoic acid |
| D-3,4-Dichlorophenylalanine | 52794-98-6 | C9H9NO2Cl2 | 234.08 | D-Phe(3,4-DiCl)-OH; H-D-Phe(3,4-Cl2)-OH; (R)-2-Amino-3-(3,4-dichlorophenyl)propionic acid |
| D-Isovaline | 3059-97-0 | C5H11NO2 | 117.2 | (R)-(-)-2-Amino-2-methylbutanoicacidmonohydrate(e.e.); (R)-(-)-2-AMINO-2-METHYLBUTANOIC ACID MONOHYDRATE 99+% (99+% E.E.); (R)-(-)-2-Amino-2-methylbutanoic acid; D(-)-Isovaline; D-ISO-VALINE((R)-2-AMINO-2-METHYLBUTANOIC ACID ); (R)-alpha-Ethylalanine (>98 |
| (R)-2-Amino-2-methyl-4-pentenoic acid | 96886-55-4 | C6H11NO2 | 129.16 | (S)-(-)-2-AMINO-2-METHYL-4-PENTENOIC ACID HYDRATE; (S)-(-)-2-AMINO-2-METHYL-4-PENTENOIC ACID MONOHYDRATE; L-ALPHA-ALLYLALANINE HYDRATE; L-ALPHA-ALLYLALANINE, MONOHYDRATE; 2-Allyl-D-Alanine; 2-Allyl-L-Alanine; (S)-(-)-2-Amino-2-methyl-4-pentenoicacidmonohy |
| (R)-2-Amino-2-(4-fluorophenyl)ethanol | 174770-74-2 | C8H10FNO | 155.17 | (2R)-2-amino-2-(4-fluorophenyl)ethanol; (2R)-2-amino-2-(4-fluorophenyl)ethanol |
| (R)-beta-Amino-3-chlorophenethyl Alcohol | 926291-77-2 | C8H10ClNO | 171.62 | (2R)-2-amino-2-(3-chlorophenyl)ethanol; (2R)-2-amino-2-(3-chlorophenyl)ethanol |
| 2,4,5-Trifluoro-D-phenylalanine | 1217601-63-2 | C9H8F3NO2 | 219.16 | H-D-Phe(2,4,5-F3)-OH |
| D-2,3-Diaminopropionic acid hydrochloride | 6018-56-0 | C3H8N2O2·HCl | 140.57 | D-Dap-OH HCl; (R)-2,3-Diaminopropionic acid hydrochloride; D Dap OH HCl |
| Boc-D-alanine | 7764-95-6 | C8H15NO4 | 189.20 | Boc-D-Ala-OH; N-(tert-Butoxycarbonyl)-D-alanine |
| 2-(R)-Fmoc-amino-3-azidopropionic acid | 1016163-79-3 | C18H16N4O4 | 352.30 | Fmoc-D-Ala(N3)-OH; Fmoc-D-Dap(N3)-OH; 3-Azido-N-Fmoc-D-alanine; Fmoc-d-aza-oh; (2R)-3-azido-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; Fmoc D AZA OH |
| Fmoc-3,3-diphenyl-D-alanine | 189937-46-0 | C30H25NO4 | 463.52 | Fmoc-D-Ala(3,3-diphenyl)-OH |
| (R)-(+)-1-Phenylethanol | 1517-69-7 | C8H10O | 122.16 | (1R)-1-phenylethanol; (1R)-1-phenylethanol |
| Boc-D-homoproline | 28697-17-8 | C11H19NO4 | 229.27 | (R)-N-Boc-piperidine-2-carboxylic acid; Boc-D-pipecolic acid |
| Boc-R-Pip-3MeOH | 140695-85-8 | C11H21NO3 | 215.29 | (R)-1-BOC-3-(hydroxymethyl)piperidine; tert-butyl(3R)-3-(hydroxymethyl)piperidine-1-carboxylate |
| N-(t-Butoxycarbonyl)-D-nipecotic acid | 163438-09-3 | C11H19NO4 | 229.27 | Boc-D-Pic(3)-OH; Boc-D-Nipc-OH; (R)-1-(t-Butoxycarbonyl)piperidine-3-carboxylic acid; (R)-Boc-Nipecotic Acid; (R)-N-BOC-piperidine-3-carboxylic acid; 1-Boc-D-nipecotic acid; (R)-Boc-Nip-OH; (3R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-3-carboxylic |
| (R)-(+)-1-Benzyl-3-pyrrolidinol | 101930-07-8 | C11H15NO | 177.24 | (3R)-1-(phenylmethyl)-3-pyrrolidinol; (3R)-1-benzylpyrrolidin-3-ol |
| (R)-1-Aminoindane Hydrochloride | 10305-73-4 | C9H12ClN | 169.65 | (1R)-2,3-dihydro-1H-inden-1-amine;hydrochloride; (1R)-2,3-dihydro-1H-inden-1-amine;hydrochloride |
| Fmoc-(2S,4R)-4-amino-1-Boc-pyrrolidine-2-carboxylic acid | 176486-63-8 | C25H28N2O6 | 452.50 | Fmoc-ABPC(2S,4R)-OH |
| (R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid | 103733-65-9 | C10H11NO2 | 177.2 | H-D-TIC-OH; (3R)-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid; 3-Isoquinolinecarboxylic Acid, 1,2,3,4-Tetrahydro-, (3R)-; D-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid |
| (R)-1-Amino-1,2,3,4-Tetrahydronaphthalene | 23357-46-2 | C10H13N | 147.22 | (1R)-1,2,3,4-tetrahydronaphthalen-1-amine; (1R)-1,2,3,4-tetrahydronaphthalen-1-amine |
| (R)-4-Chloro-alpha-methylbenzyl Alcohol | 75968-40-0 | C8H9ClO | 156.61 | (1R)-1-(4-chlorophenyl)ethanol; (1R)-1-(4-chlorophenyl)ethanol |
| (R)-4-Bromo-alpha-methylbenzyl Alcohol | 76155-78-7 | C8H9BrO | 201.06 | (1R)-1-(4-bromophenyl)ethanol; (1R)-1-(4-bromophenyl)ethanol |
| (R)-1-(m-Tolyl)ethanol | 42070-91-7 | C9H12O | 136.19 | (1R)-1-(3-methylphenyl)ethanol; (1R)-1-(3-methylphenyl)ethanol |
| (R)-3-Methoxy-alpha-methylbenzyl Alcohol | 120523-12-8 | C9H12O2 | 152.19 | (1R)-1-(3-methoxyphenyl)ethanol; (1R)-1-(3-methoxyphenyl)ethanol |
| (R)-1-(3-Fluorophenyl)ethanol | 126534-33-6 | C8H9FO | 140.15 | (1R)-1-(3-fluorophenyl)ethanol; (1R)-1-(3-fluorophenyl)ethanol |
| (R)-3-Bromo-alpha-methylbenzyl Alcohol | 134615-24-0 | C8H9BrO | 201.06 | (1R)-1-(3-bromophenyl)ethanol; (1R)-1-(3-bromophenyl)ethanol |
| (R)-1-(2-Methoxyphenyl)ethanol | 113724-48-4 | C9H12O2 | 152.19 | (1R)-1-(2-methoxyphenyl)ethanol; (1R)-1-(2-methoxyphenyl)ethanol |
| (R)-1-(2-Fluorophenyl)ethanol | 162427-79-4 | C8H9FO | 140.15 | (1R)-1-(2-fluorophenyl)ethanol; (1R)-1-(2-fluorophenyl)ethanol |
| (R)-2-Chloro-alpha-methylbenzyl Alcohol | 120466-66-2 | C8H9ClO | 156.61 | (1R)-1-(2-chlorophenyl)ethanol; (1R)-1-(2-chlorophenyl)ethanol |
| (R)-2-Bromo-alpha-methylbenzyl Alcohol | 76116-20-6 | C8H9BrO | 201.06 | (1R)-1-(2-bromophenyl)ethanol; (1R)-1-(2-bromophenyl)ethanol |
| (R)-(+)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene | 76189-55-4 | C44H32P2 | 622.67 | [1-(2-diphenylphosphino-1-naphthalenyl)-2-naphthalenyl]-diphenylphosphine; [1-(2-diphenylphosphanylnaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane |
| (R)-(+)-Tetrahydro-2-furoic Acid | 87392-05-0 | C5H8O3 | 116.12 | (2R)-2-oxolanecarboxylic acid; (2R)-oxolane-2-carboxylic acid |
| D-Tryptophan | 153-94-6 | C11H12N2O2 | 204.20 | D-Trp-OH; (R)-2-Amino-3-(3-indolyl)propionic acid |
| D-tert-Leucinol | 112245-09-7 | C6H15NO | 117.19 | |
| (R)-(-)-1-Aminoindane | 10277-74-4 | C9H11N | 133.19 | (1R)-2,3-dihydro-1H-inden-1-amine; (1R)-2,3-dihydro-1H-inden-1-amine |
| (R)-(-)-1-Amino-2-propanol | 2799-16-8 | C3H9NO | 75.11 | (2R)-1-amino-2-propanol; (2R)-1-aminopropan-2-ol |
| (R)-(-)-1,2-Propanediol | 4254-14-2 | C3H8O2 | 76.09 | (2R)-propane-1,2-diol; (2R)-propane-1,2-diol |
| (R)-(-)-1,1'-Binaphthyl-2,2'-diyl Hydrogenphosphate | 39648-67-4 | C20H13O4P | 348.29 | 13-hydroxy-12,14-dioxa-13$l^{5}-phosphapentacyclo[13.8.0.0^{2,11}.0^{3,8}.0^{18,23}]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaene 13-oxide; 13-hydroxy-12,14-dioxa-13$l^{5}-phosphapentacyclo[13.8.0.0^{2,11}.0^{3,8}.0^{18,23}]tricosa-1(15),2(11),3,5,7,9,1 |
| (R)-3-(Boc-amino)pyrrolidine | 122536-77-0 | C9H18N2O2 | 186.25 | N-[(3R)-3-pyrrolidinyl]carbamic acid tert-butyl ester; tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate |
| D-Cystine bis(methyl ester) dihydrochloride | 144000-36-2 | C8H16N2O4S2·2HCl | 341.28 | (H-D-Cys-OMe)2 2HCl; Dimethyl D-cystinate dihydrochloride |
| D-Cystine | 349-46-2 | C6H12N2O4S2 | 240.30 | (H-D-Cys-OH)2; (S,S)-3,3'-Dithio-bis(2-aminopropionic acid) |
| L-Cystine bis-4-nitroanilide | 34199-07-0 | C18H20N6O6S2 | 480.50 | (H-L-Cys-pNA)2; L-CYSTINE BIS-P-NITROANILIDE; cystine-bis-4-nitroanilide; L-CYSTINYL-BIS-4-NITROANILIDE |
| L-Cystine bis(tert-butyl ester) dihydrochloride | 38261-78-8 | C14H28N2O4S2·2HCl | 425.44 | (H-L-Cys-OtBu)2 2HCl; tert-butyl (2R)-2-amino-3-[[(2R)-2-amino-3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]disulfanyl]propanoate,dihydrochloride; (2R,2'R)-Di-tert-butyl 3,3'-disulfanediylbis(2-aminopropanoate) dihydrochloride |
| L-Cystine bis-ethyl ester dihydrochloride(Disulfide Bond) | 22735-07-5 | C10H20N2O4S2·2HCl | 369.33 | (H-L-Cys-OEt)2 2HCl; [3-[(2-azaniumyl-3-ethoxy-3-oxopropyl)disulfanyl]-1-ethoxy-1-oxopropan-2-yl]azanium,dichloride; L-Cystin-diethylester; L-cistine diethyl ester dihydrochloride; diethyl L-cystinate dihydrochloride; (H-Cys-OEt)2 2HCl,(Disulfide bond); L |
| trans,trans-Farnesol | 106-28-5 | C15H26O | 222.37 | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
| (3aR,3bS,6S,6aR,7aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2',3':4,5]furo[2,3-d][1,3]dioxol-5(3aH)-one | 20513-98-8 | C9H12O6 | 216.19 | (1S,2R,6R,8R,9S)-9-hydroxy-4,4-dimethyl-3,5,7,11-tetraoxatricyclo[6.3.0.0^{2,6}]undecan-10-one; (1S,2R,6R,8R,9S)-9-hydroxy-4,4-dimethyl-3,5,7,11-tetraoxatricyclo[6.3.0.0^{2,6}]undecan-10-one |
| (2S,4S)-3-Benzyloxycarbonyl-4-methyl-2-phenyl-1,3-oxazolidin-5-one | 171860-41-6 | C18H17NO4 | 311.3 | (2S,4S)-3-BENZYLOXYCARBONYL-4-METHYL-2-PHENYL-1,3-OXAZOLIDIN-5-ONE; (2S, 4S) Z-5-OXAZOLIDINONE(2-PH, 4-ME); Benzyl (2S,4S)-4-methyl-5-oxo-2-phenyl-1,3-oxazolidine-3-carboxylate |
| (1R,2S)-(-)-2-Amino-1,2-diphenylethanol | 23190-16-1 | C14H15NO | 213.28 | (1R,2S)-2-amino-1,2-diphenylethanol; (1R,2S)-2-amino-1,2-diphenylethanol |
| Capsaicin | 404-86-4 | C18H27NO3 | 305.41 | (E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide |
| (E) 3',6'-bis(diethylamino)-2-(4-oxopent-2-en-2-ylamino)spiro(isoindoline-1,9'-xanthen)-3-one | 1391913-90-8 | C33H38N4O3 | 638.68 | |
| Pentafluorphenol-tetramethyluronium hexafluorophosphat | 206190-14-9 | C11H12F5N2O.PF6 | 428.18 | (Dimethylamino)dimethyl(2,3,4,5,6-pentafluorophenoxy)methanaminium hexafluorophosphate; PENTAFLUOROPHENOL-TETRAMETHYLURONIUM HEXAFLUOROPHOSPHATE; PFTU; Pentafluorphenol-tetramethyluronium hexafluorophosphat; Pftu; 1,1,3,3-Tetramethyl-2-(perfluorophenyl)is |
| (Dap22)-ShK | 220384-25-8 | C166H268N54O48S7 | 4012.8 | |
| Amino-BCheptane-COOH HCl(S,R,S,R/R,S,R,S) | 14932-25-3 | C8H13NO2HCl | 191.66 | (1S,2R,3S,4R/1R,2S,3R,4S)-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid hydrochloride (1:1); (CIS)-2-AMINO-3-CARBOXYBICYCLO[2.2.1]HEPTANE HYDROCHLORIDE |
| (Benzotriazol-1-yloxy)dipyrrolidinocarbenium hexafluorophosphate | 105379-24-6 | 431.32 | HBPYU; (BENZOTRIAZOL-1-YLOXY)DIPYRROLIDINOCARBENIUM HEXAFLUOROPHOSPHATE; O-(BENZOTRIAZOL-1-YL)-N,N,N',N'-BIS(TETRAMETHYLENE)URONIUM HEXAFLUOROPHOSPHATE; O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene; O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene | |
| (Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate | 190849-64-0 | 459.37 | HBPipU; O-(BENZOTRIAZOL-1-YL)-N,N,N',N'-BIS(PENTAMETHYLENE)URONIUM HEXAFLUOROPHOSPHATE; HBPIPU; (BENZOTRIAZOL-1-YLOXY)DIPIPERIDINOCARBENIUM HEXAFLUOROPHOSPHATE; HBPIPU 98+%; HBPIPU (BENZOTRIAZOL-1-YLOXY)DIPIPERIDINOCARBENIUM HEXAFLUOROPHOSPHATE; 1-(((1H-B | |
| (Arg)9 | 143413-47-2 | C54H110N36O10 | 1423.69 | Nona-arginine; Nona-l-arginine; H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH |
| (Aminomethyl)phosphonic acid | 1066-51-9 | CH6NO3P | 111.04 | aminomethylphosphonic acid |
| Acetyl-L-cystine bis-methyl ester[Disulfide bond] | 32381-28-5 | C12H20N2O6S2 | 352.43 | (Ac-L-Cys-OMe)2; Dimethyl diacetyl cystinate |
| Fmoc-Ala-Thr[Psi(Me,Me)Pro]-OH | 252554-79-3 | C25H28N2O6 | 452.51 | Fmoc-Ala-Thr[y(Me,Me)Pro]-OH; (4S,5R)-3-(Fmoc-Ala)-2,2,5-trimethyl-oxazolidine-4-carboxylic acid; Fmoc-Ala-Thr(psi(Me,Me))-OH; Fmoc-Ala-Thr(y(Me,Me))-OH; (4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-c |
| Fmoc-(2S,4S)-4-amino-1-Boc-pyrrolidine-2-carboxylic acid | 174148-03-9 | C25H28N2O6 | 452.50 | Fmoc-ABPC(2S,4S)-OH |
| 7-Ethyl-10-hydroxycamptothecin | 86639-52-3 | C22H20N2O5 | 392.40 | (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione |
| (4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid | 186046-78-6 | C20H17N3O5 | 379.4 | (4-benzhydryloxycarbonylamino-2-oxo-2h-pyrimidin-1-yl)-acetic acid; AK-33847 |
| (3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid | 49642-07-1 | C8H17NO3 | 175.23 | Statine; H-(3S,4S)Sta-OH |
| 2-[(S)-2-(9-Fluorenylmethoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-3-yl]acetic acid | 270062-99-2 | C26H23NO4 | 413.47 | Fmoc-Tic-(C#CH2)OH; 2-[(3S)-2-(9H-fluoren-9-ylmethoxycarbonyl)-3,4-dihydro-1H-isoquinolin-3-yl]acetic acid; (S)-2-(2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)acetic acid; Fmoc-(S)-2-tetrahydroisoquinoline acetic acid; Fmoc-T |
| 1-Methyl-4-nitroimidazole | 3034-41-1 | C4H5N3O2 | 127.10 | 1-methyl-4-nitroimidazole; 1-methyl-4-nitroimidazole |
| (3R,4R)-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride | 1062580-52-2 | C14H24Cl2N2 | 291.26 | (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine;dihydrochloride; (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine;dihydrochloride |
| (3-Hydroxy-3H-1,2,3-triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinylphosphonium hexafluorophosphate | 156311-83-0 | 521.38 | PyAOP; (7-AZABENZOTRIAZOL-1-YLOXY)TRIPYRROLIDINO-PHOSPHONIUM HEXAFLUOROPHOSPHATE; 7-AZABENZOTRIAZOL-1-YLOXY-TRIS-(PYRROLIDINO)PHOSPHONIUM HEXAFLUOROPHOSPHATE; (7-AZABENZOTRIAZOLE-1-YLOXY)TRIPYRROLIDINOPHOSPHONIUM HEXAFLUOROPHOSPHATE; PYAOP; ((3H-[1,2,3]Tr | |
| (3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol | 1632118-70-7 | C26H46O3 | 406.64 | (3R,5S,6S,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-[(2R)-5-hydroxypentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol; (3R,5S,6S,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-[(2R)-5-hydroxypentan-2-yl]-10 |
| (Boc-NH-7,7-Me2-BChept-3-yl]acetic acid(R,R,S,S) | 654680-62-3 | C16H27NO4 | 297.39 | (1R,3R,4S,6S)-4-[(tert-butoxycarbonyl)amino]-4,7,7-trimethylbicyclo[4.1.0]heptane-3-carboxylic acid |
| Boc-4-(aminomethyl)-L-phenylalanine | 137452-49-4 | C15H22N2O4 | 294.35 | Boc-L-Phe(4-CH2NH2)-OH; Boc-p-(aminomethyl)-L-Phe-OH; (S)-Boc-2-amino-3-(4-aminomethylphenyl)propionic acid |
| Fmoc-4-amino-L-phenylalanine | 95753-56-3 | C24H22N2O4 | 402.44 | Fmoc-L-Phe(4-NH2)-OH; Fmoc-p-amino-L-Phe-OH; (S)-Fmoc-2-amino-3-(4-aminophenyl)propionic acid |
| (2S,5R)-5-Hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | (2S,5R)-5-Hydroxypipecolic acid HCl; (2S,5R)-5-hydroxypipecolic acid hydrochloride | ||
| (2S,4S)-4-Fluoro-pyrrolidine-2-carboxylic acid | 2438-57-5 | C5H8FNO2 | 133.12 | cis-4-Fluoro-L-Pro-OH; cis-4-Fluoro-L-proline; (2S,4S)-4-fluoropyrrolidine-2-carboxylic acid; cis-4-Fluoroproline; (4S)-4-fluoro-L-proline; cis 4 Fluoro L Pro OH |
| Fmoc-O-tert-butyl-L-trans-4-hydroxyproline | 122996-47-8 | C24H27NO5 | 409.47 | Fmoc-L-Hyp(tBu)-OH |
| Fmoc-L-trans-4-hydroxyproline | 88050-17-3 | C20H19NO5 | 353.37 | Fmoc-L-Hyp-OH; Fmoc L Hyp OH |
| L-4-trans-Hydroxyproline ethyl ester hydrochloride | 33996-30-4 | C7H13NO3·HCl | 195.62 | L-Hyp-OEt HCl; (2S,4R)-(-)-Ethyl 4-hydroxy-2-pyrrolidin-carboxylate hydrochloride |
| Boc-(2S,4S)-4-amino-1-Fmoc-pyrrolidine-2-carboxylic acid | 221352-74-5 | C25H28N2O6 | 452.60 | Boc-(2S,4S)-4-amino-1-Fmoc-pyrrolidine-2-carboxylic acid; (2S,4S)-Boc-4-amino-1-fmoc-pyrrolidine-2-carboxylic acid; 1,2-Pyrrolidinedicarboxylic acid,4-[[(1,1-dimethylethoxy)carbonyl]amino]-, 1-(9H-fluoren-9-ylmethyl)ester, (2S,4S)-; (4S)-1-Fmoc-4-(Boc-ami |
| (2S,3S)-Fmoc-Apns-OH | 210754-59-9 | C25H23NO5 | 417.46 | Fmoc-(2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid; (2S,3S)-Fmoc-AHPBA; (2S,3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-hydroxy-4-phenylbutanoic acid; cis-1-Amino-4-phenylcyclohexanecarboxylic acid, N-FMOC protected; Fmoc-Apc-OH; Fmoc-Apns-OH; N-Fmoc-( |
| (2S,3S)-3-[(t-Butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyric acid | 116661-86-0 | C15H21NO5 | 295.33 | Boc-AHPBA-OH; Boc-Apns-OH; (2S,3S)-3-[(t-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyric acid; N-TERT-BOC-(2R,3R)-3-AMINO-2-HYDROXY-4--PHENYLBUTYRIC ACID; N-BOC-(2S-3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYRIC ACID; (2S,3S)-3-N-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY |
| (2S,3S)-3-Amino-2-hydroxy-5-methylhexanoic acid | 73397-20-3 | C7H15NO3 | 161.20 | 3(S)-amino-2(S)-hydroxy-5-methylhexanoic acid; (2S,3S)-3-AMINO-2-HYDROXY-5-METHYL-HEXANOIC ACID |
| (2S,3S)-3-Amino-2-hydroxy-4-phenylbutyric acid hydrochloride salt | 129593-20-0 | C10H13NO3·HCl | 231.68 | (2S,3S)-H-Apns-OH HCl; (2S,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYRIC ACID HYDROCHLORIDE; (2S,3S)-3-Amino-2-hydroxy-4-phenylbutanoic acid hydrochloride; (2S,3S)-2-hydroxy-3-amino-4-phenylbutyric acid hydrochloride |
| L-Isoleucic acid | 51576-04-6 | C6H12O3 | 132.16 | 2S-hydroxy-3S-methylpentanoic acid |
| Boc-D-Aze-OH | 228857-58-7 | C9H15NO4 | 201.22 | Boc-D-Azetidine-2-carboxylic acid; (R)-1-(Tert-butoxycarbonyl)azetidine-2-carboxylic acid; Boc D Aze OH |
| (2S,3R)-3-[(t-Butoxycarbonyl)amino]-4-phenyl-1,2-epoxybutane | 156474-22-5 | C15H21NO3 | 263.33 | threo-N-Boc-D-phenylalanine epoxide; 2-Methyl-2-propanyl {(1R)-1-[(2S)-2-oxiranyl]-2-phenylethyl}carba mate; (2S,3R)-3-phenylproline; trans-3-phenyl-l-proline; tert-butyl [(2R,3S)]-(-)-(1-oxiranyl-2-phenylethyl)carbamate; (2S)-[1'(R)-Boc-amino-2'-phenylet |
| (2S,3R)-3-(Boc-amino)-2-hydroxy-4-(4-nitrophenyl)butyric acid | 112898-24-5 | C15H20N2O7 | 340.30 | Boc-(2S,3R)-AHNPB-OH; (2S,3R)-3-(Boc-amino)-2-hydroxy-4-(4-nitrophenyl)butyric acid; (2S,3R)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-4-(4-nitrophenyl)butanoic acid |
| Z-O-benzyl-L-threonine | 69863-36-1 | C19H21NO5 | 343.40 | Z-L-Thr(Bzl)-OH; (2S,3R)-3-phenylmethoxy-2-(phenylmethoxycarbonylamino)butanoic acid; Cbz-Thr(Bzl)-OH; Cbz-Thr(Bn)-OH; N-Z-O-Benzyl-L-threonine; N-Cbz-O-Benzyl-L-threonine |
| L-Threonine amide hydrochloride | 33209-01-7 | C4H10N2O2·HCl | 154.60 | L-Thr-NH2 HCl; H-Thr-NH2 HCl; 2-Amino-3-hydroxy-(2S,3R)butanamide monohydrochloride; L-Threoninamide hydrochloride |
| L-Proline amide hydrochloride | 42429-27-6 | C5H10N2O·HCl | 150.60 | L-Pro-NH2 HCl; (S)-Pyrrolidine-2-carboxylic acid amide hydrochloride; (2S)-pyrrolidine-2-carboxamide hydrochloride; HCl H-L-Pro-NH2; L-Prolinamidehydrochloride; dl-prolinamide hydrochloride; Pro-NH2 HCl |
| (2S)-2-Amino-8-nonenoic acid | 924307-76-6 | C9H17NO2 | 171.24 | |
| L-Phenylalanine amide hydrochloride | 65864-22-4 | C9H12N2O·HCl | 200.70 | L-Phe-NH2 HCl; L-Phenylalaninamide Hydrochloride; (2S)-2-amino-3-phenylpropanamide hydrochloride |
| L-Valine amide hydrochloride | 3014-80-0 | C5H12N2O·HCl | 152.60 | L-Val-NH2 HCl; (2S)-2-amino-3-methylbutanamide hydrochloride; H-Val-NH2 HCl; L-Valinamide Hydrochloride |
| 3-(1-Naphthyl)-L-alanine | 55516-54-6 | C13H13NO2 | 215.25 | L-Ala(1-naphthyl)-OH; (S)-2-Amino-3-naphthalen-1-yl-propionic acid; L-1-Naphthylalanine; H-1-Nal-OH; NAPHTHALEN-2-YL-3-ALANINE; 3-(1-Naphthyl)-L-Ala; 1-naphthyl-l-alanine; L-beta-(1-Naphthyl)alanine; (2S)-2-amino-3-(naphthalen-1-yl)propanoic acid; H-Ala(1 |
| Boc-Arg-OH | 13726-76-6 | C11H22N4O4 | 274.32 | (S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid; Boc-L-Arg-OH |
| Boc-L-citrulline | 45234-13-7 | C11H21N3O5 | 275.30 | Boc-L-Cit-OH; (S)-2-Boc-amino-5-ureidopentanoic acid; Boc-L-Orn(carbamoyl)-OH; Boc L Cit OH |
| Boc-L-leucine hydrate | 13139-15-6 | C11H21NO4·H2O | 249.31 | Boc-L-Leu-OH H2O; (S)-Boc-2-amino-4-methylpentanoic acid hydrate |
| Boc-3-(2-naphthyl)-L-alanine | 58438-04-3 | C18H21NO4 | 315.36 | Boc-L-Ala(2-naphthyl)-OH; Boc-2-Nal-OH; N-(tert-Butoxycarbonyl)-3-(2-naphthyl)-L-alanine; Boc-3-(2 naphthyl)-L-alanine; BOC-2-L-NAPHTHYLALANINE; (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(naphthalen-2-yl)propanoic acid; Boc-L-2-Naphthylalanine; N-Boc-3-(2-n |
| Boc-O-methyl-L-tyrosine | 53267-93-9 | C15H21NO5 | 295.30 | Boc-L-Tyr(Me)-OH; Boc-p-methoxy-L-Phe-OH; Boc-4-methoxy-L-phenylalanine; (2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-methoxyphenyl)propanoic acid |
| Boc-N-methyl-L-tyrosine dicyclohexylammonium salt | 95105-25-2 | C15H21NO5·C12H23N | 476.63 | Boc-N-Me-L-Tyr-OH DCHA; Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)(methyl)amino)-3-(4-hydroxyphenyl)propanoate |
| Z-L-leucine | 2018-66-8 | C14H19NO4 | 265.30 | Z-L-Leu-OH; (S)-Z-2-amino-4-methylpentanoic acid; N-Benzyloxycarbonyl-L-Leucine |
| Z-L-phenylalanine | 1161-13-3 | C17H17NO4 | 299.30 | Z-L-Phe-OH; N-Carbobenzoxy-L-phenylalanine |
| L-2,3-Diaminopropionic acid hydrochloride | 1482-97-9 | C3H8N2O2·HCl | 140.60 | L-Dap-OH HCl; (S)-2,3-Diaminopropionic acid hydrochloride |
| Boc-L-pyroglutamic acid | 53100-44-0 | C10H15NO5 | 229.23 | Boc-L-Pyr-OH; Boc L Pyr OH |
| Z-L-pyroglutamic acid | 32159-21-0 | C13H13NO5 | 263.20 | Z-L-Pyr-OH |
| Boc-(2R,5S)-5-phenylpyrrolidine-2-carboxylic acid | 158706-46-8 | C16H21NO4 | 291.34 | (2R,5S)-1-(tert-Butoxycarbonyl)-5-phenylpyrrolidine-2-carboxylic acid; (2r,5s)-boc-5-phenyl-pyrrolidine-2-carboxylic acid; (5S)-1-(tert-Butoxycarbonyl)-5-phenyl-D-proline; (2R,5S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-phenylpyrrolidine-2-carboxylic acid |
| Boc-D-trans-Hyp-Ome | 135042-17-0 | C11H19NO5 | 245.3 | (2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate; 1-tert-butyl 2-methyl (2R,4S)-4-hydroxypyrrolidine-1,2-dicarboxylate; N-BOC-TRANS-4-HYDROXY-D-PROLINE METHYL ESTER |
| (2R,4R)-2-[D-Xylo-tetrahydroxybut-1-yl]-1,3-thiazolidine-4-carboxylic acid | 110270-19-4 | C8H15NO6S | 253.27 | (2R,4R)-2-[D-Xylo-tetrahydroxybutyl]-1,3-thiazolidine-4-carboxylic acid |
| Fmoc-(2R,3S)-3-phenylisoserine | 252206-27-2 | C24H21NO5 | 403.43 | (2R,3S)-3-(Fmoc-amino)-2-hydroxy-3-phenyl-propanoic acid |
| (2R,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid | 62023-61-4 | C10H13NO3 | 195.22 | H-D-AHPBA-OH; H-D-Apns-OH |
| (2R,3R)-3-[(t-Butoxycarbonyl)amino]-4-phenyl-1,2-epoxybutane | 156474-21-4 | C15H21NO3 | 263.33 | erythro-N-Boc-D-phenylalanine epoxide; 2-Methyl-2-propanyl {(1R)-1-[(2R)-2-oxiranyl]-2-phenylethyl}carba mate; tert-Butyl 8-quinolyl carbonate; O-tert-butoxycarbonyl-8-hydroxyquinoline; (R,R)-1-oxiranyl-2-phenylethylcarbamic acid tert-butyl ester; carboni |
| N-Fmoc-erythro-DL-beta-methylphenylalanine | 321524-79-2 | C25H23NO4 | 401.5 | Fmoc-DL-Phe(bR-Me)-OH; (2R,3R)/(2S,3S)-Fmoc-DL-beta-methyl-Phe-OH; (2R,3R)/(2S,3S)-racemic Fmoc-beta-methyl-phenylalanine |
| Fmoc-L-glutamine | 71989-20-3 | C20H20N2O5 | 368.40 | Fmoc-L-glutamine; NA-FMOC-L-GLUTAMINE; FMOC-GLN; FMOC-L-GLN; L-GLUTAMINE-N-FMOC; FMOC-L-GLN-OH; Fmoc-Glutamine-OH; FMOC-GLUTAMINE; Fmoc-D-Gln-OH |
| D-Alanine amide hydrochloride | 71810-97-4 | C3H8N2O·HCl | 124.60 | D-Ala-NH2 HCl; (2R)-2-aminopropanamide hydrochloride |
| Fmoc-L-aspartic acid | 119062-05-4 | C19H17NO6 | 355.35 | Fmoc-L-Asp-OH; Fmoc-Asp-OH; N-Fmoc-L-aspartic acid; N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-L-aspartic Acid; Fmoc-L-aspartic acid |
| Fmoc-D-leucine | 114360-54-2 | C21H23NO4 | 353.40 | Fmoc-D-Leu-OH; (R)-Fmoc-2-amino-4-methylpentanoic acid |
| Fmoc-D-threonine | 118609-38-4 | C19H19NO5 | 341.40 | Fmoc-D-Thr-OH |
| Fmoc-D-alanine pentafluorophenyl ester | 125043-04-1 | C24H16F5NO4 | 477.40 | Fmoc-D-Ala-Opfp; (R)-Perfluorophenyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoate |
| (2-Chlorophenyl)phenyldichloromethane | 3509-85-1 | C13H9Cl3 | 271.57 | 1-chloro-2-[dichloro(phenyl)methyl]benzene |
| (1S,4R)-(-)-4-(Fmoc-amino)-2-cyclopentene-1-carboxylic acid | 220497-64-3 | C21H19NO4 | 349.39 | (-)-(1S,4R)-N-Fmoc-4-aminocyclopent-2-ene-1-carboxylic acid; (1S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopent-2-enecarboxylic acid; (1S,4R)-Fmoc-4-aminocyclopent-2-ene-carboxylic acid; (-)-(1S,4R)-4-(Fmoc)aminocyclopent-2-enecarboxylic acid |
| (-)-(1S,4R)-4-Aminocyclopent-2-ene-1-carboxylic acid | 168471-40-7 | C6H9NO2 | 127.14 | (-)-(1S,4R)-4-Aminocyclopent-2-enecarboxylic acid |
| (-)-(1R,3S)-3-[(t-Butoxycarbonyl)amino]cyclopentanecarboxylic acid | 161660-94-2 | C11H19NO4 | 229.28 | Boc-cis-NH(3)cPen-OH; (1S,3R)-N-BOC-1-Aminocyclopentane-3-carboxylic acid; (+)-(1S,3R)-N-BOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1R,3S)-3-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid; (1R,3S)-(-)-3-(Boc-amino)cyclopentanecarboxylic acid; (-)-( |
| (+)-(1S,3R)-3-Aminocyclopentanecarboxylic acid | 71830-07-4 | C6H11NO2 | 129.16 | H-D-cis-NH(3)cPen-OH |
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | 142217-77-4 | C32H33N5O4 | 551.64 | Entecavir Intermediate IV |
| Fmoc-1,2-trans-ACHC-OH(1S,2S) | 312965-07-4 | C22H23NO4 | 365.42 | (1S,2S)-1-(9-Fluorenylmethyloxycarbonylamino)-cyclohexyl-2-carboxylic acid; (1S,2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}cyclohexane-1-carboxylic acid; (1S,2S)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID; Fmoc-(S,S)-trans-2-aminocyclohexanecarboxylic ac |
| (1S,2S)-(-)-1,2-Diphenylethylenediamine | 29841-69-8 | C14H16N2 | 212.29 | (1S,2S)-1,2-diphenylethane-1,2-diamine; (1S,2S)-1,2-diphenylethane-1,2-diamine |
| (1S,2S)-(+)-N-p-Tosyl-1,2-diphenylethylenediamine | 167316-27-0 | C21H22N2O2S | 366.48 | N-[(1S,2S)-2-amino-1,2-diphenylethyl]-4-methylbenzenesulfonamide; N-[(1S,2S)-2-amino-1,2-diphenylethyl]-4-methylbenzenesulfonamide |
| (1S,2R)-(+)-2-Amino-1,2-diphenylethanol | 23364-44-5 | C14H15NO | 213.28 | (1S,2R)-2-amino-1,2-diphenylethanol; (1S,2R)-2-amino-1,2-diphenylethanol |
| (2S,3S)-3-[(t-Butoxycarbonyl)amino]-4-cyclohexyl-1,2-epoxybutane | 107202-62-0 | C15H27NO3 | 269.38 | erythro-N-Boc-L-cyclohexylalanine epoxide; (2S,1'S)-2-(1'-Boc-Amino-2'-cyclohexylethyl)oxirane; tert-butyl N-[(1S)-2-cyclohexyl-1-[(2S)-oxiran-2-yl]ethyl]carbamate; ERYTHRO-N-BOC-L-CYCLOHEXYLALANINE EPOXIDE |
| (S)-1-Aminopropylphosphonic acid | 98048-99-8 | C3H10NO3P | 139.09 | H-D-Abu(2)P(O)-(OH)2; H-D-APrP(O)-(OH)2 |
| Z-L-seryl-L-glycine ethyl ester | 4526-93-6 | C15H20N2O6 | 324.33 | Z-Ser-Gly-OEt; (S)-Ethyl 2-(2-(((Benzyloxy)Carbonyl)Amino)-3-Hydroxypropanamido)Acetate; Z Ser Gly OEt |
| Beta-(-)-Hydrastine | 118-08-1 | C21H21NO6 | 383.39 | (1R,9S)-(-)-beta-Hydrastine;Hydrastine base |
| (+)-(1R,4S)-4-[(9-Fluorenylmethoxycarbonyl)amino]cyclopent-2-ene-1-carboxylic acid | 220497-65-4 | C21H19NO4 | 349.39 | (+)-(1R,4S)-4-(Fmoc)aminocyclopent-2-enecarboxylic acid; (1R,4S)-(+)-4-(Fmoc-amino)-2-cyclopentene-1-carboxylic acid; (+)-(1R,4S)-N-Fmoc-4-aminocyclopent-2-enecarboxylic acid; (1R,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopent-2-ene-1-carboxylic aci |
| (-)-(1S,4R)-4-[(t-Butoxycarbonyl)amino]cyclopent-2-ene-1-carboxylic acid | 151907-79-8 | C11H17NO4 | 227.26 | (-)-(1S,4R)-4-(Boc)aminocyclopent-2-enecarboxylic acid |
| (+)-(1R,4S)-4-Aminocyclopent-2-ene-1-carboxylic acid | 134003-04-6 | C6H9NO2 | 127.14 | (+)-(1R,4S)-4-Aminocyclopent-2-enecarboxylic acid |
| 4-(Boc-amino)-cyclopent-2-ene-COOH(1R,4R) | 298716-03-7 | C11H17NO4 | 227.26 | (1R,4R)-4-(tert-butoxycarbonylamino)cyclopent-2-enecarboxylic acid; (1R,4R)-4-(Boc-aMino)cyclopent-2-enecarboxylic acid; D-CAMPHOR OXIME; (1R,4R)-4-(Boc-amino)cyclopent-2-enecarboxylic acid; 2-Norbornyl oxime |
| (+)-(1S,3R)-3-[(9-Fluorenylmethoxycarbonyl)amino]cyclopentanecarboxylic acid | 220497-66-5 | C21H21NO4 | 351.40 | Fmoc-D-cis-NH(3)cPen-OH; (1S,3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopentane-1-carboxylic acid; (+)-(1S,3R)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid; (+)-(1S,3R)-N- |
| (-)-(1R,3S)-3-Aminocyclopentanecarboxylic acid | 71830-08-5 | C6H11NO2 | 129.16 | H-cis-NH(3)cPen-OH |
| Fmoc-1,2-cis-ACHC-OH(1R,2S) | 312965-06-3 | C22H23NO4 | 365.42 | (1R,2S)-1-(9-Fluorenylmethyloxycarbonylamino)-cyclohexyl-2-carboxylic acid; (1R,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclohexane-1-carboxylic acid; cis-2-(Fmoc-amino)-cyclohexanecarboxylic acid; cis-(N-9-fluorenylmethoxycarbonyl)-2-amino cyclohexane |
| 2-Aminocyclopentane-COOH(R,S/S,R) | 122672-46-2 | C6H11NO2 | 129.16 | (1R,2S/1S,2R)-2-aminocyclopentanecarboxylic acid; (1R,2S)-2-Aminocyclopentanecarboxylic acid |
| Boc-1,2-ACHC-OH(1R,2R) | 233661-54-6 | C12H21NO4 | 243.30 | (1R,2R)-2-(t-Butyloxycarbonyl)aminocyclohexylcarboxylic acid; Boc-(±)-trans-2-aminocyclohexane-1-carboxylic acid; Boc-(R,R)-trans-2-aminocyclohexanecarboxylic acid; (1R,2R)-BOC-ACHC; (1R,2R)-Boc-aminocyclohexane carboxylic acid |
| Boc-ACPC-OH(1R,2R) | 245115-25-7 | C11H19NO4 | 229.28 | (1R,2R)-2-(t-Butyloxycarbonyl)aminocyclopentane carboxylic acid; (1R,2R)-Boc-Acpc; (1R,2R)-Boc-2-aminocyclopentane carboxylic acid; (R,R)-Boc-ACPC-OH; [(2R)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl]acetic acid; (r)-2-(1-(tert-butoxycarbonyl)pyrrolidin-2-yl) |
| (1R,2R)-(+)-1,2-Diphenylethylenediamine | 35132-20-8 | C14H16N2 | 212.29 | (1R,2R)-1,2-diphenylethane-1,2-diamine; (1R,2R)-1,2-diphenylethane-1,2-diamine |
| (1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine | 144222-34-4 | C21H22N2O2S | 366.48 | N-[(1R,2R)-2-amino-1,2-diphenylethyl]-4-methylbenzenesulfonamide; N-[(1R,2R)-2-amino-1,2-diphenylethyl]-4-methylbenzenesulfonamide |
| (1R,2R)-(-)-1,2-Diaminocyclohexane | 20439-47-8 | C6H14N2 | 114.19 | (1R,2R)-cyclohexane-1,2-diamine; (1R,2R)-cyclohexane-1,2-diamine |
| (R)-1-Amino-2-methylpropylphosphonic acid | 66254-56-6 | C4H12NO3P | 153.12 | H-ValP(O)-(OH)2; H-AMePropP(O)-(OH)2 |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | 172997-92-1 | C116H186N36O28S2 | 2597.07 | ((Cys31,Nva34)-NPY (27-36))2; BWX 46; (H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2; (H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2, (Disulfide bond) |
| Z-1,4-trans-ACHC-OH | 34771-04-5 | C15H19NO4 | 277.32 | trans-1-(Benzyloxycarbonyl-amino)-cyclohexyl-4-carboxylic acid; TRANS-4-(CARBOBENZOXYAMINO)CYCLOHEXANECARBOXYLIC ACID; 4-trans-benzyloxycarbonylaminocyclohexylcarboxylic acid; trans-4-(Cbz-amino)cyclohexanecarboxylic Acid; Z-Trans-4-Amino; Z-trans-4-amino |
| Azidoacetic acid | 18523-48-3 | C2H3N3O2 | 101.06 | 2-azidoacetic acid |
| Fmoc-PNA-C(Bhoc)-OH | 186046-81-1 | C39H35N5O8 | 701.7 | 2-[[2-[4-[[(diphenylmethyl)oxy-oxomethyl]amino]-2-oxo-1-pyrimidinyl]-1-oxoethyl]-[2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]ethyl]amino]acetic acid; 2-[[2-[4-(benzhydryloxycarbonylamino)-2-oxopyrimidin-1-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamin |
| Z-1,2-diaminoethane HCl | 18807-71-1 | C10H15N2O2Cl | 230.69 | Z-NH(CH2)2NH2 HCl |
| Z-1,4-diaminobutane HCl | 18807-73-3 | C12H19N2O2Cl | 258.75 | Z-NH(CH2)4NH2 HCl |
| DL-Lysine hydrochloride | 70-53-1 | C6H14N2O2·HCl | 182.60 | DL-Lys-OH HCl; (R,S)-2,6-Diaminohexanoic acid monohydrochloride |
| Tfa-Phe-OH | 350-09-4 | C11H10F3NO3 | 261.2 | (S)-N-(trifluoroacetyl)phenylalanine; N-Trifluoroacetyl-L-phenylalanine; Tfa Phe OH |
| Fmoc-Gabapentin | 882847-19-0 | C24H27NO4 | 393.48 | 2-[1-[(9H-fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl]acetic acid; [1-((Fmoc-amino)methyl)cyclohexyl]acetic acid; [1-[(9h-fluoren-9-ylmethoxycarbonylamino)-methyl]-cyclohexyl]-acetic acid; Fmoc-1-aminomethyl-cyclohexane acetic acid |
| (±)-Nornicotine | 5746-86-1 | C9H12N2 | 148.20 | 3-(2-pyrrolidinyl)pyridine; 3-pyrrolidin-2-ylpyridine |
| (+/-)-Imazalil-[d5] Sulfate | 1398065-92-3 | C14H11D5Cl2N2O5S | 400.28 | Imazalil-d5 Sulfate; 1-[2-(2,4-Dichlorophenyl)-2-[2-(propen-1-yl-d5)oxy]ethyl]-1H-imidazole Sulfate; 1-[2-(2,4-Dichlorophenyl)-2-[2-(propenyl-d5)oxy]ethyl]-1H-imidazole Sulfate; Chloramizol-d5 Sulfate; Microban Additive IF 4-d5; R 27180-d5 |
| (±)-Methionine | 59-51-8 | C5H11NO2S | 149.21 | DL-2-Amino-4-(methylthio)butyric acid |
| (-)-Carvone | 6485-40-1 | C10H14O | 150.22 | (R)-(-)-Carvone; l-Carvone |
| 2-cis,4-trans-Abscisic acid | 14375-45-2 | C15H20O4 | 264.32 | (2Z,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid |
| DL-a-Aminopimelic acid | 627-76-9 | C7H13NO4 | 175.18 | DL-2-Aminoheptanedioic acid |
| (+)-JQ1 PA | 2115701-93-2 | C22H20ClN5OS | 437.946 | (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-N-2-propyn-1-yl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide |
| (+)-JQ1 carboxylic acid | 202592-23-2 | C19H17ClN4O2S | 400.881 | JQ-1 carboxylic acid; (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetic acid |
| Diisopropyl L-(+)-Tartrate | 2217-15-4 | C10H18O6 | 234.25 | (2R,3R)-2,3-dihydroxybutanedioic acid dipropan-2-yl ester; dipropan-2-yl (2R,3R)-2,3-dihydroxybutanedioate |
| (+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate | 80822-15-7 | C18H16O9 | 376.31 | (2S,3S)-2,3-dibenzoyloxybutanedioic acid;hydrate; (2S,3S)-2,3-dibenzoyloxybutanedioic acid;hydrate |
| (+)-Bicuculline | 485-49-4 | C20H17NO6 | 367.35 | Bicculine; Bicucullin; BRN 0098786; NSC 32192; BRN0098786; NSC32192; BRN-0098786; NSC-32192 |
| (±)-Menthol | 89-78-1 | 156.27 | 0 | |
| DAA | 1758-68-5 | C14H10N2O2 | 238.24 | |
| SNAP | 79032-48-7 | C7H12N2O4S | 220.25 | (±)-S-Nitroso-N-acetylpenicillamine |
| Spermine NONOate | 136587-13-8 | C10H26N6O2 | 262.35 | N-(2-Aminoethyl)-N-(2-hydroxy-2-nitrosohydrazino)-1,2-ethylenediamine, NOC-22, Spermine NONOate |
| Dihydroethidium (Hydroethidium) | 38483-26-0 | C21H21N3 | 315.41 | 2,7-Diamino-10-ethyl-9-phenyl-9,10-dihydrophenanthridine, DHE, Dihydroethidium |
| cIAP1 Ligand-Linker Conjugates 15 | 1225433-96-4 | C37H47N3O8 | 661.78 | cIAP1 Ligand-Linker Conjugates 15; E3 ligase Ligand-Linker Conjugates 34 |
| cIAP1 Ligand-Linker Conjugates 11 Hydrochloride | 1239866-59-1 | C35H44ClN3O7 | 654.19 | cIAP1 Ligand-Linker Conjugates 11 (Hydrochloride); E3 ligase Ligand-Linker Conjugates 33 (Hydrochloride |
| cIAP1 Ligand-Linker Conjugates 11 | 1239943-19-1 | C35H43N3O7 | 617.73 | cIAP1 Ligand-Linker Conjugates 11; E3 ligase Ligand-Linker Conjugates 33 |
| cIAP1 Ligand-Linker Conjugates 2 | 1312302-14-9 | C37H48N4O7 | 660.8 | cIAP1 Ligand-Linker Conjugates 2; E3 ligase Ligand-Linker Conjugates 37 |
| (S,R,S)-AHPC-PEG3-N3 | 1797406-80-4 | C30H43N7O7S | 645.77 | |
| Fmoc-NH-cis-BCheptane-COOH | 352707-75-6 | C23H23NO4 | 377.43 | (1S,2R,3S,4R/1R,2S,3R,4S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}bicyclo[2.2.1]heptane-2-carboxylic acid; Fmoc-3-exo-aminobicyclo[2.2.1]-heptane-2-exo-carboxylic acid; 3-(9H-fluoren-9-ylmethoxycarbonylamino)bicyclo[2.2.1]heptane-2-carboxylic acid |
| Fmoc-NH-cis-cyclopentane-COOH | 352707-76-7 | C21H21NO4 | 351.41 | (1S,2R/1R,2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}cyclopentanecarboxylic acid; (1R,2S)-Fmoc-2-amino-1-cyclopentanecarboxylic acid; cis-2-Aminocyclopentanecarboxylic acid,N-FMOC protected; CIS-2-(9-FLUORENYLMETHOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLI |
| 2-phenoxynicotinic acid | 35620-71-4 | C12H9NO3 | 215.2 | 2-Phenoxypyridine-3-carboxylic acid |
| Fmoc-DL-Ala-OH | 35661-38-2 | C18H17NO4 | 311.34 | 2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; Fmoc-D-Ala-OH 2H2O; N-Fmoc-D-alanine; FMOC-N-D-alanine |
| Acetyl-L-methionine methyl ester | 35671-83-1 | C8H15NO3S | 205.30 | Ac-L-Met-Ome; methyl n-acetylmethioninate |
| (+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine | 127184-05-8 | C10H13Cl2NO3S | 298.19 | (+)-3,3-Dichloro-2,N-epoxy-exo-10,2-bornanesultam |
| (-)-Diisopropyl D-Tartrate | 62961-64-2 | C10H18O6 | 234.25 | (2S,3S)-2,3-dihydroxybutanedioic acid dipropan-2-yl ester; dipropan-2-yl (2S,3S)-2,3-dihydroxybutanedioate |
| (-)-Hyoscyamine | 101-31-5 | C17H23NO3 | 289.37 | Daturine |
| BDP 630/650 X NHS ester | 2213445-35-1 | C33H31N4BF2O6S | 660.5 | |
| 3-O-Ethyl-L-ascorbic acid | 86404-04-8 | C8H12O6 | 204.18 | 3-O-Ethylascorbic acid; (R)-5-((S)-1,2-Dihydroxyethyl)-4-ethoxy-3-hydroxyfuran-2(5H)-one |
| Vonoprazan Impurity 28 | 56448-22-7 | C11H9NO | 171.19 | 2-phenyl-4-formylpyrrole; 5-Phenylpyrrole-3-carbaldehyde |
| 3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole | 219986-64-8 | C11H9F3N2 | 226.2 | 3-(4-methylphenyl)-5-(trifluoromethyl)pyrazole; 3-(Trifluoromethyl)-5-p-tolyl-1H-pyrazole; 3-(p-Tolyl)-5-(trifluoromethyl)-1H-pyrazole |
| Semax | 80714-61-0 | C37H51N9O10S | 813.92 | ACTH (4-7); Pro-Gly-Pro trifluoroacetate salt; L-Methionyl-L-a-glutamyl-L-histidyl-L-phenylalanyl-L-prolylglycyl-L-proline trifluoroacetate salt; Met-Glu-His-Phe-Pro-Gly-Pro |
| PHM-27 (human) | 87403-73-4 | C135H214N34O40S | 2985.41 | PHM, Human; PHI Human; Peptide Histidine Methionine, Human; His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2 |
| ACTH (1-39), rat | 77465-10-2 | C210H315N57O57S1 | 4582.16 | ACTH 1-39; ACTH (1-39) (MOUSE, RAT); ACTH (1-39) (RAT); ADRENOCORTICOTROPIC HORMONE RAT; ADRENOCORTICOTROPIC HORMONE (1-39) (RAT); CORTICOTROPIN A; H-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-ASN-VAL-A |
| PAR-2 (1-6) (mouse, rat) | 164081-25-8 | C29H55N9O8 | 657.8 | H-Ser-Leu-Ile-Gly-Arg-Leu-OH; Proteinase Activated Receptor 2 Agonist Peptide (SLIGRL), mouse; Ser-Leu-Ile-Gly-Arg-Leu; PAR-2 Agonist Peptide (SLIGRL), mouse |
| ACTH (18-39) (human) | 53917-42-3 | C112H165N27O36 | 2465.67 | Adrenocorticotropic Hormone Fragment 18-39 human; CLIP |
| ACTH (22-39) | 37548-29-1 | C90H125N19O32 | 1985.06 | Adrenocorticoptropic Hormone Fragment 22-39; ACTH (22-39) (human); H-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH |
| ACTH (1-17) | 7266-47-9 | C95H145N29O23S | 2093.41 | Adrenocorticotropic Hormone Fragment 1-17 human; a1-17-Corticotropin; H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH |
| Dynorphin A (1-8) | 75790-53-3 | C46H72N14O10 | 981.15 | Dynorphin A fragment 1-8 porcine; H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-OH |
| Argipressin Acetate | 129979-57-3 | C48H69N15O14S2 | 1144.28 | Argipressin monoacetate; (Cys-Tyr-Phe-Gln-Asn-Cys)Cycl-Pro-Arg-Gly-NH2 acetate salt; Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 acetate salt; Antidiuretic hormone acetate salt; Arginine vasopressin acetate salt; [ARG8]-vasopressin acetate salt |
| (Gln4)-Neurotensin | 61445-54-3 | C78H122N22O19 | 1671.9 | 4-Gln-neurotensin; H-Pyr-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| Calcineurin Substrate | 113873-67-9 | C92H150N28O29 | 2112.4 | H-Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH |
| Omiganan pentahydrochloride | 269062-93-3 | C90H132Cl5N27O12 | 1961.4 | MBI 226; MBI-226; MBI226; Omiganan HCl |
| [Leu15]-Gastrin I (human) | 39024-57-2 | C98H126N20O31 | 2080.16 | H-DL-Pyr-Gly-DL-Pro-DL-Trp-DL-Leu-DL-Glu-DL-Glu-DL-Glu-DL-Glu-DL-Glu-DL-Ala-DL-Tyr-Gly-DL-Trp-DL-Leu-DL-Asp-DL-Phe-NH2 |
| C-Reactive Protein (CRP) (77-82) | 130349-01-8 | C23H40N6O10 | 560.6 | H-Val-Gly-Gly-Ser-Glu-Ile-OH |
| Defensin HNP-1 (Human) | 99287-08-8 | C150H228N44O38S6 | 3442.03 | Recombinant human NP-1; NP-1, human; BD-1, human; Defensin-1, alpha-, human; Defensin-1, human; Defensin HNP-1 (human); Defensin human neutrophil peptide-1; HNP-1 |
| 4-Hydroxy-6-methylpyrimidine | 3524-87-6 | C5H6N2O | 110.11 | 4-methyl-1H-pyrimidin-6-one |
| 4-(4-Methoxyphenoxy)benzoic acid | 3525-22-2 | C14H12O4 | 244.24 | 4-(4-methoxyphenoxy)benzoic acid |
| epoxyqueuosine | 107865-20-3 | C17H23N5O8 | 425.4 | 4H-Pyrrolo[2,3-d]pyrimidin-4-one, 2-amino-5-[[(3,4-dihydroxy-6-oxobicyclo[3.1.0]hex-2-yl) amino]methyl]-1,7-dihydro-7-b-D-ribofuranosyl-; 7-(5-((2,3-Epoxy-4,5-dihydroxycyclopent-1-yl)amino)methyl)-7-deazaguanosine; 6-Amino-3-(((3,4-dihydroxy-6-oxabicyclo( |
| lysidine | 116120-47-9 | C15H25N5O6 | 371.39 | Pyrimidinium, 4-amino-2-[(5-amino-5-carboxypentyl)amino]-1-b-D-ribofuranosyl-, chloride, (S)- |
| 3-methylcytidine | 2140-64-9 | C10H15N3O5 | 257.25 | Cytidine, 3-methyl-; 3-Methylcytidine; N3-Methylcytidine; 3-methyl-4,N(4)-didehydro-3,4-dihydrocytidine |
| N6-glycinylcarbamoyladenosine | 29902-55-4 | C13H16N6O7 | 368.31 | Glycine, N-[[(9-b-D-ribofuranosyl-9H-purin-6-yl) amino]carbonyl]- |
| 1-methyl-3-(3-amino-3-carboxypropyl) pseudouridine | 52777-29-4 | C14H21N3O8 | 359.34 | 1(2H)-Pyrimidinebutanoic acid, a-amino-3,6-dihydro-3-methyl-2,6-dioxo-5-b-D-ribofuranosyl-; (1s)-1-[3-(3-amino-3-carboxypropyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl]-1,4-anhydro-d-ribitol; 3-(3-Amino-3-carboxypropyl)-1-methylpseudouridine |
| wybutosine | 55196-46-8 | C21H28N6O9 | 508.49 | 3H-Imidazo[1,2-a]purine-7-butanoic acid, 4,9-dihydro-a-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-b-D-ribofuranosyl-, methyl ester, (S)- |
| 5-methoxycarbonylmethyl-2'-O-methyluridine | 60197-31-1 | C13H18N2O8 | 330.29 | 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-1-(2-O-methyl-b-D-ribofuranosyl)-2,4-dioxo-, methyl ester; 5-methoxycarbonylmethyl-2'-o-methyluridine; Methyl 2-(1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetr |
| hydroxywybutosine | 84270-21-3 | C21H28N6O10 | 524.49 | 1H-Imidazo[1,2-a]purine-7-butanoic acid, 4,9-dihydro-b-hydroxy-a-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-1-b-D-ribofuranosyl-, methyl ester |
| N2,7,2'-O-trimethylguanosine | 872710-82-2 | C13H19N5O5 | 325.32 | Guanosine, N,7-dimethyl-2'-O-methyl-, inner salt |
| 5-(carboxyhydroxymethyl)uridine methyl ester | 89665-83-8 | C12H16N2O9 | 332.27 | 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-a-hydroxy-2,4-dioxo-1-b-D-ribofuranosyl-, methyl ester, (S)-; Chmu-methyl ester; 5-(Carboxy(hydroxy)methyl)uridine methyl ester |
| 5-(carboxyhydroxymethyl)uridine | 89708-80-5 | C11H14N2O9 | 318.24 | 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-a-hydroxy-2,4-dioxo-1-b-D-ribofuranosyl-, (S)- |
| 5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyluridine | 103285-22-9 | C31H32N2O8 | 560.59 | 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxy-2-oxolanyl]pyrimidine-2,4-dione; 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione |
| N-(2-Phenylacetyl)guanosine | 132628-16-1 | C18H19N5O6 | 401.37 | N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide; N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide |
| N6-Benzoyl-2'-deoxy-2'-fluoroadenosine | 136834-20-3 | C17H16FN5O4 | 373.34 | N-[9-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]benzamide; N-[9-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide |
| 2,6-Dichloro-7-methylpurine | 2273-93-0 | C6H4Cl2N4 | 203.03 | 2,6-dichloro-7-methylpurine; 2,6-dichloro-7-methylpurine |
| Ethylene glycol diacrylate | 2274-11-5 | C8H10O4 | 170.16 | 2-prop-2-enoyloxyethyl prop-2-enoate |
| N6-Benzyladenosine | 4294-16-0 | C17H19N5O4 | 357.36 | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(phenylmethyl)amino]-9-purinyl]oxolane-3,4-diol; (2R,3R,4S,5R)-2-[6-(benzylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
| 5'-Tosyl Adenosine | 5135-30-8 | C17H19N5O6S | 421.43 | Adenosine 5'-(4-Methylbenzenesulfonate); 5'-O-Toluenesulfonyladenosine; 5'-Tosyladenosine |
| 2',3',5'-Tri-O-acetyl Guanosine | 6979-94-8 | C16H19N5O8 | 409.35 | 2',3',5'-Tri-O-acetylguanosine; Guanosine Triacetate; NSC 66387; Triacetylguanosine |
| 5'-O-tritylthymidine | 7791-71-1 | C29H28N2O5 | 484.54 | 1-[(2R,4S,5R)-4-hydroxy-5-[(triphenylmethyl)oxymethyl]-2-oxolanyl]-5-methylpyrimidine-2,4-dione; 1-[(2R,4S,5R)-4-hydroxy-5-(trityloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione |
| MOTS-C | 1627580-64-6 | C101H152N28O22S2 | 2174.6 | H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH |
| MV1 | 1001600-54-9 | C33H44N4O5 | 576.7 | MV-1; MV 1 |
| 1-Azido-3,6,9-trioxaundecane-11-ol | 86770-67-4 | C8H17N3O4 | 219.24 | Azido-PEG4-alcohol |
| H-Phe(4-Ac)-OH HCl | 20299-31-4 | C11H14ClNO3 | 243.68 | 4-Acetyl-L-phenylalanine Hydrochloride; 4-Acetylphenylalanine hydrochloride; (S)-3-(4-Acetylphenyl)-2-aminopropanoic acid HCl; p-Acetylphenylalanine hydrochloride |
| 2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt | 67801-08-5 | C11H14N3O2 · 0.5 Cl4Zn | 323.85 | dichlorozinc;2-methoxy-4-morpholin-4-ylbenzenediazonium;dichloride |
| BDP TR NHS ester | 150152-65-1 | C25H18BF2N3O5S | 521.30 | |
| Coumarin 343 X NHS ester | 946123-12-2 | C26H29N3O7 | 495.52 | |
| Cyanine3.5 NHS ester | 2231670-85-0 | C42H44N3BF4O4 | 741.62 | |
| Cyanine5.5 NHS ester | 1469277-96-0 | C44H46N3BF4O4 | 767.66 | |
| 3-Ethynyl perylene | 132196-66-8 | C22H12 | 276.33 | |
| BDP 558/568 alkyne | 1262681-30-0 | C19H16N3BF2OS | 383.22 | |
| BDP 650/665 alkyne | 2006345-40-8 | C26H21N4BF2O2 | 470.28 | |
| BDP FL alkyne | 302795-84-2 | C17H18BF2N3O | 329.15 | |
| BDP R6G alkyne | 2006345-31-7 | C21H18N3BF2O | 377.2 | |
| BDP TR alkyne | 2006345-35-1 | C24H18N3BF2O2S | 461.29 | |
| Cyanine5 alkyne | 1223357-57-0 | C35H42ClN3O | 556.18 | |
| Cyanine7 alkyne | 1954687-62-7 | C40H48ClN3O | 622.28 | |
| FAM alkyne, 5-isomer | 510758-19-7 | C25H15O6N | 413.38 | |
| FAM alkyne, 6-isomer | 478801-49-9 | C25H15O6N | 413.38 | |
| ROX alkyne, 5-isomer | 2264016-88-6 | C36H33N3O4 | 571.66 | |
| TAMRA alkyne, 5-isomer | 945928-17-6 | C28H25N3O4 | 467.51 | |
| Cyanine5 hydrazide | 1427705-31-4 | C32H42Cl2N4O | 569.61 | |
| FAM hydrazide, 5-isomer | 2183440-64-2 | C21H15N2ClO6 | 426.81 | |
| FAM hydrazide, 6-isomer | 151890-73-2 | C21H15N2ClO6 | 426.81 | |
| BDP 630/650 alkyne | 2006345-38-4 | C26H20N3BF2O2S | 487.33 | |
| BDP 630/650 azide | 2183473-22-3 | C26H23N6BF2O2S | 532.37 | |
| BDP 630/650 maleimide | 2183473-31-4 | C29H23N4BF2O4S | 572.39 | |
| BDP FL amine | 2183473-03-0 | C20H30BClF2N4O | 426.74 | |
| BDP FL azide | 1379771-95-5 | C17H21BF2N6O | 374.20 | |
| BDP R6G amine | 2183473-05-2 | C24H30N4BClF2O | 474.78 | |
| BDP R6G azide | 2183473-23-4 | C21H21N6BF2O | 422.24 | |
| BDP R6G carboxylic acid | 174881-57-3 | C18H15BF2N2O2 | 340.13 | |
| BDP R6G maleimide | 2183473-32-5 | C24H21N4BF2O3 | 462.26 | |
| BDP TR amine | 2183473-18-7 | C27H30N4BClF2O2S | 558.88 | |
| BDP TR carboxylic acid | 150152-64-0 | C21H15N2BF2O3S | 424.23 | |
| Cyanine3 amine | 2247688-56-6 | C36H52Cl2N4O | 627.73 | |
| Cyanine3 azide | 1167421-28-4 | C33H43N6OCl | 575.19 | |
| Cyanine5 azide | 1267804-34-1 | C35H45ClN6O | 601.22 | |
| Cyanine5.5 maleimide | 1594414-90-0 | C46H49ClN4O3 | 741.36 | |
| Cyanine7 amine | 1650635-41-8 | C43H60Cl2N4O | 719.87 | |
| Cyanine7 azide | 1557397-59-7 | C40H51ClN6O | 667.33 | |
| Cyanine7.5 amine | 2104005-15-2 | C51H64Cl2N4O | 819.99 | |
| Cyanine7.5 carboxylic acid | 1686147-68-1 | C45H49ClN2O2 | 685.34 | |
| Sulfo-Cyanine3 amine | 2183440-43-7 | C36H50N4O7S2 | 714.94 | |
| Sulfo-Cyanine3 azide | 1658416-54-6 | C33H41N6KO7S2 | 736.94 | |
| Sulfo-Cyanine3 maleimide | 1656990-68-9 | C36H41KN4O9S2 | 776.96 | |
| Sulfo-Cyanine5 amine | 2183440-44-8 | C38H52N4O7S2 | 740.98 | |
| Sulfo-Cyanine5.5 amine | 2183440-45-9 | C46H54K2N4O13S4 | 1077.41 | |
| Sulfo-Cyanine7 amine | 2236573-39-8 | C43H58N4O7S2 | 807.07 | |
| BODIPY FL-X | 217190-07-3 | C20H26BF2N3O3 | 405.25 | |
| BODIPY 558/568 NHS Ester | 150173-73-2 | C20H16BF2N3O4S | 443.24 | |
| 178388-71-1 | 178388-71-1 | C14H17BF2N4O | 306.12 | |
| 3-Bodipy-propanoic Acid Ethyl Ester | 1418610-53-3 | C16H19BF2N2O2 | 320.15 | |
| BDY TR-X | 186961-29-5 | C27H28BF2N3O4S | 539.40 | |
| BDY 630-X | 268725-21-9 | C29H28BF2N3O4S | 563.43 | |
| Allyl-Bodipy-FL-510 | 926012-31-9 | C19H24BF2N3O2 | 375.23 | |
| Sulfo-Cyanine 5 Carboxylic Acid | 146368-11-8 | C33H39KN2O8S2 | 694.9 | |
| azido-Cy5 | 1048022-24-7 | C48H58N7O13S2 | 1005.16 | |
| Allyl-Cy5 | 925915-11-3 | C38H49N3O8S2 | 739.94 | |
| Cy5.5 COOH | 210892-23-2 | C41H44N2O14S4 | 917.04 | |
| NIR-641 N-succinimidyl ester | 190714-26-2 | C37H44ClN3O4 | 630.23 | |
| Cy3 NHS Ester potassium salt (1:1) | 945529-56-6 | C35H40KN3O10S2 | 765.93 | |
| FAM amine, 6-isomer | 1313393-44-0 | C27H27N2ClO6 | 510.97 | 5-aminohexylaminocarbonylfluorescein hydrochloride |
| FAM azide, 5-isomer | 510758-23-3 | C24H18N4O6 | 458.42 | |
| FAM azide, 6-isomer | 1386385-76-7 | C24H18N4O6 | 458.42 | |
| Coumarin 343 azide | 1807503-82-7 | C22H27N5O5 | 441.48 | |
| Coumarin 343 X carboxylic acid | 946123-11-1 | C22H26N2O5 | 398.45 | 6-({4-Oxo-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-5-yl}carbonylamino)hexanoic acid |
| CypHer5 | 312961-83-4 | C31H36N2O8S2 | 628.77 | 1H-Indole-1-hexanoic acid, 2-[5-(3,3-dimethyl-5-sulfo-3H-indol-2-yl)-2,4-pentadienylidene]-2,3-dihydro-3,3-dimethyl-5-sulfo-(9CI) |
| VH032-PEG4-N3 | 1797406-81-5 | C32H47N7O8S | 689.82 | (S,R,S)-AHPC-PEG4-N3; VH032-PEG4-N3; VHL Ligand-Linker Conjugates 5; E3 ligase Ligand-Linker Conjugates 4; (2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)ph |
| Thalidomide-O-amido-C4-NH2 | 1799711-24-2 | C19H22N4O6 | 402.4 | Thalidomide-O-amido-C4-NH2; Cereblon Ligand-Linker Conjugates 6; E3 Ligase Ligand-Linker Conjugates 19; N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide |
| Thalidomide-O-amido-C4-NH2 (TFA) | 1799711-25-3 | C21H23F3N4O8 | 516.42 | Thalidomide-O-amido-C4-NH2 (TFA); Cereblon Ligand-Linker Conjugates 6 (TFA); E3 ligase Ligand-Linker Conjugates 19 (TFA) |
| Pomalidomide-PEG4-Ph-NH2 | 1818885-63-0 | C27H32N4O8 | 540.57 | Pomalidomide-PEG4-Ph-NH2; Cereblon Ligand-Linker Conjugates 9; E3 Ligase Ligand-Linker Conjugates 2; 4-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| (S,R,S)-AHPC-C6-PEG3-C4-Cl | 1835705-55-9 | C38H59ClN4O7S | 751.42 | (S,R,S)-AHPC-C6-PEG3-C4-Cl; VH032-C6-PEG3-C4-Cl; VHL Ligand-Linker Conjugates 12; E3 ligase Ligand-Linker Conjugates 8 |
| (S,R,S)-AHPC-PEG2-C4-Cl | 1835705-57-1 | C32H47ClN4O6S | 651.26 | (S,R,S)-AHPC-PEG2-C4-Cl; VH032-PEG2-C4-Cl; VHL Ligand-Linker Conjugates 7; E3 ligase Ligand-Linker Conjugates 10; (2S,4R)-1-[(2S)-2-[[2-[2-(6-chlorohexoxy)ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl] |
| (S,R,S)-AHPC-PEG6-C4-Cl | 1835705-59-3 | C40H63ClN4O10S | 827.47 | (S,R,S)-AHPC-PEG6-C4-Cl; VH032-PEG6-C4-Cl; VHL Ligand-Linker Conjugates 10; E3 ligase Ligand-Linker Conjugates 9; VH032-ketone-PEG6-6C-Cl; (2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbu |
| Thalidomide-O-amido-C8-NH2 | 1950635-15-0 | C23H30N4O6 | 458.51 | Thalidomide-O-amido-C8-NH2; Cereblon Ligand-Linker Conjugates 2; E3 Ligase Ligand-Linker Conjugates 20; N-(8-aminooctyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide |
| Thalidomide-O-amido-PEG2-C2-NH2 (TFA) | 1957235-75-4 | C23H27F3N4O10 | 576.48 | Thalidomide-O-amido-PEG2-C2-NH2 (TFA); Cereblon Ligand-Linker Conjugates 10 (TFA); E3 Ligase Ligand-Linker Conjugates 24 (TFA); Thalidomide-O-amido-PEG2-C2-Amine Trifluoroacetate; N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dio |
| Thalidomide-O-amido-PEG3-C2-NH2 | 1957236-20-2 | C23H30N4O9 | 506.51 | Thalidomide-O-amido-PEG3-C2-NH2; Cereblon Ligand-Linker Conjugates 3 ; E3 Ligase Ligand-Linker Conjugates 14; N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide |
| (S,R,S)-AHPC-PEG3-NH2 | 2010159-56-3 | C30H45N5O7S | 619.77 | (S,R,S)-AHPC-PEG3-NH2; VH032-PEG3-NH2; VHL Ligand-Linker Conjugates 1; E3 ligase Ligand-Linker Conjugates 5 Free Base |
| (S,R,S)-AHPC-PEG4-NH2 | 2010159-57-4 | C32H49N5O8S | 663.83 | (S,R,S)-AHPC-PEG4-NH2; VH032-PEG4-NH2; VHL Ligand-Linker Conjugates 4 ; E3 ligase Ligand-Linker Conjugates 7 Free Base; 1-[2-[[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)ph |
| (S,R,S)-AHPC-PEG2-NH2 | 2010159-60-9 | C28H41N5O6S | 575.72 | (S,R,S)-AHPC-PEG2-NH2; VH032-PEG2-NH2 ; VHL Ligand-Linker Conjugates 3 ; E3 ligase Ligand-Linker Conjugates 6 Free Base; 1-[2-[[2-[2-(2-aminoethoxy)ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrroli |
| cIAP1 Ligand-Linker Conjugates 12 | 2095244-52-1 | C46H64N4O12S2 | 929.15 | cIAP1 Ligand-Linker Conjugates 12; E3 ligase Ligand-Linker Conjugates 38; 2-[2-[2-[2-[3-[2-[(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoyl]amino]acetyl]pyrrolidin-2-yl]-1,3-thiazole-4-carbonyl]phenoxy]ethoxy |
| Pomalidomide-PEG4-C-COOH | 2097938-44-6 | C23H29N3O10 | 507.49 | Pomalidomide-PEG4-C-COOH; Cereblon Ligand -Linker Conjugates 1; E3 Ligase Ligand-Linker Conjugates 1; 2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]acetic acid |
| VH032-thiol-C6-NH2 | 2098836-63-4 | C29H43N5O4S2 | 589.81 | VH032-thiol-C6-NH2; VHL Ligand-Linker Conjugates 14; E3 ligase Ligand-Linker Conjugates 29 |
| cIAP1 Ligand-Linker Conjugates 5 | 2113688-20-1 | C37H55N5O8S | 729.93 | cIAP1 Ligand-Linker Conjugates 5; E3 ligase Ligand-Linker Conjugates 39 |
| cIAP1 Ligand-Linker Conjugates 3 | 2222354-20-1 | C39H56N4O11S | 788.95 | cIAP1 Ligand-Linker Conjugates 3; E3 ligase Ligand-Linker Conjugates 40; 2-[2-[2-[2-[3-[2-[(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoyl]amino]acetyl]pyrrolidin-2-yl]-1,3-thiazole-4-carbonyl]phenoxy]ethoxy] |
| Pomalidomide-PEG4-C2-NH2 | 2225940-52-1 | C23H32N4O8 | 492.52 | Pomalidomide-PEG4-C2-NH2; Cereblon Ligand-Linker Conjugates 8; E3 Ligase Ligand-Linker Conjugates 22; 4-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]ethylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| (S,R,S)-AHPC-C3-NH2 | 2245697-83-8 | C27H40ClN5O4S | 566.16 | (S,R,S)-AHPC-C3-NH2; VH032-C3-NH2; VHL Ligand-Linker Conjugates 13; E3 ligase Ligand-Linker Conjugates 28; (2S,4R)-1-[(2S)-2-(5-aminopentanoylamino)-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;h |
| E3 ligase Ligand-Linker Conjugates 49 | 2351103-63-2 | C31H44N4O11 | 648.7 | |
| cIAP1 Ligand-Linker Conjugates 1 | 2357114-75-9 | C41H59N5O9S | 798 | cIAP1 Ligand-Linker Conjugates 1; E3 ligase Ligand-Linker Conjugates 41; [(Z)-2-methylidenepent-3-enyl] N-[(2S)-1-[[(1S)-2-[(2S)-2-[4-[3-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]benzoyl]-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino] |
| E3 ligase Ligand 8 | 1225383-33-4 | C31H34N2O6 | 530.61 | (2S)-2-[[(2S,3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid |
| VL285 | 1448188-57-5 | C29H32N4O4S | 532.65 | VL-285; VL 285; VL285; 4-hydroxy-1-[3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide |
| (S,R,S)-AHPC (TFA) | 1631137-51-3 | C24H31F3N4O5S | 544.49 | (S,R,S)-AHPC (TFA); MDK7526 (TFA); VH032-NH2 (TFA); VHL ligand 1 (TFA); Protein degrader 1 TFA; E3 ligase Ligand 6; 1-(2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;2,2,2-trifluoroacetic a |
| (S,R,S)-AHPC-Me | 1948273-02-6 | C23H32N4O3S | 444.59 | (S,R,S)-AHPC-Me; VHL ligand 2; E3 ligase Ligand 1A; 1-(2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-[1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| (S,R,S)-AHPC-Me hydrochloride | 1948273-03-7 | C23H33ClN4O3S | 481.05 | (S,R,S)-AHPC-Me hydrochloride; VHL ligand 2 (hydrochloride); E3 ligase Ligand 1; (2S,4R)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide;hydrochloride |
| cIAP1 ligand 1 | 2095244-42-9 | C31H42N4O6S | 598.75 | cIAP1 ligand 1; E3 ligase Ligand 12 |
| E3 ligase Ligand 14 | 2241489-43-8 | C38H52N4O7 | 676.84 | tert-butyl N-[(2S)-1-[[(1S)-1-cyclohexyl-2-[(2S,4S)-4-(3-hydroxyphenoxy)-2-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxopropan-2-yl]-N-methylcarbamate |
| Homo-PROTAC cereblon degrader 1 | 2244520-98-5 | C32H32N6O10 | 660.63 | 2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione |
| Nutlin carboxylic acid | 2249750-27-2 | C32H32Cl2N4O6 | 639.53 | Nutlin carboxylic acid; MDM2 ligand 1; E3 ligase Ligand 16 |
| TD-106 | 2250288-69-6 | C12H11N5O3 | 273.25 | TD-106; TD 106; TD106 |
| Pomalidomide-C2-NH2 (hydrochloride) | 2305369-00-8 | C15H17ClN4O4 | 352.77 | Pomalidomide-C2-NH2 (hydrochloride); Cereblon Ligand-Linker Conjugates 15 (hydrochloride) |
| (4R,5S)-nutlin carboxylic acid | 2306390-08-7 | C32H32Cl2N4O6 | 639.53 | (4R,5S)-nutlin carboxylic acid; MDM2 ligand 2; E3 ligase Ligand 15 |
| cIAP1 ligand 2 | 2357114-70-4 | C34H40N4O6S | 632.77 | cIAP1 ligand 2; E3 ligase Ligand 11 |
| E3 ligase Ligand 9 | 87304-15-2 | C21H32N2O6 | 408.49 | 2-[[2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoyl]amino]-4-methylpentanoic acid |
| VH032 thiol | 2098836-54-3 | C23H30N4O4S2 | 490.64 | PROTAC BRD4-binding moiety 3; VH032 thiol; VHL ligand 6 |
| Dasatinib carbaldehyde | 2112837-79-1 | C21H22ClN7O2S | 471.96 | Dasatinib carbaldehyde; BMS-354825 carbaldehyde; PROTAC ABL binding moiety 4 |
| GNF5-amido-Me | 778277-37-5 | C19H15F3N4O2 | 388.34 | PROTAC ABL binding moiety 2; GNF5 amido Me |
| SLF-amido-C2-COOH | 1092369-24-8 | C34H44N2O9 | 624.72 | SLF-amido-C2-COOH; PROTAC FKBP12-binding moiety 1; 4-[3-[3-(3,4-dimethoxyphenyl)-1-[1-(3,3-dimethyl-2-oxopentanoyl)piperidine-2-carbonyl]oxypropyl]anilino]-4-oxobutanoic acid |
| I-BET762 carboxylic acid | 1300019-38-8 | C20H17ClN4O3 | 396.83 | I-BET762 carboxylic acid; Molibresib carboxylic acid; GSK525762A carboxylic acid; PROTAC BRD4-binding moiety 2; 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetic acid |
| ATRA-hydroxyimino | 135325-47-2 | C20H27NO3 | 329.43 | ATRA-hydroxyimino; CRABP-II ligand 1 |
| Imatinib carbaldehyde | 1436868-85-7 | C29H29N7O2 | 507.59 | Imatinib carbaldehyde; CGP-57148B carbaldehyde; STI571 carbaldehyde; PROTAC ABL binding moiety 1 |
| SirReal1-O-propargyl | 1862237-99-7 | C21H20N4O2S2 | 424.54 | SirReal1-O-propargyl; PROTAC Sirt2-binding moiety 1; 2-((4,6-Dimethylpyrimidin-2-yl)thio)-N-(5-(3-(prop-2-yn-1-yloxy)benzyl)thiazol-2-yl)acetamide |
| PROTAC BET-binding moiety 1 | 2093387-77-8 | C25H25N7O4 | 487.51 | 4-((3-Cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino)-7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxylic acid |
| LCL161-O-Me | 2095244-43-0 | C27H36N4O4S | 512.66 | LCL161-O-Me; IAP ligand 3; PROTAC IAP binding moiety 3 |
| MV-1-NH-Me | 2095244-62-3 | C33H45N5O4 | 575.74 | MV-1-NH-Me; PROTAC IAP binding moiety 2 |
| PROTAC BRD9-binding moiety 1 | 2097512-23-5 | C23H25N3O7S2 | 519.59 | 2-[4-[2-[N'-(1,1-dioxothian-4-yl)carbamimidoyl]-5-methyl-4-oxothieno[3,2-c]pyridin-7-yl]-2-methoxyphenoxy]acetic acid |
| DUPA | 302941-52-2 | C11H16N2O9 | 320.25 | Carglumic Acid Dimer; N,N'-Carbonylbis[L-glutamic acid] |
| Bestatin-amido-Me | 339186-54-8 | C17H27N3O3 | 321.41 | Bestatin-amido-Me; PROTAC IAP binding moiety 1 |
| PROTAC BET-binding moiety 2 | 916493-82-8 | C20H17ClN4O4S | 444.89 | (S)-4-(4-Chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid |
| PROTAC AR Degrader-4 | 1351169-31-7 | C43H67N3O9 | 770.01 | PROTAC AR Degrader 4; [(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] 2-[2-[2-[2-[[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]ethoxy]e |
| PROTAC MDM2 Degrader-3 | 2249750-23-8 | C72H78Cl4N8O15 | 1437.25 | PROTAC MDM2 Degrader 3; 2-[2-[2-[2-[2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]oxyethoxy]ethoxy]ethoxy]ethyl 2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-p |
| PROTAC CRBN Degrader-1 | 2358775-70-7 | C53H72N8O13S | 1061.25 | PROTAC CRBN Degrader 1; (2S,4R)-1-[(2S)-2-[[2-[5-[2-[5-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethylamino]-2-oxoethoxy]pentoxy]ethoxy]pentoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]me |
| PROTAC CRABP-II Degrader-2 | 1225383-38-9 | C44H64N4O10 | 809 | PROTAC CRABP-II Degrader 2; (2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoi |
| PROTAC CRABP-II Degrader-1 | 1225383-40-3 | C42H60N4O9 | 964.95 | PROTAC CRABP-II Degrader 1; (2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid |
| PROTAC CRABP-II Degrader-3 | 1225383-41-4 | C46H68N4O11 | 853.05 | PROTAC CRABP-II Degrader 3; (2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8 |
| PROTAC RAR Degrader-1 | 1351169-27-1 | C51H72N4O11 | 917.14 | PROTAC RAR Degrader 1 |
| VH032-PEG5-C6-Cl | 1799506-06-1 | C38H59ClN4O9S | 783.41 | VH032-PEG5-C6-Cl; HaloPROTAC 2; N-[2-[[2-[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-1-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide |
| dBET57 | 1883863-52-2 | C34H31ClN8O5S | 699.18 | dBET57; dBET 57; dBET-57; 2-[7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]acetamide |
| dBET6 | 1950634-92-0 | C42H45ClN8O7S | 841.37 | 2-((S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)-acetamide |
| MZP-54 | 2010159-47-2 | C55H66ClN7O9S | 1036.67 | MZP-54; MZP 54; MZP54; (2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[[4-[(2S,4R)-1-acetyl-4-(4-chloroanilino)-2-methyl-3,4-dihydro-2H-quinolin-6-yl]benzoyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl] |
| MZP-55 | 2010159-48-3 | C57H70ClN7O10S | 1080.72 | MZP-55; MZP 55; MZP55; (2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[2-[[4-[(2S,4R)-1-acetyl-4-(4-chloroanilino)-2-methyl-3,4-dihydro-2H-quinolin-6-yl]benzoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5- |
| A1874 | 2064292-12-0 | C58H62Cl3F2N9O7S | 1173.59 | A1874; A 1874; A-1874; (2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-N-(4-((1-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-2-oxo-6,9,12-trioxa-3-azatetradecan-14-yl)carbamoyl)-2- |
| PROTAC BET Degrader-1 | 2093386-22-0 | C44H45N11O9 | 871.9 | 4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide |
| PROTAC BET degrader-2 | 2093388-33-9 | C41H42N10O6 | 770.84 | PROTAC BET degrader 2; 4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[3-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]propyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide |
| BETd-260 | 2093388-62-4 | C43H46N10O6 | 798.89 | ZBC260; ZBC 260; ZBC-260; BETd-260; BETd 260; BETd260. 4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[5-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]pentyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide |
| PROTAC BRD9 Degrader-1 | 2097971-01-0 | C42H45N7O12S2 | 903.98 | PROTAC BRD9 Degrader 1; N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-2-[4-[2-[N'-(1,1-dioxothian-4-yl)carbamimidoyl]-5-methyl-4-oxothieno[3,2-c]pyridin-7-yl]-2-methoxyphenoxy]acetamide |
| PROTAC Sirt2 Degrader-1 | 2098487-75-1 | C40H40N10O8S2 | 852.94 | Sirt2-PROTAC-1; Sirt2 PROTAC-1; Sirt2-PROTAC1; Sirt2 PROTAC 1; N-[4-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]butyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetam |
| AT6 | 2098836-50-9 | C48H58ClN9O7S3 | 1004.68 | AT6; AT 6; AT-6; 1-[2-acetamido-3-[2-[2-[2-[[2-[7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetyl]amino]ethoxy]ethoxy]ethylsulfanyl]-3-methylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-t |
| PROTAC CDK9 Degrader-1 | 2118356-96-8 | C33H35N5O7 | 613.66 | CDK9PROTAC; CDK9 PROTAC; CDK9-PROTAC; N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-[4-[5-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxypentoxy]phenyl]acetamide |
| BETd-246 | 2140289-17-2 | C48H55N11O10 | 946.02 | BETd-246; BETd 246; BETd246; 4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[3-[2-[2-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]ethoxy]ethoxy]propyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxam |
| PROTAC ER Degrader-3 | 2158322-29-1 | C71H77N7O12 | 1220.41 | PROTAC ER Degrader 3; tert-butyl N-[(2S)-1-[[(3S,4S)-7-cyano-5-[4-[2-[2-[2-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]benzoyl]-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-2-oxo-3,4-dihy |
| QCA570 | 2207569-08-0 | C39H33N7O4S | 695.79 | QCA570; QCA-570; QCA 570; 3-(4-(5-(4-((3-Benzyl-9-methyl-4H,6H-thieno[2,3-e][1,2,4]-triazolo[3,4-c][1,4]oxazepin-2-yl)ethynyl)-1H-pyrazol-1-yl)pent-1-yn-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
| JH-XI-10-02 | 2209085-22-1 | C53H69N5O9 | 920.14 | JH XI-10-02; JH-XI 10-02; JH-XI-10 02; JH XI 10 02; JHXI1002; 3-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-N-[(5R,8S,9S,10S,13S,14R)-17-isoquinolin-7-yl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16 |
| MS4078 | 2229036-62-6 | C45H52ClN9O8S | 914.47 | MS-4078; MS4078; MS 4078; 2-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]-N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]acetamide |
| MS4077 | 2230077-10-6 | C55H72ClN9O13S | 1134.73 | MS4077; MS 4077; MS-4077; 2-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]-N-[2-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]e |
| Gefitinib-based PROTAC 3 | 2230821-27-7 | C47H57ClFN7O8S | 934.51 | Gefitinib-based Proteolysis-targeting Chimera 3; 1-[2-[3-[2-[5-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypentoxy]ethoxy]propanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamid |
| PROTAC FLT-3 degrader 1 | 2230826-81-8 | C52H61N9O9S2 | 1020.23 | (2S,4R)-1-[(2S)-2-[3-[2-[2-[2-[4-[(5-tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]imidazo[2,1-b][1,3]benzothiazol-6-yl]oxyethoxy]ethoxy]propanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carbox |
| MT-802 | 2231744-29-7 | C41H41N9O8 | 787.82 | MT802; MT 802; MT-802; 2-[2-[2-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethoxy]ethoxy]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]acetamide |
| PROTAC MDM2 Degrader-4 | 2249750-24-9 | C70H74Cl4N8O14 | 1393.19 | PROTAC MDM2 Degrader 4; 2-[2-[2-[2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]oxyethoxy]ethoxy]ethyl 2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yl |
| PROTAC MDM2 Degrader-1 | 2249944-98-5 | C74H84Cl4N10O13 | 1463.33 | PROTAC MDM2 Degrader 1; 2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]-N-[3-[2-[2-[3-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydro |
| PROTAC MDM2 Degrader-2 | 2249944-99-6 | C70H76Cl4N10O12 | 1391.22 | PROTAC MDM2 Degrader 2; 2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]-N-[2-[2-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimi |
| PROTAC FAK degrader 1 | 2301916-69-6 | C47H56F3N9O8S2 | 996.13 | |
| VZ185 | 2306193-61-1 | C53H67FN8O8S | 995.21 | VZ185; VZ-185; VZ 185; (2S,4R)-N-[[2-[5-[4-[[2,6-dimethoxy-4-(2-methyl-1-oxo-2,7-naphthyridin-4-yl)phenyl]methyl]piperazin-1-yl]pentoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hy |
| PROTAC ERRalpha Degrader-1 | 2306388-84-9 | C54H49Cl2F6N7O8 | 1108.91 | PROTAC ERRalpha Degrader 1; (E)-N-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]ethyl]-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cy |
| PROTAC ERRalpha Degrader-2 | 2306388-85-0 | C57H55Cl2F6N7O8 | 1150.99 | (E)-N-[5-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]pentyl]-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enamide |
| ERD-308 | 2320561-35-9 | C55H65N5O9S2 | 1004.26 | ERD-308; ERD 308; ERD308; (2S,4R)-1-[(2S)-2-[[2-[5-[ethyl-[2-[4-[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophene-3-carbonyl]phenoxy]ethyl]amino]pentoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrro |
| dMCL1-2 | 2351218-88-5 | C61H66N10O12S | 1163.3 | dMCL1-2; dMCL1 2; dMCL12; 7-[5-[[4-[4-(dimethylsulfamoyl)piperazin-1-yl]phenoxy]methyl]-1,3-dimethylpyrazol-4-yl]-1-[2-[4-[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]piperazin-1-yl]ethyl]-3-(3-naphthalen-1-yloxypropyl)indole-2-carboxy |
| Boc-C5-O-C5-O-C6-Cl | 1835705-52-6 | C21H41ClO4 | 393 | Boc-C5-O-C5-O-C6-Cl; PROTAC Linker 2; tert-butyl 6-[5-(6-chlorohexoxy)pentoxy]hexanoate |
| Tos-PEG4-NH-Boc | 1246999-33-6 | C20H33NO8S | 447.54 | Tos-PEG4-NH-Boc; PROTAC Linker 7; t-Boc-N-Amido-PEG4-Tos; 2-[2-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate |
| Cl-C6-PEG4-O-CH2COOH | 1799506-30-1 | C16H31ClO7 | 370.87 | PROTAC Linker 4; 2-[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]acetic acid |
| Boc-C1-PEG2-C4-Cl | 1835705-53-7 | C14H27ClO4 | 294.81 | PROTAC Linker 1; tert-butyl 2-[2-(6-chlorohexoxy)ethoxy]acetate |
| NH2-PEG3-C1-Boc | 189808-70-6 | C12H25NO5 | 263.33 | NH2-PEG3-C1-Boc; PROTAC Linker 5; Amino-PEG3-CH2CO2-t-butyl ester; H2N-PEG3-CH2COOtBu; tert-butyl 2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]acetate |
| Azido-PEG4-acetic Acid | 201467-81-4 | C10H19N3O6 | 277.27 | 2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]acetic acid; 2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]acetic acid |
| Tos-PEG3-NH-Boc | 206265-94-3 | C18H29NO7S | 403.49 | N-BOC 2-[(2-p-Tosyloxyethoxy)ethoxy]ethylamine; Tos-PEG3-NH-Boc; PROTAC Linker 9; 2-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate |
| 4,7,10,13-Tetraoxahexadecane-1,16-dioic Acid | 31127-85-2 | C12H22O8 | 294.30 | 3-[2-[2-[2-(2-carboxyethoxy)ethoxy]ethoxy]ethoxy]propanoic acid; 3-[2-[2-[2-(2-carboxyethoxy)ethoxy]ethoxy]ethoxy]propanoic acid |
| Tetraethylene glycol di(p-toluenesulfonate) | 37860-51-8 | C22H30O9S2 | 502.60 | 2-[2-[2-[2-(4-methylphenyl)sulfonyloxyethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate |
| PEG3-O-CH2COOH | 51951-05-4 | C8H16O6 | 208.21 | PEG3-O-CH2COOH; PROTAC Linker 8; HO-PEG3-CH2COOH; 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]acetic acid |
| PEG6-(CH2CO2H)2 | 77855-76-6 | C14H26O10 | 354.35 | 3,6,9,12,15,18-hexaoxaicosanedioic acid; 2-[2-[2-[2-[2-[2-(carboxymethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetic acid |
| Azido-PEG4-Amine | 951671-92-4 | C10H22N4O4 | 262.31 | 2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethanamine; 2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethanamine |
| SNIPER(ABL)-033 | 2222354-18-7 | 1211.42 | ||
| SNIPER(BRD)-1 | 2095244-54-3 | 1056.73 | ||
| SNIPER(AR)-51 | 2113688-43-8 | 984.21 | ||
| SNIPER(ABL)-062 | 2140260-89-3 | 1089.64 | ||
| SNIPER(ABL)-039 | 2222354-29-0 | 1114.77 | ||
| SNIPER(ABL)-058 | 2222354-61-0 | 1150.39 | ||
| SNIPER(ABL)-024 | 2222355-77-1 | 1031.15 | ||
| (+)-CBI-CDPI2 | 128300-15-2 | C36H28N6O4 | 608.65 | (+)-CBI CDPI2; (+) CBI CDPI2 |
| Brevetoxin PbTx-9 | 142353-09-1 | C50H74O14 | 899.12 | |
| Cryptophycin | 124689-65-2 | C36H45ClN2O8 | 669.2 | (3S,6R,10R,13E,16S)-10-[(3-chloro-4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(1S)-1-[(2R,3R)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone |
| (+)-CBI-CDPI1 | 128300-14-1 | C25H20N4O3 | 424.45 | (+) CBI CDPI1; (+)-CBI CDPI1 |
| Apaziquone | 141304-51-0 | C15H18O3 | 246.3 | 1H-INDOLE-4,7-DIONE, 5-(1-AZIRIDINYL)-3-(HYDROXYMETHYL)-2-(3-HYDROXY-1-PROPENYL)-1-METHYL-, (E)-; APAZIQUONE |
| Duocarmycin TM | 157922-77-5 | C25H23ClN2O5 | 466.91 | [(1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydrobenzo[e]indol-3-yl]-(5,6,7-trimethoxy-1H-indol-2-yl)methanone |
| Dxd | 1599440-33-1 | C26H24FN3O6 | 493.48 | N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-2-hydroxyacetamide; N-((1S,9S)-9-Ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy |
| Duocarmycin MB | 1613286-58-0 | C27H26ClN3O4 | 491.97 | tert-butyl N-[2-[1-(chloromethyl)-5-hydroxy-1,2-dihydrobenzo[e]indole-3-carbonyl]-1H-indol-6-yl]carbamate |
| DC1 | 169901-27-3 | C34H28ClN5O4S | 638.14 | DC1, an analogue of the minor groove-binding DNA alkylator CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer. |
| MMAF sodium | 1799706-65-2 | C39H64N5NaO8 | 753.94 | Monomethylauristatin F sodium |
| DRF-1042 | 200619-13-2 | C22H20N2O6 | 408.4 | DRF-1042; DRF 1042; DRF1042; 5-(2'-Hydroxyethoxy)-20(S)-camptothecin. (4S)-4-ethyl-4-hydroxy-12-(2-hydroxyethoxy)-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione |
| Top1 inhibitor 1 | 2302772-05-8 | C24H22N6O2 | 426.47 | |
| DC1-SMe | 501666-85-9 | C35H30ClN5O4S2 | 684.23 | DC1-SMe; DC1 SMe; DC1SMe; N-[2-[(1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydrobenzo[e]indole-3-carbonyl]-1H-indol-5-yl]-5-[3-(methyldisulfanyl)propanoylamino]-1H-indole-2-carboxamide |
| DC0-NH2 | 615538-51-7 | C31H24ClN5O3 | 550.01 | DC0 NH2; DC0NH2; DC0-NH2 |
| N-Me-L-Ala-maytansinol | 77668-69-0 | C32H44ClN3O9 | 650.16 | |
| Boc-Val-Dil-Dap-Doe | 135383-62-9 | C40H63N5O7S | 758.03 | N-Boc-Val-Dil-Dap-Doe; Carbamic acid, [1-[[[2-methoxy-4-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-(1-methylpropyl)-4-oxobutyl]methylamino]carbonyl]-2-methylpropyl]-, 1,1-dimethylethyl ester, stereoisome |
| Fr901465 | 146478-73-1 | C27H41NO9 | 523.62 | FR-901465; (2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate; [(Z,2S)-4-[[(2R,3R,5S,6S)-2,5- |
| Spliceostatin A | 391611-36-2 | C28H43NO8 | 521.65 | [(Z,2S)-4-[[(2R,3R,5S,6S)-6-[(2E,4E)-5-[(3R,4R,5R,7S)-4-hydroxy-7-methoxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]carbamoyl]but-3-en-2-yl] acetate; (2Z,4S)-N-[(2R,3R,5S,6S)-2,5-Dimethyl-6-[(2E)-3-methyl-5-[( |
| Sudemycin E | 1197054-49-1 | C27H41NO7 | 491.63 | |
| Lys-SMCC-DM1 | 1281816-04-3 | C53H75ClN6O15S | 1103.71 | (2S)-2-amino-6-[[4-[[3-[3-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-m |
| Vc-seco-DUBA | 1345681-58-4 | C65H75ClN12O17 | 1331.81 | [(1S)-1-(chloromethyl)-3-[6-[(4-hydroxybenzoyl)amino]imidazo[1,2-a]pyridine-2-carbonyl]-9-methyl-1,2-dihydrobenzo[e]indol-5-yl] N-[2-[[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxycarbonylamino]-3-methylbutanoyl]amino]pe |
| MC-Alkyl-Hydrazine Modified MMAF | 1404071-64-2 | C59H92N10O12 | 1133.42 | |
| PEG4-aminooxy-MMAF | 1415246-35-3 | C47H82N6O12 | 923.19 | |
| AcLys-PABC-VC-Aur0101 | 1438851-17-2 | C66H103N13O13S | 1318.67 | |
| Sulfo-PDBA-DM4 | 1461704-01-7 | C42H60ClN3O15S3 | 978.58 | Soravtansine; DM4-Sulfo-TBA; 4-[[5-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropa |
| Mal-VC-PAB-DM1 | 1464051-44-2 | C61H82ClN9O17 | 1248.81 | |
| MC-GGFG-DX8951 | 1600418-29-8 | C49H51FN8O11 | 946.97 | 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(2-((2-(((S)-1-((2-(((1R,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-2-oxoethyl)amino)-1-oxo-3-phenylpropan- |
| MC-Val-Cit-PAB-clindamycin | 1639793-13-7 | C46H72ClN8O11S | 980.63 | |
| MC-Val-Cit-PAB-Retapamulin | 1639793-15-9 | C58H86N7O10S | 1073.41 | |
| AmPEG6C2-Aur0131 | 1650569-94-0 | C54H92N6O15 | 1065.34 | |
| AZ1508 | 1817736-04-1 | C56H85N9O11S | 1092.39 | AZ1508; AZ 1508; AZ-1508; MC-Lys-MMETA; (2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S,3S)-2-[[(2R,4R)-1,4-dimethylpiperidine-2-carbonyl]amino]-3-methylpentanoyl]-ethylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-5-[4-[[(2S)-6-amino-2-[6-(2,5-dioxopy |
| MC-Sq-Cit-PAB-Gefitinib | 1941168-63-3 | C50H61ClFN10O9 | 1000.53 | MC Sq Cit PAB Gefitinib |
| MC-Sq-Cit-PAB-Dolastatin10 | 1941168-65-5 | C70H105N12O12S | 1338.72 | MC Sq Cit PAB Dolastatin10 |
| Nitro-PDS-Tubulysin M | 1941168-69-9 | C54H73N8O11S3 | 1106.4 | Nitro PDS Tubulysin M |
| MC-Val-Cit-PAB-carfilzomib | 2055896-83-6 | C68H96N11O13 | 1275.56 | MC Val Cit PAB carfilzomib |
| MC-Val-Cit-PAB-tubulysin5a | 2055896-86-9 | C66H96N11O13S | 1283.6 | MC Val Cit PAB tubulysin5a |
| MC-Val-Cit-PAB-Indibulin | 2055896-95-0 | C50H55ClN9O8 | 945.48 | MC Val Cit PAB Indibulin |
| MC-Val-Cit-PAB-duocarmycin | 2055896-98-3 | C54H65ClN9O9 | 1019.6 | MC Val Cit PAB duocarmycin |
| VCP-Eribulin | 2130869-17-7 | C59H86N6O16 | 1135.34 | |
| MAC glucuronide phenol-linked SN-38 | 2246380-69-6 | C50H54N6O20S | 1091.06 | |
| SC-VC-PAB-DM1 | 2259318-47-1 | C61H82ClN9O19 | 1280.81 | |
| Mal-VC-PAB-ABAEP-Azonafide | 2259318-48-2 | C61H71N11O12 | 1150.28 | |
| Mal-PEG4-VA-PBD | 2259318-50-6 | C70H83N9O17 | 1322.46 | |
| Mal-C2-Gly3-EDA-PNU-159682 | 2259318-53-9 | C46H53N7O18 | 991.95 | |
| MCC-Modified Daunorubicinol | 721945-30-8 | C39H44N4O13 | 776.79 | |
| MMAF-OMe | 863971-12-4 | C40H67N5O8 | 745.99 | MMAF-OMe, Monomethyl auristatin F methyl ester; methyl (2S)-2-[[(2R,3R)-3-methoxy-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl |
| Val-Cit-PAB-MMAF | 863971-56-6 | C68H103N11O16 | 1330.61 | 2-[[3-[1-[4-[[2-[[2-[[4-[[5-(carbamoylamino)-2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methoxycarbonyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrol |
| DBA-DM4 | 905449-84-5 | C42H60ClN3O12S2 | 898.52 | 4-[[5-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-2-methyl |
| MA-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-52-8 | C74H98N10O27 | 1559.64 | Mal-PEG4-VC-PAB-DMEA-PNU-159682 |
| MA-PEG4-VA-PBD | 1342820-68-1 | C68H79N9O17 | 1294.43 | Mal-PEG4-VA-PBD |
| CL2A-SN 38 | 1279680-68-0 | C73H97N11O22 | 1480.63 | CL2A-SN-38 |
| DBCO-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-56-2 | C86H106N10O26 | 1695.84 | DBCO-PEG4-VC-PAB-DMEA-PNU-159682 |
| 4-Formyl-N-(2-(2-Methoxy-4-Methylphenoxy)ethyl)benzamide | 1226006-54-7 | C18H19NO4 | 313.35 | |
| N-(2-(2-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1226394-63-3 | C18H19NO3 | 297.35 | |
| Fmoc-PEG4-NHS Ester | 1314378-14-7 | C30H36N2O10 | 584.61 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| Mal-PEG4-VA | 1800456-31-8 | C26H42N4O11 | 586.63 | |
| SPDMB | 2101206-29-3 | C14H16N2O4S2 | 340.42 | (2,5-dioxopyrrolidin-1-yl) 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate |
| Propargyl-O-C1-amido-PEG4-C2-NHS ester | 2101206-92-0 | C20H30N2O10 | 458.46 | 2,5-dioxopyrrolidin-1-yl 17-oxo-4,7,10,13,19-pentaoxa-16-azadocos-21-yn-1-oate; (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[(2-prop-2-ynoxyacetyl)amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| (2S,2'S)-Bis(2,5-dioxopyrrolidin-1-Yl) 4,4'-disulfanediylbis(2-(((benzyloxy)carbonyl)amino)butanoate) | 299402-08-7 | C32H34N4O12S2 | 730.76 | (2,5-dioxopyrrolidin-1-yl) 4-[[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxo-3-(phenylmethoxycarbonylamino)butyl]disulfanyl]-2-(phenylmethoxycarbonylamino)butanoate |
| 2,5-dioxopyrrolidin-1-yl 3-(4-hydroxyphenoxy)propanoate | 616889-42-0 | C13H13NO6 | 279.25 | |
| EC089 | 625827-91-0 | C36H46N14O14S | 930.9 | 2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-[[3-carboxy-1-[[1-[[3-carboxy-1-[(1-carboxy-2-sulfanylethyl)amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
| Sulfo-SIAB sodium | 144650-93-1 | C13H10IN2NaO8S | 504.19 | sodium;1-[4-[(2-iodoacetyl)amino]benzoyl]oxy-2,5-dioxopyrrolidine-3-sulfonate; Sulfo-N-succinimidyl (N-Iodoacetyl)aminobenzoate |
| endo-BCN-PEG3-NHS ester | 2101206-94-2 | C24H34N2O9 | 494.53 | 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
| 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate | 2243565-12-8 | C22H30N2O8 | 450.48 | endo-BCN-PEG2-OSu; endo-BCN-PEG2-NHS ester |
| 2,5-dioxopyrrolidin-1-yl 14-oxo-4,7,10,16-tetraoxa-13-azanonadec-18-yn-1-oate | 2101206-78-2 | C18H26N2O9 | 414.41 | Propargyl-O-C1-amido-PEG3-C2-NHS ester |
| Maleimide-NH-PEG3-CH2CH2COOPFP Ester | 2101206-13-5 | C21H21F5N2O8 | 524.39 | perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate |
| Ala-Ala-Asn-PAB | 2149584-00-7 | C17H25N5O5 | 379.41 | (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-N-[4-(hydroxymethyl)phenyl]butanediamide |
| JUN68744 | 1703768-74-4 | C33H45N5O9 | 655.74 | JUN68744; JUN-68744; JUN 68744; PSMA-617-linker; PSMA 617-linker; PSMA617-linker; Vipivotide tetraxetan Linker; (((S)-5-((S)-2-((1r,4S)-4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid |
| Mal-amido-PEG8-acid | 1334177-86-4 | C26H44N2O13 | 592.63 | Mal-amido-PEG8-C2-acid; 3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid |
| 6-(Boc-amino)hexyl bromide | 142356-33-0 | C11H22BrNO2 | 280.20 | tert-butyl N-(6-bromohexyl)carbamate |
| m-PEG4-NHS ester | 622405-78-1 | C14H23NO8 | 333.33 | Methyl-PEG4-NHS Ester; (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]propanoate |
| (S)-di-tert-butyl 2-(3-((S)-6-amino-1-tert-butoxy-1-oxohexan-2-yl)ureido)pentanedioate | 1025796-31-9 | C24H45N3O7 | 487.63 | 1,5-Bis(1,1-dimethylethyl) N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-L-glutamate |
| (S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic Acid | 1026987-94-9 | C23H40N2O9 | 488.57 | DUPA(OtBu)-OH; L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester; 2-[3-(1,3-bis-tert-butoxycarbonylpropyl)ureido]pentanedioic acid 1-tert-butyl ester |
| m-PEG1-NHS ester | 1027371-75-0 | C8H11NO5 | 201.18 | 2, 5-Dioxopyrrolidin-1-yl 3-methoxypropanoate |
| (2S,2'S)-Bis(2,5-Dioxopyrrolidin-1-yl) 4,4'-Disulfanediylbis(2-Acetamidobutanoate) | 102814-00-6 | C20H26N4O10S2 | 546.57 | (2,5-dioxopyrrolidin-1-yl) 2-acetamido-4-[[3-acetamido-4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]disulfanyl]butanoate |
| 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate | 1042435-35-7 | C16H23NO9 | 373.36 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]propanoate |
| 2,5-Dioxopyrrolidin-1-yl 2,5,7,10-Tetraoxatridecan-13-Oate | 1053657-02-5 | C13H21NO8 | 319.31 | |
| Sulfo-SIAB | 106145-13-5 | C13H11IN2O8S | 482.2 | Sulfo SIAB |
| 4-Formyl-N-(2-Isopropoxyethyl)benzamide | 1061567-05-2 | C13H17NO3 | 235.28 | |
| Ac-S-PEG8-NHS | 1070798-99-0 | C25H43NO13S | 597.67 | 2,5-Dioxopyrrolidin-1-Yl 2-Oxo-6,9,12,15,18,21,24,27-Octaoxa-3-Thiatriacontan-30-Oate; Ac-S-dPEG(8)-NHS; (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-(2-acetylsulfanylethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| m-PEG2-NHS ester | 1127247-34-0 | C10H15NO6 | 245.23 | 2,5-Dioxopyrrolidin-1-Yl 3-(2-Methoxyethoxy)propanoate; (2,5-dioxopyrrolidin-1-yl) 3-(2-methoxyethoxy)propanoate |
| 2,5-Dioxopyrrolidin-1-yl 3-(benzyloxy)propanoate | 1134280-63-9 | C14H15NO5 | 277.27 | |
| 2,5-Dioxopyrrolidin-1-yl 3-((2-Fluorobenzyl)oxy)propanoate | 1134280-64-0 | C14H14FNO5 | 295.26 | |
| 2,5-Dioxopyrrolidin-1-yl 3-((2,4-Difluorobenzyl)oxy)propanoate | 1134280-65-1 | C14H13F2NO5 | 313.25 | |
| N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide | 1137575-49-5 | C12H14ClNO3 | 255.7 | 4-[2-(2-Chloroethoxy)ethyl]carbamoylbenzaldehyde |
| Mal-Tetra-EG-Osu | 1151762-45-6 | C20H26N2O12 | 486.43 | |
| Propanoic Acid,3-[(23-Mercapto-3,6,9,12,15,18,21-Heptaoxatricos-1-Yl)oxy], 2,5-Dioxo-1-Pyrrolidinyl Ester | 1159006-15-1 | C23H41NO12S | 555.64 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-(2-sulfanylethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| 2,5-Dioxopyrrolidin-1-yl 4-((2-(1,3-Dioxoisoindolin-2-Yl)ethyl)disulfanyl)butanoate | 1190203-91-8 | C18H18N2O6S2 | 422.48 | |
| 2,5-Dioxopyrrolidin-1-yl 3-(4-Methoxyphenoxy)propanoate | 1199815-10-5 | C14H15NO6 | 293.27 | |
| 2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate | 1222787-24-7 | C31H39N7O9S2 | 717.81 | |
| 4-Formyl-N-(2-Phenoxyethyl)benzamide | 1225575-00-7 | C16H15NO3 | 269.3 | |
| 4-Formyl-N-(2-(m-Tolyloxy)ethyl)benzamide | 1225587-15-4 | C17H17NO3 | 283.32 | |
| N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225588-22-6 | C16H14FNO3 | 287.29 | |
| N-(2-(3-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225588-29-3 | C16H14FNO3 | 287.29 | |
| N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225705-45-2 | C16H14FNO3 | 287.29 | |
| N-(2-(3-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-49-7 | C18H19NO3 | 297.35 | |
| N-(2-(4-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-59-9 | C18H19NO3 | 297.35 | |
| N-(2-(2,6-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1225936-91-3 | C18H19NO3 | 297.35 | |
| 4-Formyl-N-(2-(2-Isopropylphenoxy)ethyl)benzamide | 1225964-49-7 | C19H21NO3 | 311.37 | |
| 4-Formyl-N-(2-(2,4,5-Trimethylphenoxy)ethyl)benzamide | 1225964-74-8 | C19H21NO3 | 311.37 | |
| N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1225972-65-5 | C16H14ClNO3 | 303.74 | |
| N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide | 1225979-81-6 | C19H19NO3 | 309.36 | |
| N-(2-(Benzo[d][1,3]dioxol-5-yloxy)ethyl)-4-Formylbenzamide | 1226006-03-6 | C17H15NO5 | 313.3 | N-[2-(1,3-benzodioxol-5-yloxy)ethyl]-4-formylbenzamide |
| N-(2-(3-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | 1226006-55-8 | C18H19NO4 | 313.35 | |
| 4-Formyl-N-(2-(4-Methoxyphenoxy)ethyl)benzamide | 1226012-11-8 | C17H17NO4 | 299.32 | |
| N-(2-(3-(Dimethylamino)phenoxy)ethyl)-4-Formylbenzamide | 1226019-77-7 | C18H20N2O3 | 312.36 | |
| N-(2-(4-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1226050-10-7 | C16H14ClNO3 | 303.74 | |
| N-(2-(2,4-Difluorophenoxy)ethyl)-4-Formylbenzamide | 1226050-21-0 | C16H13F2NO3 | 305.28 | |
| N-(2-(4-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | 1226072-27-0 | C18H19NO4 | 313.35 | |
| 4-Formyl-N-(2-(3-isopropylphenoxy)ethyl)benzamide | 1226076-16-9 | C19H21NO3 | 311.37 | |
| 4-Formyl-N-(2-(mesityloxy)ethyl)benzamide | 1226076-32-9 | C19H21NO3 | 311.37 | |
| N-(2-(3,4-dimethylphenoxy)ethyl)-4-formylbenzamide | 1226096-54-3 | C18H19NO3 | 297.35 | |
| 4-Formyl-N-(2-(o-Tolyloxy)ethyl)benzamide | 1226105-58-3 | C17H17NO3 | 283.32 | |
| N-(2-(3-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1226200-04-9 | C16H14ClNO3 | 303.74 | |
| 4-Formyl-N-(2-(4-Isopropylphenoxy)ethyl)benzamide | 1226217-30-6 | C19H21NO3 | 311.37 | |
| 4-Formyl-N-(2-(2,3,6-Trimethylphenoxy)ethyl)benzamide | 1226218-43-4 | C19H21NO3 | 311.37 | |
| N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | 1226221-04-0 | C18H19NO4 | 313.35 | |
| 4-Formyl-N-(2-(p-Tolyloxy)ethyl)benzamide | 1226279-82-8 | C17H17NO3 | 283.32 | |
| N-(2-(3,5-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1226305-62-9 | C18H19NO3 | 297.35 | |
| N-(2-(2,3-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1226305-75-4 | C18H19NO3 | 297.35 | |
| 4-Formyl-N-(2-(3-Methoxyphenoxy)ethyl)benzamide | 1226324-22-6 | C17H17NO4 | 299.32 | |
| N-(2-(2,5-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1226371-65-8 | C18H19NO3 | 297.35 | |
| 4-Formyl-N-(2-(2-Methoxyphenoxy)ethyl)benzamide | 1226372-18-4 | C17H17NO4 | 299.32 | |
| N-(2-(2,4-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1226394-74-6 | C18H19NO3 | 297.35 | |
| N-(2-(3,4-Difluorophenoxy)ethyl)-4-Formylbenzamide | 1226403-39-9 | C16H13F2NO3 | 305.28 | |
| 4-Formyl-N-(2-(naphthalen-2-Yloxy)ethyl)benzamide | 1228153-04-5 | C20H17NO3 | 319.35 | |
| 1-((4-((2-(2-(7-Amino-4-Methyl-1-Oxo-1H-Isochromen-3-Yl)acetamido)ethyl)disulfanyl)butanoyl)oxy)-2,5-Dioxopyrrolidine-3-Sulfonic Acid | 1246497-13-1 | C22H25N3O10S3 | 587.64 | |
| 2,5-Dioxopyrrolidin-1-Yl 3-(2,4-Di-Tert-Pentylphenoxy)propanoate | 124709-46-2 | C23H33NO5 | 403.51 | |
| t-Boc-N-amido-PEG1-NHS ester | 1260092-55-4 | C14H22N2O7 | 330.33 | 2,5-Dioxopyrrolidin-1-Yl 3-(2-((tert-Butoxycarbonyl)amino)ethoxy)propanoate |
| Bromoacetamido-PEG4-NHS ester | 1260139-70-5 | C17H27BrN2O9 | 483.31 | 2,5-Dioxopyrrolidin-1-Yl 1-Bromo-2-Oxo-6,9,12,15-Tetraoxa-3-Azaoctadecan-18-Oate |
| NHS-PEG(5)-CO-OBzl | 1263044-84-3 | C25H35NO11 | 525.55 | 1-Benzyl 19-(2,5-Dioxopyrrolidin-1-Yl) 4,7,10,13,16-Pentaoxanonadecane-1,19-Dioate |
| 2,5-Dioxopyrrolidin-1-Yl 1-Bromo-3-Methyl-2-Oxo-6,9,12,15-Tetraoxa-3-Azaoctadecan-18-Oate | 1283658-70-7 | C18H29BrN2O9 | 497.33 | |
| 2,5-Dioxopyrrolidin-1-Yl 1-Bromo-2-Oxo-6,9,12,15,18,21,24,27-Octaoxa-3-Azatriacontan-30-Oate | 1283658-79-6 | C25H43BrN2O13 | 659.52 | |
| (E)-2,5-Dioxopyrrolidin-1-Yl 17-Bromo-4,7,10,13-Tetraoxaheptadec-15-En-1-Oate | 1283658-84-3 | C17H26BrNO8 | 452.29 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-(4-bromobut-2-enoxy)ethoxy]ethoxy]ethoxy]propanoate |
| 2,5-Dioxopyrrolidin-1-Yl 4-Methyl-4-((2-Methyl-5-Oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-Yl)disulfanyl)pentanoate | 1286715-33-0 | C21H37NO6S2Si | 491.74 | 2-trimethylsilylethyl 4-[[5-(2,5-dioxopyrrolidin-1-yl)oxy-2-methyl-5-oxopentan-2-yl]disulfanyl]-4-methylpentanoate |
| 3-((2,5-Dioxopyrrolidin-1-Yl)oxy)-3-Oxopropyl Acrylate | 1311459-55-8 | C10H11NO6 | 241.2 | |
| m-PEG9-NHS ester | 1316189-13-5 | C24H43NO13 | 553.6 | Methyl-PEG8-NHS; 2,5-Dioxopyrrolidin-1-Yl 2,5,8,11,14,17,20,23,26-Nonaoxanonacosan-29-Oate |
| Boc-NMe-Val-Val-Dil-Dap-OH | 1352202-13-1 | C45H66N4O9 | 807.03 | (2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-1-[[(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylbutanoyl]amino]-3-methyl-1-oxobutan-2-yl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoic acid |
| (S)-2-(N-Methyl-3-(Methyldisulfanyl)propanamido)propanoic Acid | 138148-62-6 | C8H15NO3S2 | 237.34 | (2S)-2-[methyl-[3-(methyldisulfanyl)propanoyl]amino]propanoic acid |
| DBCO-C6-NHS ester | 1384870-47-6 | C25H22N2O5 | 430.45 | DBCO-NHS ester 2; (2,5-dioxopyrrolidin-1-yl) 6-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-6-oxohexanoate |
| DBCO-NHS ester 3 | 1393350-27-0 | C24H20N2O5 | 416.43 | |
| 2,5-Dioxopyrrolidin-1-yl 3-((3-((3-(trityloxy)propanoyl)oxy)propanoyl)oxy)propanoate | 145069-77-8 | C32H31NO9 | 573.59 | [3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl] 3-(3-trityloxypropanoyloxy)propanoate |
| Mal-L-PA-NH-Boc | 1491152-23-8 | C12H16N2O6 | 284.27 | 2-(2,5-dioxopyrrol-1-yl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid |
| Mal-PEG3-NHS ester | 1537892-36-6 | C17H22N2O9 | 398.36 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]propanoate |
| Mc-Val-Cit-PAB-Cl | 1639351-92-0 | C28H39ClN6O6 | 591.1 | |
| 2,5-Dioxopyrrolidin-1-yl 3-Hydroxypropanoate | 178106-34-8 | C7H9NO5 | 187.15 | (2,5-dioxopyrrolidin-1-yl) 3-hydroxypropanoate |
| CL2A | 1846605-04-6 | C51H79N9O18 | 1106.22 | |
| Boc-Gly-Gly-Phe-Gly-OH | 187794-49-6 | C20H28N4O7 | 436.46 | 2-[[(2S)-2-[[2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetic acid |
| 4-Formyl-N-(2-Methoxyethyl)benzamide | 199679-16-8 | C11H13NO3 | 207.23 | |
| MAL-Tri-EG-Osu | 2055353-77-8 | C20H27N3O10 | 469.44 | Mal-propionylamido-PEG3-NHS ester; (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]propanoate |
| PDB-Pfp | 2088570-81-2 | C15H10F5NO2S2 | 395.37 | Perfluorophenyl 4-(pyridin-2-Yldisulfanyl)butanoate; (2,3,4,5,6-pentafluorophenyl) 4-(pyridin-2-yldisulfanyl)butanoate |
| NHPI-PEG3-C2-NHS ester | 2101206-14-6 | C21H24N2O10 | 464.42 | 2,5-Dioxopyrrolidin-1-Yl 3-(2-(2-(2-(1,3-Dioxoisoindolin-2-Yloxy)ethoxy)ethoxy)ethoxy)propanoate |
| Ald-Ph-amido-PEG3-C2-Pfp ester | 2101206-21-5 | C23H22F5NO7 | 519.42 | 2,3,4,5,6-Pentafluorophenyl 3-[2-(2-{2-[(4-Formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
| Propargyl-O-C1-amido-PEG2-C2-NHS ester | 2101206-30-6 | C16H22N2O8 | 370.35 | 2,5-Dioxopyrrolidin-1-Yl 11-Oxo-4,7,13-Trioxa-10-Azahexadec-15-Yn-1-Oate |
| NHPI-PEG2-C2-NHS ester | 2101206-31-7 | C19H20N2O9 | 420.37 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(1,3-dioxoisoindol-2-yl)oxyethoxy]ethoxy]propanoate |
| (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]ethoxy]propanoate | 2101206-32-8 | C21H26N2O9 | 450.44 | |
| PDdB-Pfp | 2101206-44-2 | C17H14F5NO2S2 | 423.42 | Perfluorophenyl 4-Methyl-4-(pyridin-2-Yldisulfanyl)pentanoate; (2,3,4,5,6-pentafluorophenyl) 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate |
| Mal-amide-PEG3-CH2 NHS ester | 2101206-45-3 | C19H25N3O10 | 455.42 | 2, 5-Dioxopyrrolidin-1-yl 15-(2, 5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3, 6, 9-trioxa-12-azapentadecan-1-oate; (2,5-dioxopyrrolidin-1-yl) 2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]acetate |
| NHPI-PEG4-C2-Pfp ester | 2101206-46-4 | C25H24F5NO9 | 577.45 | Perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate; (2,3,4,5,6-pentafluorophenyl) 3-[2-[2-[2-[2-(1,3-dioxoisoindol-2-yl)oxyethoxy]ethoxy]ethoxy]ethoxy]propanoate |
| NHPI-PEG2-C2-Pfp ester | 2101206-47-5 | C21H16F5NO7 | 489.35 | Perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate; (2,3,4,5,6-pentafluorophenyl) 3-[2-[2-(1,3-dioxoisoindol-2-yl)oxyethoxy]ethoxy]propanoate |
| Ald-Ph-amido-PEG2-C2-Pfp ester | 2101206-60-2 | C21H18F5NO6 | 475.36 | Perfluorophenyl 3-(2-(2-(4-Formylbenzamido)ethoxy)ethoxy)propanoate; (2,3,4,5,6-pentafluorophenyl) 3-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]propanoate |
| Ald-Ph-amido-PEG1-C2-Pfp ester | 2101206-67-9 | C19H14F5NO5 | 431.31 | Perfluorophenyl 3-(2-(4-Formylbenzamido)ethoxy)propanoate; (2,3,4,5,6-pentafluorophenyl) 3-[2-[(4-formylbenzoyl)amino]ethoxy]propanoate |
| Ald-Ph-amido-PEG1-C2-NHS ester | 2101206-80-6 | C17H18N2O7 | 362.33 | 2,5-Dioxopyrrolidin-1-Yl 3-(2-(4-Formylbenzamido)ethoxy)propanoate |
| SPDMV-sulfo | 2101206-86-2 | C15H18N2O7S3 | 434.51 | 1-(4-Methyl-4-(Pyridin-2-Yldisulfanyl)pentanoyloxy)-2,5-Dioxopyrrolidine-3-Sulfonic Acid |
| NHPI-PEG3-C2-Pfp ester | 2101206-87-3 | C23H20F5NO8 | 533.4 | Perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-Yloxy)ethoxy)ethoxy)ethoxy)propanoate; (2,3,4,5,6-pentafluorophenyl) 3-[2-[2-[2-(1,3-dioxoisoindol-2-yl)oxyethoxy]ethoxy]ethoxy]propanoate |
| (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]propanoate | 216145-65-2 | C17H29NO10 | 407.41 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]propanoate; Propanoic Acid, 3-[(14-hydroxy-3, 6, 9, 12-tetraoxatetradec-1-yl)oxy]-, 2, 5-dioxo-1-pyrrolidinyl Ester |
| 2,5-dioxopyrrolidin-1-yl 3-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)oxy)propanoate | 221553-42-0 | C11H10N2O7 | 282.21 |